data_2mkk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkk _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.478 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo . . . . . 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 . . . . . 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.471 ' H ' HG11 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . 0.441 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.577 ' H ' HD11 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 110.649 -0.13 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.512 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.403 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.432 ' H ' HD21 ' A' ' 288' ' ' LEU . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 257' ' ' ARG . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 261' ' ' SER . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.512 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.542 ' HB ' ' HH ' ' A' ' 404' ' ' TYR . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.462 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.542 ' HH ' ' HB ' ' A' ' 352' ' ' VAL . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.409 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.401 ' HE3' ' HA3' ' A' ' 242' ' ' GLY . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.549 HG11 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.431 ' H ' ' HB2' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.549 ' H ' HG11 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.542 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.405 ' CD2' ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.444 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.444 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.7 tttp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.794 0.33 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.407 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.436 ' C ' ' H ' ' A' ' 288' ' ' LEU . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 286' ' ' PHE . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 367' ' ' ALA . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.459 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.42 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 340' ' ' ARG . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 411' ' ' ALA . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.436 ' H ' ' HE3' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.439 ' H ' ' CG2' ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.415 ' HZ2' ' HB3' ' A' ' 324' ' ' LYS . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.478 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.478 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . 0.481 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.467 ' CD2' ' H ' ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.481 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.436 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.439 ' HE1' ' HE1' ' A' ' 321' ' ' MET . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 248' ' ' THR . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 246' ' ' ASP . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 72.5 tttt . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.439 ' HE1' ' HE1' ' A' ' 245' ' ' TRP . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.544 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.544 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.436 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.482 ' H ' HD22 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.426 ' H ' HD21 ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.43 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.467 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.467 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.456 ' CD2' HG22 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.472 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.686 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.686 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.438 ' HB ' ' HH ' ' A' ' 404' ' ' TYR . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 356' ' ' ALA . 23.4 m-70 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.456 HG22 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.23 0.066 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.438 ' HH ' ' HB ' ' A' ' 352' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 248' ' ' THR . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 N--CA 1.457 -0.083 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.496 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.416 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.5 HG21 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.502 HD11 ' H ' ' A' ' 335' ' ' ASP 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.502 ' H ' HD11 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.502 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.502 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.448 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.408 ' N ' ' CD1' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.448 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.574 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo . . . . . 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 281' ' ' TYR . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 . . . . . 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.502 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.461 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.534 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 384' ' ' THR . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 382' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 408' ' ' VAL . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 411' ' ' ALA . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.468 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.478 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo -74.14 -13.54 23.46 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 62.73 21.84 63.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.859 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 52.73 33.19 13.45 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.736 0.768 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.8 t70 55.16 19.67 2.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.375 1.07 . . . . 0.0 112.867 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.91 67.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.707 -0.496 . . . . 0.0 112.566 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.49 -29.52 16.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.887 0.843 . . . . 0.0 110.935 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.9 m80 41.22 54.33 7.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.0 0.92 . . . . 0.0 112.541 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.23 -18.32 30.47 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.754 2.302 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -145.46 160.83 41.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.023 0.929 . . . . 0.0 109.543 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 277' ' ' PRO . 20.8 p -145.18 59.01 5.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 276' ' ' CYS . 32.4 Cg_exo -62.15 161.45 26.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.004 2.469 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.84 -10.68 25.12 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.492 2.794 . . . . 0.0 111.174 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.18 159.28 18.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.301 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.414 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -166.51 -53.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -152.59 94.91 3.13 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.337 1.055 . . . . 0.0 109.271 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.61 32.96 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.666 3.577 . . . . 0.0 111.94 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.86 -172.54 0.67 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.871 0.868 . . . . 0.0 111.444 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.6 m -57.7 148.29 57.87 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 308' ' ' GLY . 94.5 Cg_endo -73.53 0.09 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.053 3.168 . . . . 0.0 111.95 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.58 34.78 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.519 0.728 . . . . 0.0 111.056 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 306' ' ' PRO . . . 81.25 5.0 90.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 42.5 tp -90.31 -19.29 24.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.011 0.906 . . . . 0.0 111.034 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t -76.47 151.24 36.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.891 0.877 . . . . 0.0 110.287 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.471 ' H ' HG11 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.511 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.577 ' H ' HD11 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.453 ' CG2' ' HA ' ' A' ' 390' ' ' PRO . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 387' ' ' HIS . 1.4 t70 -160.62 -178.27 6.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 61.02 -17.34 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.673 2.389 . . . . 0.0 114.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.464 ' CG ' ' H ' ' A' ' 388' ' ' LYS . 28.7 t-80 -160.03 -178.26 6.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 55.0 mtmt -77.98 -10.24 59.5 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.292 0.637 . . . . 0.0 111.968 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -95.48 161.2 28.61 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 122.797 0.439 . . . . 0.0 110.779 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 384' ' ' THR . 50.8 Cg_exo -58.46 -179.79 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.014 3.81 . . . . 0.0 115.676 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.1 tt 54.82 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 128.683 2.793 . . . . 0.0 115.884 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 176.64 -55.49 0.11 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.442 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m -154.93 156.04 35.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.711 0.755 . . . . 0.0 110.649 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.449 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 111.095 2.895 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.633 -3.245 . 0.3 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.468 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.842 1 O4'-C1'-N19 112.653 4.453 . 0.3 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.276 5.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.539 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C5'-C4'-C3' 109.329 -4.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.512 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.403 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.432 ' H ' HD21 ' A' ' 288' ' ' LEU . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 257' ' ' ARG . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.37 15.22 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.98 -155.45 42.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -132.48 22.31 4.35 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.487 0.715 . . . . 0.0 111.861 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.99 -10.53 59.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -74.97 -176.67 38.18 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -68.16 -27.0 66.04 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.538 -0.39 . . . . 0.0 110.432 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -157.51 137.14 8.49 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.08 -15.45 25.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.196 2.598 . . . . 0.0 113.122 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -128.3 172.3 11.19 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.372 0.669 . . . . 0.0 111.38 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 61.8 m 49.6 45.52 2.93 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.4 161.24 44.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.522 2.148 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.78 -31.88 93.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.418 2.745 . . . . 0.0 112.495 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.462 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 59.1 mtpt -143.06 154.72 44.24 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.874 1.27 . . . . 0.0 107.78 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.447 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.432 HD21 ' H ' ' A' ' 261' ' ' SER . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 65.06 -154.43 0.28 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.0 133.17 22.89 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 118.51 0.595 . . . . 0.0 112.171 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.58 -19.66 48.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.487 2.791 . . . . 0.0 111.586 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 170.06 19.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.975 0.51 . . . . 0.0 111.052 172.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.2 t -149.29 152.5 35.97 Favored Pre-proline 0 C--O 1.234 0.252 0 C-N-CA 123.639 0.776 . . . . 0.0 109.145 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.72 -8.75 6.15 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.567 2.844 . . . . 0.0 113.998 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -102.98 5.89 38.56 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.18 75.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.581 0.61 . . . . 0.0 113.268 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.64 146.71 51.45 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.382 1.091 . . . . 0.0 110.281 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m -154.4 105.9 2.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.431 1.092 . . . . 0.0 109.121 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.512 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.542 ' HB ' ' HH ' ' A' ' 404' ' ' TYR . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.57 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.462 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.68 137.03 34.58 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 50.77 14.9 0.2 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.09 1.756 . . . . 0.0 115.61 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -145.19 164.85 30.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.431 1.014 . . . . 0.0 111.21 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -103.35 19.22 20.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.469 1.107 . . . . 0.0 111.368 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.82 87.3 55.17 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.37 171.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.374 1 C-N-CA 127.021 5.147 . . . . 0.0 117.102 -170.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 5.8 tp -134.29 -13.62 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.071 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 137.97 -2.84 3.03 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.717 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m -71.27 103.53 2.86 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.896 1.348 . . . . 0.0 108.91 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.542 ' HH ' ' HB ' ' A' ' 352' ' ' VAL . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.409 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.462 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C5'-C4'-C3' 110.889 -3.074 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 O4'-C1'-N19 111.775 3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.447 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.097 0 O4'-C1'-N19 112.026 3.826 . 0.174 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.492 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.65 1 O4'-C1'-N19 114.671 6.471 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.57 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.836 0 C3'-C2'-C1' 104.827 3.697 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.453 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.401 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.34 158.73 44.41 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.3 155.8 50.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.88 2.48 30.24 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.354 -0.498 . . . . 0.0 111.852 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.64 -17.37 53.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.931 0.332 . . . . 0.0 111.163 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -96.27 1.73 62.75 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.48 179.04 6.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.557 0.743 . . . . 0.0 110.535 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -72.77 148.85 90.08 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 -13.48 15.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.753 2.968 . . . . 0.0 113.896 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.3 155.59 49.13 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.674 0.79 . . . . 0.0 109.494 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 88.9 m -134.69 155.96 79.05 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 122.708 0.403 . . . . 0.0 111.448 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.37 171.13 14.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.342 3.361 . . . . 0.0 110.127 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.79 -8.1 20.34 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.4 2.734 . . . . 0.0 111.715 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -74.37 157.02 36.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.456 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.452 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 302' ' ' ASP . 4.5 t60 63.75 -151.18 0.31 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' A' ' 301' ' ' HIS . 65.8 m-20 -121.27 137.91 27.4 Favored Pre-proline 0 C--N 1.34 0.162 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -167.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.0 -24.5 20.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.494 2.796 . . . . 0.0 111.602 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.7 167.08 25.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 111.965 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 51.2 m -149.5 158.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 125.025 1.33 . . . . 0.0 109.067 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.54 -12.86 18.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.381 2.721 . . . . 0.0 112.502 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -86.79 7.14 28.2 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.68 7.4 85.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 61.5 tp -79.48 151.83 30.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 110.859 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m -148.43 115.45 6.1 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.568 ' HD2' ' C6 ' ' B' ' 1' ' ' ' U' . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.549 HG11 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.431 ' H ' ' HB2' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.549 ' H ' HG11 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.542 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.542 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.33 130.07 34.67 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 49.01 19.54 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.324 1.45 . . . . 0.0 114.511 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -146.88 -162.35 1.52 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.824 0.849 . . . . 0.0 109.539 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -141.72 7.65 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.789 0.836 . . . . 0.0 111.675 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.558 ' H ' ' CD ' ' A' ' 390' ' ' PRO . 63.0 m-85 -134.84 -29.82 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.558 ' CD ' ' H ' ' A' ' 389' ' ' TYR . 97.5 Cg_endo -76.44 -113.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.842 2.361 . . . . 0.0 112.229 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.73 162.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.449 0.699 . . . . 0.0 110.286 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -174.18 -42.81 0.05 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t -164.61 172.87 12.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.344 0.572 . . . . 0.0 110.67 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.405 ' CD2' ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.568 ' C6 ' ' HD2' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C5'-C4'-C3' 112.11 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.821 -3.119 . 0.254 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.456 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 O4'-C1'-N19 112.522 4.322 . 0.092 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.452 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.305 1 O4'-C1'-N19 112.953 4.753 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 C5'-C4'-C3' 110.068 -3.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.444 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.444 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -80.01 2.19 8.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.51 -150.97 4.39 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.628 0.632 . . . . 0.0 112.07 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.57 27.48 10.46 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.724 0.81 . . . . 0.0 111.927 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.91 7.94 3.77 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.628 0.771 . . . . 0.0 110.589 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.25 175.24 44.72 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -149.59 169.06 21.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.627 0.771 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.474 ' H ' ' CD ' ' A' ' 274' ' ' PRO . 83.8 t60 -115.32 -37.18 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.958 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.474 ' CD ' ' H ' ' A' ' 273' ' ' HIS . 51.8 Cg_exo -59.15 154.75 43.75 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.994 2.462 . . . . 0.0 112.404 176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -84.22 7.8 17.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.359 0.664 . . . . 0.0 111.829 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 69.2 m -68.21 161.56 67.71 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.067 0.547 . . . . 0.0 110.519 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.95 160.07 13.26 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.058 3.172 . . . . 0.0 112.327 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.49 -2.14 11.71 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.815 3.01 . . . . 0.0 112.2 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.442 ' HE3' " C5'" ' B' ' 1' ' ' ' U' . 65.7 tttp -69.79 154.91 41.33 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.614 0.366 . . . . 0.0 110.342 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.421 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.469 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.29 154.46 36.81 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -139.82 138.47 19.88 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -69.74 -9.05 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.053 3.169 . . . . 0.0 112.993 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 5.2 mp -142.67 166.33 24.95 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.741 0.781 . . . . 0.0 110.763 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.4 t -147.1 161.28 37.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.559 1.544 . . . . 0.0 107.51 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -55.98 -6.75 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.075 2.517 . . . . 0.0 113.635 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -108.54 7.82 26.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.505 0.722 . . . . 0.0 111.971 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.67 37.1 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.914 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.02 167.5 23.19 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.934 1.367 . . . . 0.0 112.342 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 144.03 34.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.44 0.296 . . . . 0.0 110.531 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.556 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -168.53 -34.6 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -82.09 129.13 34.73 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.201 0.6 . . . . 0.0 110.45 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 47.83 36.31 5.76 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.023 0.529 . . . . 0.0 111.57 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 pttp 49.0 27.69 1.76 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.204 1.402 . . . . 0.0 113.767 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -134.74 162.5 57.31 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.679 0.792 . . . . 0.0 110.167 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.77 143.74 37.26 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.723 2.949 . . . . 0.0 111.881 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.435 HG12 ' C6 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -147.84 -27.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.78 29.02 9.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.239 0.472 . . . . 0.0 112.407 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t -110.18 149.91 29.41 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 117.585 0.692 . . . . 0.0 109.92 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.442 " C5'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 110.941 -3.039 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 1 C5'-C4'-C3' 108.033 -4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.421 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 114.129 5.929 . 0.036 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.469 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 104.462 3.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.556 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.364 4.164 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.524 ' H ' HD11 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.407 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo -77.77 -5.22 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.59 13.32 82.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.44 83.56 7.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.44 168.21 17.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.332 0.653 . . . . 0.0 111.195 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.11 27.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -130.11 174.8 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.888 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -141.01 142.97 29.62 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.048 0.539 . . . . 0.0 110.149 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.99 -19.93 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.642 2.895 . . . . 0.0 114.768 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.23 6.0 2.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.618 0.644 . . . . 0.0 112.724 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.32 160.86 66.46 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.824 0.45 . . . . 0.0 110.48 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.17 170.79 7.22 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.359 2.706 . . . . 0.0 110.334 175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -49.77 150.1 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.778 2.986 . . . . 0.0 112.526 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -142.43 178.83 7.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.436 ' C ' ' H ' ' A' ' 288' ' ' LEU . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 286' ' ' PHE . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -150.77 154.43 37.32 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.14 131.45 14.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.97 -13.96 42.27 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.244 3.296 . . . . 0.0 114.169 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.74 171.93 18.63 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.423 1.011 . . . . 0.0 112.548 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 t -149.69 157.77 38.14 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 125.003 1.321 . . . . 0.0 107.795 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -11.67 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.052 2.501 . . . . 0.0 112.805 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.76 6.73 47.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.548 0.739 . . . . 0.0 111.694 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 82.81 21.38 59.66 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.678 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.62 162.02 36.56 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.701 1.25 . . . . 0.0 112.79 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p -80.31 153.6 28.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.842 0.457 . . . . 0.0 109.786 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.604 ' CD ' ' C6 ' ' B' ' 1' ' ' ' U' . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 367' ' ' ALA . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.459 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.441 ' CD1' " H1'" ' B' ' 5' ' ' ' A' . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.42 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 340' ' ' ARG . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.04 16.72 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 55.81 24.26 7.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 388' ' ' LYS . 28.5 t-80 -100.78 -147.24 0.35 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 99.0 mttt -75.13 73.17 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.521 0.729 . . . . 0.0 111.017 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.422 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 21.2 m-85 58.41 45.27 1.33 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.469 ' HG3' ' H ' ' A' ' 387' ' ' HIS . 97.5 Cg_endo -73.21 -163.21 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.401 3.401 . . . . 0.0 110.664 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.7 tt -165.17 154.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.115 0.966 . . . . 0.0 109.386 -172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -159.45 -32.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.413 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t -165.15 152.32 10.79 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.942 1.371 . . . . 0.0 111.896 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 411' ' ' ALA . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.604 ' C6 ' ' CD ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 O4'-C1'-N19 112.367 4.167 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 0 C5'-C4'-C3' 109.606 -3.93 . 0.182 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.417 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 114.146 5.946 . 0.231 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.484 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 O4'-C1'-N19 111.448 3.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.441 " H1'" ' CD1' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 C5'-C4'-C3' 110.098 -3.601 . 0.161 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.599 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.436 ' H ' ' HE3' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 269' ' ' LYS . 41.8 Cg_endo -59.41 141.38 97.46 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.12 -16.55 1.58 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.971 0.796 . . . . 0.0 112.435 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 267' ' ' PRO . 50.3 tttm 47.57 31.32 1.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 112.131 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.24 146.39 39.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.833 0.453 . . . . 0.0 110.903 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.93 -171.74 55.15 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.25 11.72 10.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.264 0.626 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -139.85 156.11 70.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.948 0.899 . . . . 0.0 109.465 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.56 156.86 44.69 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.887 2.392 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -115.7 -176.26 2.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.239 0.616 . . . . 0.0 110.804 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.8 p -60.39 159.84 21.21 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.485 0.314 . . . . 0.0 110.597 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.03 123.05 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.416 2.744 . . . . 0.0 112.52 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.84 51.46 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.872 1 C-N-CA 125.301 4.001 . . . . 0.0 110.861 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.602 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 5.9 tmtm? 61.4 -67.58 0.06 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.782 1.633 . . . . 0.0 113.204 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.464 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.439 ' CG2' ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.439 ' H ' ' CG2' ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -138.48 156.35 47.62 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.22 128.32 7.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.79 -6.63 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.453 2.769 . . . . 0.0 113.512 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.87 177.6 10.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.937 0.875 . . . . 0.0 112.114 173.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.3 t -149.74 158.45 37.4 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 124.998 1.319 . . . . 0.0 107.721 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.19 -9.09 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.841 2.361 . . . . 0.0 112.567 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.22 0.24 50.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.359 0.664 . . . . 0.0 112.009 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.54 18.38 45.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.121 -0.821 . . . . 0.0 115.143 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.62 162.35 39.3 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.876 1.338 . . . . 0.0 112.722 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p -72.14 145.25 48.24 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.265 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.415 ' HZ2' ' HB3' ' A' ' 324' ' ' LYS . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.403 ' CE2' ' HA ' ' A' ' 390' ' ' PRO . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.478 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.478 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.481 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.467 ' CD2' ' H ' ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -65.3 -1.18 2.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 54.76 20.58 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.59 1.156 . . . . 0.0 113.774 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.08 -27.97 3.8 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.15 0.58 . . . . 0.0 111.332 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -136.07 0.04 2.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.229 0.612 . . . . 0.0 110.506 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.492 ' N ' ' HD3' ' A' ' 390' ' ' PRO . 59.6 m-85 51.0 41.19 0.94 Allowed Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 389' ' ' TYR . 35.9 Cg_endo -100.08 -54.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.209 1.939 . . . . 0.0 114.244 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 392' ' ' GLY . 3.5 tp -162.63 155.37 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.603 0.761 . . . . 0.0 110.211 -173.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 391' ' ' ILE . . . 178.48 -38.84 0.08 OUTLIER Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.437 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t -168.53 -150.39 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.481 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.602 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.963 1 O4'-C1'-N19 112.3 4.1 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.599 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 113.357 5.157 . 0.066 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.464 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 111.904 3.704 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 109.789 -3.808 . 0.019 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.436 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.439 ' HE1' ' HE1' ' A' ' 321' ' ' MET . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 248' ' ' THR . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 246' ' ' ASP . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.71 -2.42 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 86.07 122.92 1.38 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -141.23 30.78 1.76 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.483 0.713 . . . . 0.0 110.53 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.05 153.61 17.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.71 0.404 . . . . 0.0 111.184 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.05 32.22 1.55 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 54.81 39.85 31.64 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.511 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 63.6 t-80 -135.08 145.33 53.87 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 108.494 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 57.2 Cg_endo -64.5 -4.23 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.617 2.878 . . . . 0.0 113.061 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -142.57 156.36 45.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.386 0.539 . . . . 0.0 110.366 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.56 156.63 90.27 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.307 0.643 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.32 159.27 53.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.618 2.879 . . . . 0.0 111.477 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.79 173.76 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.344 3.363 . . . . 0.0 111.532 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.467 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 72.5 tttt 51.51 38.39 22.06 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.156 0.983 . . . . 0.0 112.251 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CG ' ' C4 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -151.15 153.36 34.84 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -147.25 114.21 4.18 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -91.76 26.77 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 125.982 4.455 . . . . 0.0 113.558 -171.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mp -68.22 -41.17 81.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -167.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 46.8 t -159.26 139.87 9.07 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 120.586 1.539 . . . . 0.0 112.855 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.36 1.22 3.19 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.6 2.867 . . . . 0.0 112.063 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.84 18.67 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.193 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.41 25.22 9.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 31.5 tp -134.19 9.64 3.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.581 0.752 . . . . 0.0 110.975 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p -115.76 39.03 3.12 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.166 0.986 . . . . 0.0 110.348 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.439 ' HE1' ' HE1' ' A' ' 245' ' ' TRP . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.544 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.544 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.436 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 391' ' ' ILE . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 386' ' ' LYS . 27.4 t0 -136.91 -178.49 5.21 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.439 ' H ' ' CG ' ' A' ' 385' ' ' ASP . 40.7 ttmt -51.7 154.86 1.83 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.28 1.032 . . . . 0.0 111.243 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -58.81 -11.14 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.476 1.11 . . . . 0.0 113.489 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -73.42 -29.73 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 110.944 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -154.74 58.16 1.94 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.057 0.943 . . . . 0.0 109.819 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.28 168.22 22.85 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.8 2.333 . . . . 0.0 111.217 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 6.2 tp 41.12 78.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.681 1.192 . . . . 0.0 112.198 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.11 -1.26 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.69 -1.061 . . . . 0.0 115.212 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p -165.26 159.52 17.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.577 1.689 . . . . 0.0 112.536 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.482 ' H ' HD22 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.467 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 O4'-C1'-N19 111.506 3.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 0 C3'-C2'-C1' 104.673 3.526 . 0.309 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 O4'-C1'-N19 113.259 5.059 . 0.169 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.453 ' C4 ' ' CG ' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 O4'-C1'-N19 111.648 3.448 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 107.71 -5.194 . 0.579 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.43 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.467 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo -83.27 -10.5 10.03 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.4 13.63 77.23 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.574 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -83.95 15.15 3.53 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.771 0.829 . . . . 0.0 111.859 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.55 165.69 24.78 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.211 0.604 . . . . 0.0 110.754 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.39 1.48 87.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.252 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -146.38 163.88 34.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.439 0.696 . . . . 0.0 110.458 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 23.5 t60 47.35 54.14 15.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.703 0.801 . . . . 0.0 112.187 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.32 169.71 20.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.883 3.055 . . . . 0.0 111.21 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.21 157.41 45.47 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.612 0.765 . . . . 0.0 109.833 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.51 -52.02 1.43 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.457 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.29 150.55 25.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.157 1.904 . . . . 0.0 110.07 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.8 122.95 7.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.283 2.655 . . . . 0.0 109.917 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -156.37 153.18 28.54 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.471 ' CD2' ' C2 ' ' B' ' 4' ' ' ' U' . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 67.1 -149.16 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.09 125.0 27.15 Favored Pre-proline 0 N--CA 1.461 0.121 0 CA-C-N 118.937 0.789 . . . . 0.0 112.554 -168.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.92 -35.23 12.54 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.907 2.405 . . . . 0.0 112.137 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.62 159.06 24.1 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.39 0.276 . . . . 0.0 111.576 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 m -150.9 156.96 35.86 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 123.921 0.888 . . . . 0.0 109.314 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.1 -13.64 20.12 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.5 2.8 . . . . 0.0 112.394 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -88.75 5.8 41.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.71 0.804 . . . . 0.0 111.939 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.32 82.71 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.839 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.41 144.68 54.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.871 0.835 . . . . 0.0 110.519 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m -162.42 80.48 0.52 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.305 1.042 . . . . 0.0 108.587 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.568 ' HE3' " C1'" ' B' ' 1' ' ' ' U' . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.456 ' CD2' HG22 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.472 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.472 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.686 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.686 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.438 ' HB ' ' HH ' ' A' ' 404' ' ' TYR . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' A' ' 356' ' ' ALA . 23.4 m-70 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.473 ' HE1' ' C4 ' ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.456 HG22 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.14 -178.98 3.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -151.76 17.93 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -129.85 -30.21 2.05 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.704 -0.622 . . . . 0.0 112.452 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -135.79 -13.95 1.9 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.731 0.812 . . . . 0.0 110.908 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -142.38 166.38 21.46 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.102 0.961 . . . . 0.0 109.087 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -92.35 -169.94 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.961 3.774 . . . . 0.0 110.43 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.401 ' CG1' ' HA ' ' A' ' 384' ' ' THR . 10.9 tt -137.32 157.22 34.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 CA-C-O 120.942 0.401 . . . . 0.0 112.018 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.66 15.91 57.51 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.15 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t -145.2 164.93 29.83 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 118.295 1.048 . . . . 0.0 113.512 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.438 ' HH ' ' HB ' ' A' ' 352' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.568 " C1'" ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 C5'-C4'-C3' 109.309 -4.127 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.881 2 C3'-C2'-C1' 105.6 4.555 OUTLIER-DELTA 0.055 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.473 ' C4 ' ' HE1' ' A' ' 360' ' ' MET . . . . . . . . 0 O4'--C4' 1.415 -3.179 0 O4'-C1'-N19 112.069 3.869 . 0.292 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.471 ' C2 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 112.091 3.891 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.482 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 C5'-C4'-C3' 108.426 -4.716 . 0.31 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.471 ' HA2' H5'' ' B' ' 1' ' ' ' U' . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 248' ' ' THR . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.437 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 269' ' ' LYS . 57.4 Cg_endo -78.18 -174.02 2.07 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.39 16.21 0.26 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.482 1.039 . . . . 0.0 113.921 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 267' ' ' PRO . 28.9 mtpp -86.2 16.81 4.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.169 0.985 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.31 157.56 19.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.696 0.799 . . . . 0.0 111.333 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.7 -172.29 42.88 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.28 -6.59 59.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.542 0.737 . . . . 0.0 111.302 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -64.82 145.08 98.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.64 158.88 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.729 2.953 . . . . 0.0 113.489 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.43 11.84 9.59 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.642 0.777 . . . . 0.0 111.848 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 84.4 m -127.03 58.44 29.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.613 0.765 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.35 160.27 50.47 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.252 2.635 . . . . 0.0 110.813 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.61 -14.17 34.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.017 3.145 . . . . 0.0 113.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.535 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 22.6 tptm -151.88 143.62 23.65 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.289 0.636 . . . . 0.0 109.673 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.467 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CE2' ' C2 ' ' B' ' 4' ' ' ' U' . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.496 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.416 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -160.16 -44.91 0.05 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -156.37 104.89 2.03 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.44 -16.06 34.64 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.293 2.662 . . . . 0.0 113.976 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.49 165.79 34.69 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.919 0.781 . . . . 0.0 112.472 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 t -144.41 154.33 56.69 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.351 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.16 -11.51 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.351 2.701 . . . . 0.0 113.485 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.66 10.42 41.38 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.236 0.614 . . . . 0.0 111.381 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.75 89.69 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.24 -0.755 . . . . 0.0 114.789 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.524 HD21 ' H ' ' A' ' 309' ' ' LEU . 1.6 pt? -94.52 177.2 6.01 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.652 1.226 . . . . 0.0 111.658 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p -134.1 160.32 38.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.358 1.463 . . . . 0.0 109.15 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.67 ' HE3' ' C6 ' ' B' ' 1' ' ' ' U' . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.5 HG21 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.502 HD11 ' H ' ' A' ' 335' ' ' ASP 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.502 ' H ' HD11 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.502 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.502 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.409 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.448 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . 0.441 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 13.1 t70 -90.19 128.97 36.5 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.424 ' HE2' HG21 ' A' ' 285' ' ' VAL . 49.2 tptt -160.88 148.5 15.67 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.614 0.365 . . . . 0.0 110.547 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 48.3 -80.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.495 1.918 . . . . 0.0 113.639 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.59 3.93 23.34 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 122.815 0.446 . . . . 0.0 111.487 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 41.6 p90 44.19 51.53 8.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 112.519 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.56 -21.34 25.88 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.473 2.115 . . . . 0.0 113.852 -170.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.557 HG21 ' H ' ' A' ' 392' ' ' GLY . 7.7 tt -157.69 -71.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.202 1.364 . . . . 0.0 114.121 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.557 ' H ' HG21 ' A' ' 391' ' ' ILE . . . 81.57 105.2 0.36 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.636 0.636 . . . . 0.0 111.662 -171.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t 53.73 -163.21 0.11 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.528 1.131 . . . . 0.0 111.793 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.448 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.67 ' C6 ' ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.914 1 C5'-C4'-C3' 108.78 -4.48 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 1 C5'-C4'-C3' 108.745 -4.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.467 " H4'" ' CD1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.846 1 O4'-C1'-N19 112.667 4.467 . 0.22 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C2 ' ' CE2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C5'-C4'-C3' 110.888 -3.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.464 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.418 2 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.481 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.481 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.43 ' CZ ' " O4'" ' B' ' 3' ' ' ' U' . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.574 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo -76.71 -161.97 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.34 -3.42 2.89 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.967 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.83 -4.83 51.48 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.88 0.84 . . . . 0.0 110.495 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -65.34 163.45 15.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.669 0.787 . . . . 0.0 111.066 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.71 90.26 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.23 165.41 27.47 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.281 1.032 . . . . 0.0 109.328 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.403 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 57.4 t-80 -68.91 140.11 91.17 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 73.3 Cg_endo -69.18 -9.94 27.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.364 2.71 . . . . 0.0 112.334 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 52.91 30.46 9.26 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.439 1.096 . . . . 0.0 112.885 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 36.1 t 49.57 81.14 0.27 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.134 0.973 . . . . 0.0 111.533 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.97 153.61 72.2 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.318 2.678 . . . . 0.0 110.994 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.11 -13.92 21.06 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.87 3.047 . . . . 0.0 112.04 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -134.05 160.04 38.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.367 0.667 . . . . 0.0 110.207 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.45 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.51 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -159.93 -54.81 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.22 85.46 2.84 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.03 2.14 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.03 3.153 . . . . 0.0 114.325 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.08 168.77 24.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 119.184 0.902 . . . . 0.0 112.873 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 68.3 m -145.71 175.77 2.57 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.776 1.23 . . . . 0.0 108.881 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.67 -11.6 14.99 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.121 2.547 . . . . 0.0 111.777 170.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 309' ' ' LEU . 19.3 t0 -115.64 173.92 6.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.56 1.544 . . . . 0.0 109.171 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -66.12 10.98 0.53 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.001 0.81 . . . . 0.0 113.29 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 307' ' ' ASP . 42.5 tp -73.26 150.31 42.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.962 0.905 . . . . 0.0 111.096 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.401 ' H ' HD12 ' A' ' 309' ' ' LEU . 59.2 m -139.17 144.15 38.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.362 1.065 . . . . 0.0 108.412 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.502 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.461 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.534 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 384' ' ' THR . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 382' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.2 166.18 24.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -81.04 -37.29 29.33 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.756 . . . . 0.0 113.003 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -155.41 -10.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -80.26 53.71 1.83 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 44.0 t80 65.29 140.95 0.06 OUTLIER Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 125.975 1.71 . . . . 0.0 108.921 -166.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -56.89 -13.08 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.015 2.477 . . . . 0.0 114.672 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 32.6 pt -143.19 170.83 9.99 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.848 0.749 . . . . 0.0 112.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 126.98 -4.4 7.38 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.48 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t -171.0 160.6 6.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.783 1.292 . . . . 0.0 112.795 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 408' ' ' VAL . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 413' ' ' VAL . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 411' ' ' ALA . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.457 " O4'" ' CE ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.481 0 O4'-C1'-N19 109.706 1.506 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.45 " H4'" ' CE1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 109.82 -3.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.43 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 O4'-C1'-N19 114.153 5.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.51 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.461 0 C5'-C4'-C3' 110.102 -3.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.405 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 112.021 3.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.426 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.469 ' C ' HD13 ' A' ' 262' ' ' LEU . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo . . . . . 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.446 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 . . . . . 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.497 ' H ' HG13 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' PHE . . . . . 0.438 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.759 ' H ' HD12 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 110.649 -0.13 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.438 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 405' ' ' LEU . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 240' ' ' LEU . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.515 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.621 ' HA ' HG22 ' A' ' 255' ' ' THR . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.44 ' N ' HD12 ' A' ' 252' ' ' LEU . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 252' ' ' LEU . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.413 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 288' ' ' LEU . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 262' ' ' LEU . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' A' ' 260' ' ' GLY . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 379' ' ' TYR . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 339' ' ' VAL . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.676 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 405' ' ' LEU . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 262' ' ' LEU . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.405 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HE3' ' HA3' ' A' ' 242' ' ' GLY . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.645 HG13 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.416 ' H ' ' HB1' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.645 ' H ' HG13 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.604 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 411' ' ' ALA . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 407' ' ' ALA . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.503 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 247' ' ' ILE . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 255' ' ' THR . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.7 tttp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.794 0.33 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 423' ' ' LYS . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 360' ' ' MET . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.403 ' H ' ' H ' ' A' ' 359' ' ' GLY . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 366' ' ' LEU . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.667 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 405' ' ' LEU . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 420' ' ' PHE . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 416' ' ' LYS . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 357' ' ' LEU . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HA ' HG22 ' A' ' 255' ' ' THR . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 250' ' ' ALA . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 252' ' ' LEU . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.413 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 263' ' ' SER . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 262' ' ' LEU . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 261' ' ' SER . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 324' ' ' LYS . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 333' ' ' LEU . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 339' ' ' VAL . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.687 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.407 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 430' ' ' LEU . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.409 ' H ' ' HE3' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.455 HG23 ' CD1' ' A' ' 256' ' ' PHE . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 255' ' ' THR . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 262' ' ' LEU . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.585 ' H ' HG22 ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 243' ' ' VAL . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 363' ' ' ALA . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 347' ' ' ASP . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.457 ' N ' HD13 ' A' ' 346' ' ' LEU . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 338' ' ' PHE . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.476 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 416' ' ' LYS . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 262' ' ' LEU . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 72.5 tttt . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.563 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 366' ' ' LEU . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 339' ' ' VAL . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.437 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 382' ' ' ILE . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.667 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 221' ' ' SER . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.414 HG23 ' CD2' ' A' ' 256' ' ' PHE . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 255' ' ' THR . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.44 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.492 ' CD2' HG23 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 333' ' ' LEU . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.491 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 357' ' ' LEU 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 356' ' ' ALA . 7.1 m80 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 360' ' ' MET . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 339' ' ' VAL . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.23 0.066 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.413 ' O ' HG12 ' A' ' 408' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 404' ' ' TYR . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.411 HG23 ' CD2' ' A' ' 256' ' ' PHE . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 262' ' ' LEU . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 N--CA 1.457 -0.083 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.703 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 330' ' ' PRO . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.448 ' HG3' HD21 ' A' ' 296' ' ' LEU . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 332' ' ' VAL 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.501 ' H ' HD13 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.562 ' H ' HG13 ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.495 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 366' ' ' LEU . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.68 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.495 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 426' ' ' ILE . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 224' ' ' LEU . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.459 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 250' ' ' ALA . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 263' ' ' SER . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.458 ' N ' HD13 ' A' ' 262' ' ' LEU . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.596 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo . . . . . 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 281' ' ' TYR . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.777 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 . . . . . 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.462 HD22 ' C ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.528 HD13 ' HB1' ' A' ' 380' ' ' ALA . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 366' ' ' LEU . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 382' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.668 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 224' ' ' LEU . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 430' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.426 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.468 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.469 ' C ' HD13 ' A' ' 262' ' ' LEU . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo -74.14 -13.54 23.46 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 62.73 21.84 63.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.859 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 52.73 33.19 13.45 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.736 0.768 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.8 t70 55.16 19.67 2.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.375 1.07 . . . . 0.0 112.867 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.91 67.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.707 -0.496 . . . . 0.0 112.566 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.49 -29.52 16.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.887 0.843 . . . . 0.0 110.935 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.9 m80 41.22 54.33 7.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.0 0.92 . . . . 0.0 112.541 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.23 -18.32 30.47 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.754 2.302 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -145.46 160.83 41.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.023 0.929 . . . . 0.0 109.543 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 277' ' ' PRO . 20.8 p -145.18 59.01 5.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 276' ' ' CYS . 32.4 Cg_exo -62.15 161.45 26.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.004 2.469 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.84 -10.68 25.12 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.492 2.794 . . . . 0.0 111.174 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.18 159.28 18.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.301 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.4 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.446 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -166.51 -53.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -152.59 94.91 3.13 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.337 1.055 . . . . 0.0 109.271 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.61 32.96 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.666 3.577 . . . . 0.0 111.94 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.86 -172.54 0.67 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.871 0.868 . . . . 0.0 111.444 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.6 m -57.7 148.29 57.87 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.53 0.09 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.053 3.168 . . . . 0.0 111.95 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.58 34.78 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.519 0.728 . . . . 0.0 111.056 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 81.25 5.0 90.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 42.5 tp -90.31 -19.29 24.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.011 0.906 . . . . 0.0 111.034 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t -76.47 151.24 36.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.891 0.877 . . . . 0.0 110.287 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.497 ' H ' HG13 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.527 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.759 ' H ' HD12 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.451 ' CG2' ' HA ' ' A' ' 390' ' ' PRO . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -160.62 -178.27 6.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 61.02 -17.34 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.673 2.389 . . . . 0.0 114.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 388' ' ' LYS . 28.7 t-80 -160.03 -178.26 6.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 55.0 mtmt -77.98 -10.24 59.5 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.292 0.637 . . . . 0.0 111.968 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -95.48 161.2 28.61 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 122.797 0.439 . . . . 0.0 110.779 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 384' ' ' THR . 50.8 Cg_exo -58.46 -179.79 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.014 3.81 . . . . 0.0 115.676 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.1 tt 54.82 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 128.683 2.793 . . . . 0.0 115.884 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 176.64 -55.49 0.11 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.442 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m -154.93 156.04 35.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.711 0.755 . . . . 0.0 110.649 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.438 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 405' ' ' LEU . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 111.095 2.895 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.633 -3.245 . 0.3 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.468 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.842 1 O4'-C1'-N19 112.653 4.453 . 0.3 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.276 5.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.565 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C5'-C4'-C3' 109.329 -4.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 240' ' ' LEU . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.515 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.621 ' HA ' HG22 ' A' ' 255' ' ' THR . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.44 ' N ' HD12 ' A' ' 252' ' ' LEU . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 252' ' ' LEU . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.413 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 288' ' ' LEU . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 262' ' ' LEU . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.37 15.22 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.98 -155.45 42.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -132.48 22.31 4.35 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.487 0.715 . . . . 0.0 111.861 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.99 -10.53 59.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -74.97 -176.67 38.18 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -68.16 -27.0 66.04 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.538 -0.39 . . . . 0.0 110.432 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -157.51 137.14 8.49 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.08 -15.45 25.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.196 2.598 . . . . 0.0 113.122 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -128.3 172.3 11.19 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.372 0.669 . . . . 0.0 111.38 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 61.8 m 49.6 45.52 2.93 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.4 161.24 44.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.522 2.148 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.78 -31.88 93.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.418 2.745 . . . . 0.0 112.495 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.405 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 59.1 mtpt -143.06 154.72 44.24 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.874 1.27 . . . . 0.0 107.78 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' A' ' 260' ' ' GLY . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 65.06 -154.43 0.28 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.0 133.17 22.89 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 118.51 0.595 . . . . 0.0 112.171 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.58 -19.66 48.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.487 2.791 . . . . 0.0 111.586 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.484 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -161.99 170.06 19.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.975 0.51 . . . . 0.0 111.052 172.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.2 t -149.29 152.5 35.97 Favored Pre-proline 0 C--O 1.234 0.252 0 C-N-CA 123.639 0.776 . . . . 0.0 109.145 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.72 -8.75 6.15 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.567 2.844 . . . . 0.0 113.998 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -102.98 5.89 38.56 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.18 75.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.581 0.61 . . . . 0.0 113.268 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.64 146.71 51.45 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.382 1.091 . . . . 0.0 110.281 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m -154.4 105.9 2.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.431 1.092 . . . . 0.0 109.121 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 379' ' ' TYR . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.572 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 339' ' ' VAL . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.68 137.03 34.58 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 50.77 14.9 0.2 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.09 1.756 . . . . 0.0 115.61 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -145.19 164.85 30.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.431 1.014 . . . . 0.0 111.21 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -103.35 19.22 20.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.469 1.107 . . . . 0.0 111.368 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.82 87.3 55.17 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.37 171.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.374 1 C-N-CA 127.021 5.147 . . . . 0.0 117.102 -170.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.43 HD11 ' H3 ' ' B' ' 3' ' ' ' U' . 5.8 tp -134.29 -13.62 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.071 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 137.97 -2.84 3.03 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.717 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m -71.27 103.53 2.86 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.896 1.348 . . . . 0.0 108.91 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.676 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 405' ' ' LEU . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.405 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C5'-C4'-C3' 110.889 -3.074 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 O4'-C1'-N19 111.775 3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.453 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.097 0 O4'-C1'-N19 112.026 3.826 . 0.174 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.492 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.65 1 O4'-C1'-N19 114.671 6.471 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.572 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.836 0 C3'-C2'-C1' 104.827 3.697 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.453 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.452 ' HG ' ' H ' ' A' ' 252' ' ' LEU . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.34 158.73 44.41 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.3 155.8 50.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.88 2.48 30.24 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.354 -0.498 . . . . 0.0 111.852 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.64 -17.37 53.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.931 0.332 . . . . 0.0 111.163 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -96.27 1.73 62.75 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.48 179.04 6.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.557 0.743 . . . . 0.0 110.535 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -72.77 148.85 90.08 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 -13.48 15.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.753 2.968 . . . . 0.0 113.896 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.3 155.59 49.13 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.674 0.79 . . . . 0.0 109.494 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 88.9 m -134.69 155.96 79.05 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 122.708 0.403 . . . . 0.0 111.448 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.37 171.13 14.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.342 3.361 . . . . 0.0 110.127 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.79 -8.1 20.34 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.4 2.734 . . . . 0.0 111.715 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -74.37 157.02 36.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.458 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.452 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.437 ' CG ' ' H ' ' A' ' 302' ' ' ASP . 4.5 t60 63.75 -151.18 0.31 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.437 ' H ' ' CG ' ' A' ' 301' ' ' HIS . 65.8 m-20 -121.27 137.91 27.4 Favored Pre-proline 0 C--N 1.34 0.162 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -167.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.0 -24.5 20.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.494 2.796 . . . . 0.0 111.602 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.7 167.08 25.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 111.965 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 51.2 m -149.5 158.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 125.025 1.33 . . . . 0.0 109.067 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.54 -12.86 18.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.381 2.721 . . . . 0.0 112.502 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -86.79 7.14 28.2 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.68 7.4 85.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 61.5 tp -79.48 151.83 30.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 110.859 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m -148.43 115.45 6.1 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.405 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.558 ' HD2' ' C6 ' ' B' ' 1' ' ' ' U' . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.645 HG13 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.416 ' H ' ' HB1' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.645 ' H ' HG13 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.604 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.33 130.07 34.67 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 49.01 19.54 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.324 1.45 . . . . 0.0 114.511 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -146.88 -162.35 1.52 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.824 0.849 . . . . 0.0 109.539 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -141.72 7.65 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.789 0.836 . . . . 0.0 111.675 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.622 ' H ' ' CD ' ' A' ' 390' ' ' PRO . 63.0 m-85 -134.84 -29.82 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 389' ' ' TYR . 97.5 Cg_endo -76.44 -113.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.842 2.361 . . . . 0.0 112.229 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.73 162.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.449 0.699 . . . . 0.0 110.286 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -174.18 -42.81 0.05 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t -164.61 172.87 12.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.344 0.572 . . . . 0.0 110.67 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.67 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 411' ' ' ALA . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 407' ' ' ALA . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.558 ' C6 ' ' HD2' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C5'-C4'-C3' 112.11 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.408 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.821 -3.119 . 0.254 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.458 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 O4'-C1'-N19 112.522 4.322 . 0.092 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.452 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.305 1 O4'-C1'-N19 112.953 4.753 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 C5'-C4'-C3' 110.068 -3.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.503 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 247' ' ' ILE . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 255' ' ' THR . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -80.01 2.19 8.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.51 -150.97 4.39 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.628 0.632 . . . . 0.0 112.07 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.57 27.48 10.46 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.724 0.81 . . . . 0.0 111.927 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.91 7.94 3.77 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.628 0.771 . . . . 0.0 110.589 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.25 175.24 44.72 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -149.59 169.06 21.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.627 0.771 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.528 ' H ' ' CD ' ' A' ' 274' ' ' PRO . 83.8 t60 -115.32 -37.18 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.958 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.528 ' CD ' ' H ' ' A' ' 273' ' ' HIS . 51.8 Cg_exo -59.15 154.75 43.75 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.994 2.462 . . . . 0.0 112.404 176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -84.22 7.8 17.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.359 0.664 . . . . 0.0 111.829 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 69.2 m -68.21 161.56 67.71 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.067 0.547 . . . . 0.0 110.519 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.95 160.07 13.26 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.058 3.172 . . . . 0.0 112.327 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.49 -2.14 11.71 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.815 3.01 . . . . 0.0 112.2 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.435 ' HE3' " C5'" ' B' ' 1' ' ' ' U' . 65.7 tttp -69.79 154.91 41.33 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.614 0.366 . . . . 0.0 110.342 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.402 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.469 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.29 154.46 36.81 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -139.82 138.47 19.88 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -69.74 -9.05 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.053 3.169 . . . . 0.0 112.993 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 5.2 mp -142.67 166.33 24.95 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.741 0.781 . . . . 0.0 110.763 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.4 t -147.1 161.28 37.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.559 1.544 . . . . 0.0 107.51 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -55.98 -6.75 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.075 2.517 . . . . 0.0 113.635 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -108.54 7.82 26.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.505 0.722 . . . . 0.0 111.971 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.67 37.1 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.914 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.02 167.5 23.19 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.934 1.367 . . . . 0.0 112.342 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 144.03 34.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.44 0.296 . . . . 0.0 110.531 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.561 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 423' ' ' LYS . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 360' ' ' MET . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.403 ' H ' ' H ' ' A' ' 359' ' ' GLY . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.441 ' O ' HD13 ' A' ' 366' ' ' LEU . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -168.53 -34.6 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -82.09 129.13 34.73 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.201 0.6 . . . . 0.0 110.45 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 47.83 36.31 5.76 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.023 0.529 . . . . 0.0 111.57 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 pttp 49.0 27.69 1.76 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.204 1.402 . . . . 0.0 113.767 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -134.74 162.5 57.31 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.679 0.792 . . . . 0.0 110.167 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.77 143.74 37.26 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.723 2.949 . . . . 0.0 111.881 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.436 HG12 ' C6 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -147.84 -27.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.78 29.02 9.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.239 0.472 . . . . 0.0 112.407 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t -110.18 149.91 29.41 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 117.585 0.692 . . . . 0.0 109.92 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.667 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 405' ' ' LEU . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 420' ' ' PHE . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 416' ' ' LYS . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 357' ' ' LEU . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.435 " C5'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 110.941 -3.039 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 1 C5'-C4'-C3' 108.033 -4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.402 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 114.129 5.929 . 0.036 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.469 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 104.462 3.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.561 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.364 4.164 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HA ' HG22 ' A' ' 255' ' ' THR . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 250' ' ' ALA . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 252' ' ' LEU . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.413 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 263' ' ' SER . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 262' ' ' LEU . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo -77.77 -5.22 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.59 13.32 82.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.44 83.56 7.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.44 168.21 17.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.332 0.653 . . . . 0.0 111.195 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.11 27.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -130.11 174.8 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.888 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 63.7 t-80 -141.01 142.97 29.62 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.048 0.539 . . . . 0.0 110.149 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 273' ' ' HIS . 52.0 Cg_exo -59.99 -19.93 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.642 2.895 . . . . 0.0 114.768 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.23 6.0 2.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.618 0.644 . . . . 0.0 112.724 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.32 160.86 66.46 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.824 0.45 . . . . 0.0 110.48 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.17 170.79 7.22 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.359 2.706 . . . . 0.0 110.334 175.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -49.77 150.1 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.778 2.986 . . . . 0.0 112.526 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -142.43 178.83 7.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 261' ' ' SER . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -150.77 154.43 37.32 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.14 131.45 14.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.97 -13.96 42.27 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.244 3.296 . . . . 0.0 114.169 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.74 171.93 18.63 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.423 1.011 . . . . 0.0 112.548 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 t -149.69 157.77 38.14 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 125.003 1.321 . . . . 0.0 107.795 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -11.67 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.052 2.501 . . . . 0.0 112.805 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.76 6.73 47.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.548 0.739 . . . . 0.0 111.694 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 82.81 21.38 59.66 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.678 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.62 162.02 36.56 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.701 1.25 . . . . 0.0 112.79 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p -80.31 153.6 28.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.842 0.457 . . . . 0.0 109.786 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.604 ' CD ' ' C6 ' ' B' ' 1' ' ' ' U' . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.43 ' OE1' " H1'" ' B' ' 2' ' ' ' U' . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 333' ' ' LEU . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 339' ' ' VAL . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.687 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.463 ' CD1' " H1'" ' B' ' 5' ' ' ' A' . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.407 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.04 16.72 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 55.81 24.26 7.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.524 ' H ' ' HG3' ' A' ' 390' ' ' PRO . 28.5 t-80 -100.78 -147.24 0.35 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.517 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 99.0 mttt -75.13 73.17 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.521 0.729 . . . . 0.0 111.017 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.422 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 21.2 m-85 58.41 45.27 1.33 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HG3' ' H ' ' A' ' 387' ' ' HIS . 97.5 Cg_endo -73.21 -163.21 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.401 3.401 . . . . 0.0 110.664 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.7 tt -165.17 154.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.115 0.966 . . . . 0.0 109.386 -172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -159.45 -32.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.413 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t -165.15 152.32 10.79 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.942 1.371 . . . . 0.0 111.896 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.468 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 430' ' ' LEU . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.604 ' C6 ' ' CD ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 O4'-C1'-N19 112.367 4.167 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.43 " H1'" ' OE1' ' A' ' 327' ' ' GLN . . . . . . . . 0 O4'--C4' 1.418 -2.915 0 C5'-C4'-C3' 109.606 -3.93 . 0.182 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.417 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 114.146 5.946 . 0.231 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.484 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 O4'-C1'-N19 111.448 3.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.463 " H1'" ' CD1' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 C5'-C4'-C3' 110.098 -3.601 . 0.161 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.599 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.409 ' H ' ' HE3' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.455 HG23 ' CD1' ' A' ' 256' ' ' PHE . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 255' ' ' THR . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 262' ' ' LEU . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -59.41 141.38 97.46 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.12 -16.55 1.58 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.971 0.796 . . . . 0.0 112.435 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 50.3 tttm 47.57 31.32 1.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 112.131 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.24 146.39 39.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.833 0.453 . . . . 0.0 110.903 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.93 -171.74 55.15 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.25 11.72 10.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.264 0.626 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -139.85 156.11 70.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.948 0.899 . . . . 0.0 109.465 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.56 156.86 44.69 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.887 2.392 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -115.7 -176.26 2.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.239 0.616 . . . . 0.0 110.804 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.8 p -60.39 159.84 21.21 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.485 0.314 . . . . 0.0 110.597 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.03 123.05 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.416 2.744 . . . . 0.0 112.52 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.84 51.46 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.872 1 C-N-CA 125.301 4.001 . . . . 0.0 110.861 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.613 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 5.9 tmtm? 61.4 -67.58 0.06 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.782 1.633 . . . . 0.0 113.204 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.464 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.585 ' H ' HG22 ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -138.48 156.35 47.62 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.22 128.32 7.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.79 -6.63 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.453 2.769 . . . . 0.0 113.512 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -153.87 177.6 10.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.937 0.875 . . . . 0.0 112.114 173.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.3 t -149.74 158.45 37.4 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 124.998 1.319 . . . . 0.0 107.721 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.19 -9.09 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.841 2.361 . . . . 0.0 112.567 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.22 0.24 50.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.359 0.664 . . . . 0.0 112.009 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.54 18.38 45.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.121 -0.821 . . . . 0.0 115.143 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.62 162.35 39.3 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.876 1.338 . . . . 0.0 112.722 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p -72.14 145.25 48.24 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.265 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 243' ' ' VAL . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 363' ' ' ALA . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 347' ' ' ASP . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.457 ' N ' HD13 ' A' ' 346' ' ' LEU . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 338' ' ' PHE . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 389' ' ' TYR . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -65.3 -1.18 2.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 54.76 20.58 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.59 1.156 . . . . 0.0 113.774 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.08 -27.97 3.8 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.15 0.58 . . . . 0.0 111.332 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -136.07 0.04 2.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.229 0.612 . . . . 0.0 110.506 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 390' ' ' PRO . 59.6 m-85 51.0 41.19 0.94 Allowed Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 389' ' ' TYR . 35.9 Cg_endo -100.08 -54.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.209 1.939 . . . . 0.0 114.244 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 392' ' ' GLY . 3.5 tp -162.63 155.37 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.603 0.761 . . . . 0.0 110.211 -173.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.446 ' H ' HD12 ' A' ' 391' ' ' ILE . . . 178.48 -38.84 0.08 OUTLIER Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.437 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t -168.53 -150.39 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.476 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.613 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.963 1 O4'-C1'-N19 112.3 4.1 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.599 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 113.357 5.157 . 0.066 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.464 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 111.904 3.704 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 109.789 -3.808 . 0.019 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 416' ' ' LYS . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.403 ' C ' HD13 ' A' ' 262' ' ' LEU . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.71 -2.42 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 86.07 122.92 1.38 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -141.23 30.78 1.76 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.483 0.713 . . . . 0.0 110.53 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.05 153.61 17.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.71 0.404 . . . . 0.0 111.184 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.05 32.22 1.55 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 54.81 39.85 31.64 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.522 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 63.6 t-80 -135.08 145.33 53.87 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 108.494 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 57.2 Cg_endo -64.5 -4.23 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.617 2.878 . . . . 0.0 113.061 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -142.57 156.36 45.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.386 0.539 . . . . 0.0 110.366 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.56 156.63 90.27 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.307 0.643 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.32 159.27 53.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.618 2.879 . . . . 0.0 111.477 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.79 173.76 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.344 3.363 . . . . 0.0 111.532 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.425 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 72.5 tttt 51.51 38.39 22.06 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.156 0.983 . . . . 0.0 112.251 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CG ' ' C4 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -151.15 153.36 34.84 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -147.25 114.21 4.18 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -91.76 26.77 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 125.982 4.455 . . . . 0.0 113.558 -171.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mp -68.22 -41.17 81.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -167.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 46.8 t -159.26 139.87 9.07 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 120.586 1.539 . . . . 0.0 112.855 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.36 1.22 3.19 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.6 2.867 . . . . 0.0 112.063 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.84 18.67 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.193 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.41 25.22 9.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 31.5 tp -134.19 9.64 3.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.581 0.752 . . . . 0.0 110.975 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p -115.76 39.03 3.12 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.166 0.986 . . . . 0.0 110.348 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.563 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 366' ' ' LEU . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 339' ' ' VAL . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.437 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 382' ' ' ILE . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 391' ' ' ILE . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -136.91 -178.49 5.21 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -51.7 154.86 1.83 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.28 1.032 . . . . 0.0 111.243 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -58.81 -11.14 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.476 1.11 . . . . 0.0 113.489 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -73.42 -29.73 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 110.944 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -154.74 58.16 1.94 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.057 0.943 . . . . 0.0 109.819 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.28 168.22 22.85 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.8 2.333 . . . . 0.0 111.217 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 6.2 tp 41.12 78.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.681 1.192 . . . . 0.0 112.198 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.11 -1.26 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.69 -1.061 . . . . 0.0 115.212 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p -165.26 159.52 17.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.577 1.689 . . . . 0.0 112.536 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.667 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 221' ' ' SER . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.425 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 O4'-C1'-N19 111.506 3.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 0 C3'-C2'-C1' 104.673 3.526 . 0.309 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 O4'-C1'-N19 113.259 5.059 . 0.169 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.453 ' C4 ' ' CG ' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 O4'-C1'-N19 111.648 3.448 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 107.71 -5.194 . 0.579 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.414 HG23 ' CD2' ' A' ' 256' ' ' PHE . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 255' ' ' THR . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.44 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo -83.27 -10.5 10.03 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.4 13.63 77.23 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.574 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -83.95 15.15 3.53 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.771 0.829 . . . . 0.0 111.859 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.55 165.69 24.78 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.211 0.604 . . . . 0.0 110.754 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.39 1.48 87.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.252 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -146.38 163.88 34.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.439 0.696 . . . . 0.0 110.458 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 23.5 t60 47.35 54.14 15.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.703 0.801 . . . . 0.0 112.187 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.32 169.71 20.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.883 3.055 . . . . 0.0 111.21 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.21 157.41 45.47 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.612 0.765 . . . . 0.0 109.833 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.51 -52.02 1.43 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.457 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.29 150.55 25.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.157 1.904 . . . . 0.0 110.07 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.8 122.95 7.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.283 2.655 . . . . 0.0 109.917 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -156.37 153.18 28.54 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.441 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.471 ' CD2' ' C2 ' ' B' ' 4' ' ' ' U' . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 67.1 -149.16 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.09 125.0 27.15 Favored Pre-proline 0 N--CA 1.461 0.121 0 CA-C-N 118.937 0.789 . . . . 0.0 112.554 -168.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.92 -35.23 12.54 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.907 2.405 . . . . 0.0 112.137 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.447 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -162.62 159.06 24.1 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.39 0.276 . . . . 0.0 111.576 176.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 m -150.9 156.96 35.86 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 123.921 0.888 . . . . 0.0 109.314 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.1 -13.64 20.12 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.5 2.8 . . . . 0.0 112.394 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -88.75 5.8 41.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.71 0.804 . . . . 0.0 111.939 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.32 82.71 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.839 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.41 144.68 54.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.871 0.835 . . . . 0.0 110.519 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m -162.42 80.48 0.52 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.305 1.042 . . . . 0.0 108.587 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.582 ' HE3' " C1'" ' B' ' 1' ' ' ' U' . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.492 ' CD2' HG23 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 333' ' ' LEU . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.491 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 357' ' ' LEU 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 356' ' ' ALA . 7.1 m80 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 360' ' ' MET . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 339' ' ' VAL . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.14 -178.98 3.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -151.76 17.93 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -129.85 -30.21 2.05 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.704 -0.622 . . . . 0.0 112.452 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -135.79 -13.95 1.9 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.731 0.812 . . . . 0.0 110.908 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.402 ' HB3' ' HD2' ' A' ' 390' ' ' PRO . 78.4 m-85 -142.38 166.38 21.46 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.102 0.961 . . . . 0.0 109.087 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 389' ' ' TYR . 40.2 Cg_endo -92.35 -169.94 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.961 3.774 . . . . 0.0 110.43 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.431 ' CG1' ' HA ' ' A' ' 384' ' ' THR . 10.9 tt -137.32 157.22 34.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 CA-C-O 120.942 0.401 . . . . 0.0 112.018 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.66 15.91 57.51 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.15 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t -145.2 164.93 29.83 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 118.295 1.048 . . . . 0.0 113.512 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.413 ' O ' HG12 ' A' ' 408' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 404' ' ' TYR . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.582 " C1'" ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 C5'-C4'-C3' 109.309 -4.127 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.881 2 C3'-C2'-C1' 105.6 4.555 OUTLIER-DELTA 0.055 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.441 " H4'" ' CD1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.179 0 O4'-C1'-N19 112.069 3.869 . 0.292 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.471 ' C2 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 112.091 3.891 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.511 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 C5'-C4'-C3' 108.426 -4.716 . 0.31 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.47 ' HA2' H5'' ' B' ' 1' ' ' ' U' . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.411 HG23 ' CD2' ' A' ' 256' ' ' PHE . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 262' ' ' LEU . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.18 -174.02 2.07 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.39 16.21 0.26 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.482 1.039 . . . . 0.0 113.921 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -86.2 16.81 4.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.169 0.985 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.31 157.56 19.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.696 0.799 . . . . 0.0 111.333 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.7 -172.29 42.88 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.28 -6.59 59.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.542 0.737 . . . . 0.0 111.302 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 63.4 t60 -64.82 145.08 98.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 273' ' ' HIS . 75.8 Cg_exo -53.64 158.88 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.729 2.953 . . . . 0.0 113.489 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.43 11.84 9.59 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.642 0.777 . . . . 0.0 111.848 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 84.4 m -127.03 58.44 29.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.613 0.765 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.35 160.27 50.47 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.252 2.635 . . . . 0.0 110.813 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.61 -14.17 34.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.017 3.145 . . . . 0.0 113.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.518 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 22.6 tptm -151.88 143.62 23.65 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.289 0.636 . . . . 0.0 109.673 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.468 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CE2' ' C2 ' ' B' ' 4' ' ' ' U' . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.703 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 330' ' ' PRO . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -160.16 -44.91 0.05 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -156.37 104.89 2.03 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.44 -16.06 34.64 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.293 2.662 . . . . 0.0 113.976 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.49 165.79 34.69 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.919 0.781 . . . . 0.0 112.472 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 t -144.41 154.33 56.69 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.351 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.16 -11.51 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.351 2.701 . . . . 0.0 113.485 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.66 10.42 41.38 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.236 0.614 . . . . 0.0 111.381 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.75 89.69 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.24 -0.755 . . . . 0.0 114.789 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 309' ' ' LEU . 1.6 pt? -94.52 177.2 6.01 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.652 1.226 . . . . 0.0 111.658 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p -134.1 160.32 38.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.358 1.463 . . . . 0.0 109.15 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.67 ' HE3' ' C6 ' ' B' ' 1' ' ' ' U' . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.448 ' HG3' HD21 ' A' ' 296' ' ' LEU . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 332' ' ' VAL 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.501 ' H ' HD13 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.562 ' H ' HG13 ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.425 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.495 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 366' ' ' LEU . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.449 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 13.1 t70 -90.19 128.97 36.5 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.417 ' HE2' HG21 ' A' ' 285' ' ' VAL . 49.2 tptt -160.88 148.5 15.67 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.614 0.365 . . . . 0.0 110.547 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 48.3 -80.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.495 1.918 . . . . 0.0 113.639 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.59 3.93 23.34 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 122.815 0.446 . . . . 0.0 111.487 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 41.6 p90 44.19 51.53 8.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 112.519 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.56 -21.34 25.88 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.473 2.115 . . . . 0.0 113.852 -170.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.6 HG23 ' H ' ' A' ' 392' ' ' GLY . 7.7 tt -157.69 -71.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.202 1.364 . . . . 0.0 114.121 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 391' ' ' ILE . . . 81.57 105.2 0.36 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.636 0.636 . . . . 0.0 111.662 -171.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t 53.73 -163.21 0.11 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.528 1.131 . . . . 0.0 111.793 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.68 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.495 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 426' ' ' ILE . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.67 ' C6 ' ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.914 1 C5'-C4'-C3' 108.78 -4.48 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 1 C5'-C4'-C3' 108.745 -4.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.468 " H4'" ' CD1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.846 1 O4'-C1'-N19 112.667 4.467 . 0.22 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C2 ' ' CE2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C5'-C4'-C3' 110.888 -3.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.475 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.418 2 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 224' ' ' LEU . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.459 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.43 ' CZ ' " O4'" ' B' ' 3' ' ' ' U' . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 250' ' ' ALA . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 263' ' ' SER . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.458 ' N ' HD13 ' A' ' 262' ' ' LEU . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.596 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo -76.71 -161.97 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.34 -3.42 2.89 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.967 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.83 -4.83 51.48 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.88 0.84 . . . . 0.0 110.495 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -65.34 163.45 15.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.669 0.787 . . . . 0.0 111.066 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.71 90.26 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.23 165.41 27.47 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.281 1.032 . . . . 0.0 109.328 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 57.4 t-80 -68.91 140.11 91.17 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 73.3 Cg_endo -69.18 -9.94 27.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.364 2.71 . . . . 0.0 112.334 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 52.91 30.46 9.26 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.439 1.096 . . . . 0.0 112.885 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 36.1 t 49.57 81.14 0.27 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.134 0.973 . . . . 0.0 111.533 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.97 153.61 72.2 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.318 2.678 . . . . 0.0 110.994 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.11 -13.92 21.06 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.87 3.047 . . . . 0.0 112.04 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -134.05 160.04 38.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.367 0.667 . . . . 0.0 110.207 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.51 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.777 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -159.93 -54.81 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.22 85.46 2.84 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.03 2.14 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.03 3.153 . . . . 0.0 114.325 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -153.08 168.77 24.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 119.184 0.902 . . . . 0.0 112.873 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 68.3 m -145.71 175.77 2.57 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.776 1.23 . . . . 0.0 108.881 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.67 -11.6 14.99 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.121 2.547 . . . . 0.0 111.777 170.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -115.64 173.92 6.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.56 1.544 . . . . 0.0 109.171 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -66.12 10.98 0.53 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.001 0.81 . . . . 0.0 113.29 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.26 150.31 42.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.962 0.905 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 59.2 m -139.17 144.15 38.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.362 1.065 . . . . 0.0 108.412 172.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.462 HD22 ' C ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.528 HD13 ' HB1' ' A' ' 380' ' ' ALA . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 366' ' ' LEU . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 391' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.2 166.18 24.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -81.04 -37.29 29.33 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.756 . . . . 0.0 113.003 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -155.41 -10.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -80.26 53.71 1.83 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 44.0 t80 65.29 140.95 0.06 OUTLIER Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 125.975 1.71 . . . . 0.0 108.921 -166.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 389' ' ' TYR . 66.2 Cg_exo -56.89 -13.08 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.015 2.477 . . . . 0.0 114.672 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 32.6 pt -143.19 170.83 9.99 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.848 0.749 . . . . 0.0 112.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 126.98 -4.4 7.38 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.48 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t -171.0 160.6 6.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.783 1.292 . . . . 0.0 112.795 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.668 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 224' ' ' LEU . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 430' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.457 " O4'" ' CE ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.481 0 O4'-C1'-N19 109.706 1.506 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.485 " H4'" ' CE1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 109.82 -3.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.43 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 O4'-C1'-N19 114.153 5.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.51 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.461 0 C5'-C4'-C3' 110.102 -3.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.421 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 112.021 3.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.426 ' H ' HD22 ' A' ' 224' ' ' LEU . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 262' ' ' LEU . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo . . . . . 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.446 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 288' ' ' LEU . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 . . . . . 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.497 ' H ' HG13 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . 0.438 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.759 ' H ' HD12 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 110.649 -0.13 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.438 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 405' ' ' LEU . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 240' ' ' LEU . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.515 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.621 ' HA ' HG22 ' A' ' 255' ' ' THR . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.44 ' N ' HD12 ' A' ' 252' ' ' LEU . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 252' ' ' LEU . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.413 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 288' ' ' LEU . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 262' ' ' LEU . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' A' ' 260' ' ' GLY . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 379' ' ' TYR . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 339' ' ' VAL . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.676 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 405' ' ' LEU . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.405 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.414 ' HE3' ' HA3' ' A' ' 242' ' ' GLY . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.645 HG13 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.416 ' H ' ' HB1' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.645 ' H ' HG13 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.604 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 411' ' ' ALA . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 407' ' ' ALA . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.503 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 247' ' ' ILE . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 255' ' ' THR . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.7 tttp . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.794 0.33 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 423' ' ' LYS . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 360' ' ' MET . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.403 ' H ' ' H ' ' A' ' 359' ' ' GLY . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 366' ' ' LEU . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.667 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 405' ' ' LEU . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 420' ' ' PHE . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 416' ' ' LYS . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 357' ' ' LEU . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HA ' HG22 ' A' ' 255' ' ' THR . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 250' ' ' ALA . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 252' ' ' LEU . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.413 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 263' ' ' SER . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 262' ' ' LEU . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.787 0.327 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 261' ' ' SER . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 333' ' ' LEU . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 339' ' ' VAL . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.687 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.407 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 430' ' ' LEU . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.409 ' HE3' ' H ' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.455 HG23 ' CD1' ' A' ' 256' ' ' PHE . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 255' ' ' THR . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.489 HD13 ' C ' ' A' ' 262' ' ' LEU . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.585 ' H ' HG22 ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 243' ' ' VAL . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 363' ' ' ALA . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 347' ' ' ASP . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.457 ' N ' HD13 ' A' ' 346' ' ' LEU . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 338' ' ' PHE . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.476 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 416' ' ' LYS . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.403 ' ND2' HD21 ' A' ' 362' ' ' ASN . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 262' ' ' LEU . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 72.5 tttt . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.563 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.403 HD21 ' ND2' ' A' ' 228' ' ' ASN . 64.8 m-20 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 366' ' ' LEU . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 339' ' ' VAL . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.437 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 382' ' ' ILE . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.667 HD22 ' C ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 221' ' ' SER . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.414 HG23 ' CD2' ' A' ' 256' ' ' PHE . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 255' ' ' THR . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.44 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.492 ' CD2' HG23 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 333' ' ' LEU . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.491 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 357' ' ' LEU 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 356' ' ' ALA . 23.4 m-70 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 339' ' ' VAL . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.23 0.066 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.413 ' O ' HG12 ' A' ' 408' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 404' ' ' TYR . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.411 HG23 ' CD2' ' A' ' 256' ' ' PHE . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 262' ' ' LEU . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 N--CA 1.457 -0.083 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.703 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 330' ' ' PRO . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.448 ' HG3' HD21 ' A' ' 296' ' ' LEU . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 332' ' ' VAL 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.501 ' H ' HD13 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.562 ' H ' HG13 ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.495 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 366' ' ' LEU . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.68 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.495 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 426' ' ' ILE . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 224' ' ' LEU . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.459 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 250' ' ' ALA . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 263' ' ' SER . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.458 ' N ' HD13 ' A' ' 262' ' ' LEU . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.596 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo . . . . . 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 281' ' ' TYR . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.777 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 . . . . . 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.462 HD22 ' C ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.528 HD13 ' HB1' ' A' ' 380' ' ' ALA . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 366' ' ' LEU . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 382' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.668 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 224' ' ' LEU . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 430' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -142.72 152.53 42.45 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.745 0.418 . . . . 0.0 110.166 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -152.49 162.04 41.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.648 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.7 p -150.62 153.63 36.03 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.533 0.333 . . . . 0.0 111.422 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.29 7.49 67.92 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 119.388 -0.673 . . . . 0.0 114.001 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -93.46 18.49 9.75 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.284 1.042 . . . . 0.0 111.649 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.426 HD22 ' H ' ' A' ' 224' ' ' LEU . 2.8 mm? -67.98 157.51 86.66 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.44 148.02 44.66 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.616 2.877 . . . . 0.0 112.34 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.43 -2.93 12.93 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 124.296 3.331 . . . . 0.0 112.281 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -73.43 134.53 44.0 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.956 0.344 . . . . 0.0 110.561 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -146.23 160.99 41.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.17 0.988 . . . . 0.0 109.181 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -149.23 152.24 35.64 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.798 0.439 . . . . 0.0 109.998 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -142.6 4.81 1.56 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.06 0.544 . . . . 0.0 112.043 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.466 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 23.6 t-20 -87.0 -30.43 0.4 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 75.0 Cg_endo -78.12 -178.86 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.982 1.788 . . . . 0.0 111.924 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 33.8 pt -124.57 173.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.258 1.023 . . . . 0.0 109.499 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.57 159.84 23.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.453 0.644 . . . . 0.0 112.45 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.3 t -90.72 -176.9 4.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.475 1.11 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 73.3 m -79.72 -1.36 38.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -118.21 140.78 49.28 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.78 0.718 . . . . 0.0 111.851 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.7 m -145.74 157.8 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.023 0.929 . . . . 0.0 110.346 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.468 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 25.1 t80 -104.81 155.53 18.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.442 1.097 . . . . 0.0 109.75 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.74 92.88 2.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -81.93 -178.12 52.21 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 123.508 0.575 . . . . 0.0 112.002 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.56 -120.39 5.26 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 35.0 m 43.8 48.95 4.68 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.653 1.181 . . . . 0.0 113.88 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.15 9.2 3.17 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.002 3.135 . . . . 0.0 111.682 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -97.48 33.26 2.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.615 0.766 . . . . 0.0 112.296 -171.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.4 t70 55.14 25.37 7.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.853 1.261 . . . . 0.0 113.743 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 27.1 pt -80.66 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 O-C-N 121.878 -0.514 . . . . 0.0 109.894 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 70.6 p -120.1 -174.06 2.69 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.503 0.721 . . . . 0.0 109.758 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -59.07 -9.44 1.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.042 0.537 . . . . 0.0 111.966 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.88 62.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.738 -0.601 . . . . 0.0 110.368 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -66.1 -35.56 90.7 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 255' ' ' THR . 3.8 pp -91.54 -14.84 29.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.575 0.687 . . . . 0.0 112.354 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.1 p -79.31 -18.34 12.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 118.758 0.708 . . . . 0.0 110.006 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -101.78 -24.81 14.01 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 252' ' ' LEU . 4.3 m -73.26 -25.91 60.89 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.245 0.475 . . . . 0.0 110.658 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -120.27 24.28 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.441 0.296 . . . . 0.0 110.66 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -64.31 121.22 13.79 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.7 167.48 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.097 0.959 . . . . 0.0 109.719 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -71.33 -17.04 62.46 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.292 0.237 . . . . 0.0 111.163 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -90.17 -156.93 32.81 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 7.5 t -75.74 152.58 37.4 Favored 'General case' 0 CA--C 1.527 0.093 0 O-C-N 122.473 -0.428 . . . . 0.0 111.468 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 262' ' ' LEU . 2.2 tm? -157.38 115.07 3.1 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.5 m -120.17 139.45 52.61 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.923 0.392 . . . . 0.0 110.414 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 34.5 m -81.54 155.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.406 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -143.51 122.66 12.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.484 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 23.7 t90 -151.6 131.91 7.2 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 97.4 Cg_endo -74.14 -13.54 23.46 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.416 2.744 . . . . 0.0 112.665 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 62.73 21.84 63.49 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.616 -0.547 . . . . 0.0 112.859 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 52.73 33.19 13.45 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.736 0.768 . . . . 0.0 111.546 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 26.8 t70 55.16 19.67 2.97 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.375 1.07 . . . . 0.0 112.867 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.65 4.91 67.11 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.707 -0.496 . . . . 0.0 112.566 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.49 -29.52 16.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.887 0.843 . . . . 0.0 110.935 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.9 m80 41.22 54.33 7.53 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.0 0.92 . . . . 0.0 112.541 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.23 -18.32 30.47 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.754 2.302 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -145.46 160.83 41.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.023 0.929 . . . . 0.0 109.543 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 277' ' ' PRO . 20.8 p -145.18 59.01 5.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 276' ' ' CYS . 32.4 Cg_exo -62.15 161.45 26.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.004 2.469 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.84 -10.68 25.12 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.492 2.794 . . . . 0.0 111.174 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.18 159.28 18.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.99 0.916 . . . . 0.0 110.301 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -175.32 -176.06 43.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.4 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -138.44 143.64 39.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.04 163.97 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 O-C-N 122.17 -0.331 . . . . 0.0 110.998 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 4.6 m-85 -142.71 170.98 14.69 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.675 0.39 . . . . 0.0 111.292 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.446 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -159.37 164.2 34.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.921 0.391 . . . . 0.0 111.187 174.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.7 133.96 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.86 151.06 17.73 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.044 0.45 . . . . 0.0 111.886 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.0 2.66 22.84 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.8 mm? -85.97 82.89 7.94 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.249 0.477 . . . . 0.0 110.875 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -62.07 -25.65 67.82 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.2 -27.62 56.94 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.472 0.309 . . . . 0.0 111.521 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 32.6 t -86.17 -27.67 24.42 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.5 t -61.82 -40.44 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -80.48 -22.4 41.05 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.125 0.421 . . . . 0.0 111.433 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 30.9 t -72.86 -33.42 66.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.95 0.341 . . . . 0.0 110.879 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.4 -24.9 24.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.846 -0.534 . . . . 0.0 110.628 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.84 -14.4 59.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.919 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.08 -14.4 18.61 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.171 0.441 . . . . 0.0 111.036 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.14 32.41 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.1 m -88.01 157.09 19.0 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -155.79 145.01 20.76 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.838 -0.538 . . . . 0.0 112.155 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -166.51 -53.78 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.251 0.621 . . . . 0.0 110.308 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -152.59 94.91 3.13 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.337 1.055 . . . . 0.0 109.271 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.61 32.96 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 124.666 3.577 . . . . 0.0 111.94 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.86 -172.54 0.67 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.871 0.868 . . . . 0.0 111.444 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.6 m -57.7 148.29 57.87 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.53 0.09 8.58 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 124.053 3.168 . . . . 0.0 111.95 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.58 34.78 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.519 0.728 . . . . 0.0 111.056 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 81.25 5.0 90.36 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.059 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 42.5 tp -90.31 -19.29 24.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.011 0.906 . . . . 0.0 111.034 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 13.1 t -76.47 151.24 36.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.891 0.877 . . . . 0.0 110.287 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -158.75 152.12 22.84 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.362 0.665 . . . . 0.0 109.756 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -144.51 156.58 44.23 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.9 -0.5 . . . . 0.0 111.106 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -144.22 155.51 43.91 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.656 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -156.07 -171.92 3.91 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.551 1.54 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 163.23 33.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.976 1.262 . . . . 0.0 111.646 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 60.8 mtt -123.1 12.21 9.58 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.179 0.591 . . . . 0.0 112.03 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 39.9 t -146.12 156.72 43.63 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.66 0.384 . . . . 0.0 110.273 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 19.6 t -147.69 10.46 0.94 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.902 0.481 . . . . 0.0 111.251 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -139.13 -13.78 1.18 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -144.94 135.73 24.62 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 109.399 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 91.4 mtp 47.97 32.1 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.666 0.787 . . . . 0.0 111.85 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -76.07 25.19 0.12 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.396 1.078 . . . . 0.0 112.598 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 69.5 m -101.15 14.57 31.53 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.242 0.617 . . . . 0.0 110.724 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -138.35 169.63 17.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.1 0.56 . . . . 0.0 111.911 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.23 149.24 50.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.012 0.925 . . . . 0.0 109.19 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 33.6 m -83.78 143.02 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -85.26 138.36 32.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.56 120.81 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 82.5 mt -141.53 126.07 10.42 Favored Pre-proline 0 N--CA 1.455 -0.194 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -88.11 -179.44 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 124.255 3.304 . . . . 0.0 111.84 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -130.1 157.21 43.03 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.89 162.97 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 122.965 0.506 . . . . 0.0 110.821 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 1.36 3.1 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.797 0.839 . . . . 0.0 113.167 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -85.87 161.67 18.97 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.045 -0.409 . . . . 0.0 111.003 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -70.03 151.72 45.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 70.2 m -90.43 -8.36 50.75 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.53 147.31 50.69 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.688 0.676 . . . . 0.0 111.857 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -172.52 163.71 5.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.083 0.953 . . . . 0.0 109.699 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.497 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -154.41 152.81 9.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -87.33 -17.99 31.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.293 0.637 . . . . 0.0 111.499 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.497 ' H ' HG13 ' A' ' 339' ' ' VAL . 47.3 m -73.38 163.05 71.3 Favored Pre-proline 0 C--O 1.233 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 110.005 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 47.8 Cg_endo -61.72 153.54 66.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.616 2.211 . . . . 0.0 109.878 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 80.2 p -78.76 154.8 29.69 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.273 0.559 . . . . 0.0 112.082 -174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -152.7 155.99 38.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 108.706 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -65.99 148.4 51.86 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 76.9 mt -105.74 154.31 20.65 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.242 0.617 . . . . 0.0 111.041 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -146.87 152.84 45.13 Favored Pre-proline 0 N--CA 1.456 -0.16 0 C-N-CA 124.005 0.922 . . . . 0.0 109.62 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.4 -6.07 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.685 2.924 . . . . 0.0 111.575 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.4 p -92.94 -2.44 55.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 112.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -135.18 14.66 3.53 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 122.709 0.403 . . . . 0.0 111.557 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.7 t -117.49 162.84 17.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.715 0.406 . . . . 0.0 110.389 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.5 162.59 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.21 0.604 . . . . 0.0 109.763 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.527 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 46.4 m-85 -103.42 137.27 41.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 168.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.58 148.48 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.486 0.66 . . . . 0.0 110.624 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -141.01 -149.02 5.19 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.065 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 57.13 13.46 1.62 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.77 0.828 . . . . 0.0 111.623 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 359' ' ' GLY . 2.6 pp -113.32 179.14 4.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.943 0.897 . . . . 0.0 110.455 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -75.38 14.09 0.64 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.227 1.011 . . . . 0.0 113.649 -169.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.759 ' H ' HD12 ' A' ' 357' ' ' LEU . . . 68.1 -4.71 4.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.451 0.548 . . . . 0.0 111.959 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 53.7 ttp -153.52 127.78 9.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.88 0.872 . . . . 0.0 109.359 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.9 mt -155.51 158.68 38.89 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 108.392 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -75.96 135.1 40.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -67.27 -26.41 66.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.26 -19.58 53.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 117.989 0.359 . . . . 0.0 110.742 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -82.86 -39.88 21.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 72.7 mt -70.24 -26.31 63.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.56 83.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.33 -36.34 74.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.771 0.26 . . . . 0.0 111.508 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 91.5 mt -72.52 -37.16 56.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.29 -2.74 58.66 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 119.406 -0.33 . . . . 0.0 110.55 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -104.66 -11.66 16.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.368 0.667 . . . . 0.0 111.797 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -114.44 -30.0 6.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.7 -11.78 59.99 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -171.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.14 -32.07 0.06 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 119.556 1.071 . . . . 0.0 112.718 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.88 -173.01 42.94 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -87.0 164.55 35.46 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.45 158.14 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 124.52 1.128 . . . . 0.0 109.454 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.29 -13.28 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -157.92 139.34 13.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.11 0.414 . . . . 0.0 110.113 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -152.73 170.99 18.91 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 122.793 0.437 . . . . 0.0 110.256 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 126.06 -155.55 19.28 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.2 150.47 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -114.64 154.09 29.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.451 ' CG2' ' HA ' ' A' ' 390' ' ' PRO . 15.6 p -87.78 136.9 32.76 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 122.556 0.343 . . . . 0.0 110.873 -173.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -160.62 -178.27 6.76 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.84 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt 61.02 -17.34 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.673 2.389 . . . . 0.0 114.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 388' ' ' LYS . 28.7 t-80 -160.03 -178.26 6.88 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 55.0 mtmt -77.98 -10.24 59.5 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.292 0.637 . . . . 0.0 111.968 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -95.48 161.2 28.61 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 122.797 0.439 . . . . 0.0 110.779 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 384' ' ' THR . 50.8 Cg_exo -58.46 -179.79 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.014 3.81 . . . . 0.0 115.676 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.1 tt 54.82 154.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 128.683 2.793 . . . . 0.0 115.884 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 176.64 -55.49 0.11 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.442 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 50.7 m -154.93 156.04 35.37 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.711 0.755 . . . . 0.0 110.649 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.81 151.87 34.42 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 121.817 -0.552 . . . . 0.0 111.854 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.438 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 72.7 mtp180 -150.29 155.49 39.78 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.89 0.876 . . . . 0.0 110.871 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.97 149.89 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 17.5 m -141.86 143.93 33.6 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 122.629 0.372 . . . . 0.0 111.102 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.47 -172.52 2.72 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.964 0.905 . . . . 0.0 111.006 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -127.69 5.47 6.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.111 0.965 . . . . 0.0 111.519 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -144.55 132.57 21.51 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -68.03 -23.49 64.99 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -76.0 -47.68 23.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 28.3 m -72.38 -25.05 61.36 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 120.69 0.281 . . . . 0.0 110.271 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -59.5 -73.98 0.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.868 1.267 . . . . 0.0 111.268 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -81.94 -13.67 57.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -173.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 405' ' ' LEU . 56.7 tptt -79.37 -35.22 41.17 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.537 1.062 . . . . 0.0 110.012 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -49.4 15.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.273 0.488 . . . . 0.0 110.379 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.84 -23.69 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.9 t -97.54 -15.41 20.55 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -104.33 1.93 30.82 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.256 0.48 . . . . 0.0 111.203 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.6 42.31 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.175 0.59 . . . . 0.0 112.117 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -66.9 0.99 2.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.99 0.916 . . . . 0.0 111.472 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.59 156.1 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.04 0.536 . . . . 0.0 111.219 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -92.44 99.59 12.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.66 133.2 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -145.99 151.31 37.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.591 0.71 . . . . 0.0 112.223 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -137.59 32.78 2.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.256 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.9 m 60.74 9.45 2.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.32 1.448 . . . . 0.0 114.056 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -150.42 5.18 0.53 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.559 -0.713 . . . . 0.0 111.055 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -158.92 142.22 14.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.3 m -141.73 126.43 17.99 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 19.1 tptt -157.88 179.13 9.49 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.434 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 64.5 mttp -132.12 178.73 6.57 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 109.452 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.33 146.88 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 C-N-CA 123.133 0.573 . . . . 0.0 110.528 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -141.82 147.86 37.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.703 0.801 . . . . 0.0 110.491 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.2 tt -80.11 150.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 123.655 0.782 . . . . 0.0 111.641 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.02 131.96 7.76 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.17 155.07 42.13 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.53 2.82 . . . . 0.0 111.901 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -81.19 -10.19 59.67 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.25 -1.357 . . . . 0.0 110.049 -179.383 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 111.095 2.895 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 C5'-C4'-C3' 110.633 -3.245 . 0.3 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.468 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.842 1 O4'-C1'-N19 112.653 4.453 . 0.3 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.446 1 O4'-C1'-N19 113.276 5.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.565 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.819 1 C5'-C4'-C3' 109.329 -4.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 119.801 -0.142 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.0 m -97.96 121.86 40.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.872 0.306 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 51.8 p-90 -164.91 165.99 19.9 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.6 0.76 . . . . 0.0 110.061 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.8 p -152.18 158.0 42.29 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.595 0.358 . . . . 0.0 110.693 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 73.27 11.71 79.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.539 -0.589 . . . . 0.0 113.333 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -96.65 14.49 24.74 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.136 0.968 . . . . 0.0 111.49 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 97.7 mt -122.33 107.44 34.71 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 122.793 0.437 . . . . 0.0 109.888 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -78.86 170.11 18.5 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.643 2.895 . . . . 0.0 110.106 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.46 161.43 9.55 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.695 2.93 . . . . 0.0 112.156 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -136.31 139.95 42.99 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.395 0.678 . . . . 0.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.42 169.72 24.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.448 0.699 . . . . 0.0 109.892 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -144.86 163.64 33.49 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.776 0.43 . . . . 0.0 110.011 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.3 145.34 55.85 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 122.774 0.429 . . . . 0.0 110.732 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 47.02 60.75 14.66 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.608 0.763 . . . . 0.0 110.992 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.58 144.68 55.78 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.292 2.662 . . . . 0.0 111.035 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.1 pt -146.88 165.5 7.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.673 0.789 . . . . 0.0 110.12 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -102.13 161.45 13.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.109 0.481 . . . . 0.0 110.449 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 86.8 p -90.64 -176.72 4.81 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 110.629 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.0 p -78.0 6.23 8.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -118.51 135.69 54.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 17.3 m -147.33 161.92 7.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.534 1.134 . . . . 0.0 110.025 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -128.07 153.53 46.7 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.749 0.82 . . . . 0.0 110.946 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 240' ' ' LEU . 7.2 tt -146.87 119.84 8.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.121 0.968 . . . . 0.0 108.532 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -134.87 158.32 23.44 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.912 -0.492 . . . . 0.0 112.071 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 120.68 23.96 2.69 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.3 -0.722 . . . . 0.0 111.361 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.1 m -123.73 67.88 41.39 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 117.968 0.884 . . . . 0.0 112.122 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -77.38 0.95 9.26 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.195 3.264 . . . . 0.0 110.111 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.515 ' CZ2' ' HE3' ' A' ' 324' ' ' LYS . 11.5 m0 -72.29 175.68 5.91 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.617 1.167 . . . . 0.0 111.893 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.23 1.49 4.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.873 0.869 . . . . 0.0 112.738 -174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 20.0 pt -75.82 176.29 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.885 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 78.9 p -131.99 -174.68 3.5 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.058 0.943 . . . . 0.0 108.678 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 37.5 mp0 -62.66 -9.77 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.519 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -64.92 -20.16 66.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.526 0.33 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.02 -43.96 95.07 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.621 ' HA ' HG22 ' A' ' 255' ' ' THR . 2.7 pp -83.59 -23.48 31.93 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.721 0.76 . . . . 0.0 112.369 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.44 ' N ' HD12 ' A' ' 252' ' ' LEU . 1.4 p -78.01 -16.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 118.408 0.549 . . . . 0.0 110.985 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -105.56 -16.72 14.63 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 252' ' ' LEU . 2.0 t -93.94 -12.26 29.19 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.906 0.775 . . . . 0.0 111.954 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -125.18 13.7 8.35 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.169 0.441 . . . . 0.0 111.887 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.413 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . 33.3 ptt180 -70.29 129.41 39.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.713 0.768 . . . . 0.0 111.47 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.45 174.92 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.131 1.372 . . . . 0.0 108.288 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -66.65 -3.47 6.59 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 288' ' ' LEU . . . -84.74 -167.14 42.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.848 0.737 . . . . 0.0 113.119 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.5 m -81.61 43.16 0.73 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 112.318 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 262' ' ' LEU . 3.0 tm? -63.08 128.6 36.6 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.8 m -140.99 157.88 44.72 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.252 0.621 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.55 155.12 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.617 0.767 . . . . 0.0 110.51 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.55 141.47 32.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.134 0.493 . . . . 0.0 111.269 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -141.49 156.62 66.77 Favored Pre-proline 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.555 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.37 15.22 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.679 3.586 . . . . 0.0 113.402 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.98 -155.45 42.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -132.48 22.31 4.35 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 123.487 0.715 . . . . 0.0 111.861 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.99 -10.53 59.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -74.97 -176.67 38.18 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -68.16 -27.0 66.04 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.538 -0.39 . . . . 0.0 110.432 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -157.51 137.14 8.49 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.08 -15.45 25.85 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.196 2.598 . . . . 0.0 113.122 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -128.3 172.3 11.19 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.372 0.669 . . . . 0.0 111.38 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 61.8 m 49.6 45.52 2.93 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.4 161.24 44.85 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.522 2.148 . . . . 0.0 110.007 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.78 -31.88 93.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.418 2.745 . . . . 0.0 112.495 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.405 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 59.1 mtpt -143.06 154.72 44.24 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.874 1.27 . . . . 0.0 107.78 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -136.35 144.36 16.06 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-O 121.764 0.647 . . . . 0.0 113.059 -174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.62 153.71 40.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 176.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.17 166.66 28.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 118.413 0.551 . . . . 0.0 110.95 -172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 30.4 m-85 -134.21 162.27 32.62 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.842 -0.536 . . . . 0.0 111.606 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.77 137.05 19.8 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.59 134.06 49.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.38 140.4 10.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.668 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -79.39 29.15 0.24 Allowed 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.467 1.107 . . . . 0.0 112.241 -172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' A' ' 260' ' ' GLY . 43.6 mt -116.33 115.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -168.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.32 -27.28 29.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -83.18 -22.02 33.34 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 23.8 t -92.13 -25.95 18.49 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.097 0.408 . . . . 0.0 110.313 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.82 -39.74 84.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -80.61 -26.47 37.77 Favored 'General case' 0 CA--C 1.523 -0.077 0 O-C-N 122.341 -0.225 . . . . 0.0 111.421 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 36.0 t -73.5 -32.33 64.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.34 -54.68 11.53 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.982 0.913 . . . . 0.0 110.406 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.98 -18.14 65.24 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.624 -0.227 . . . . 0.0 111.091 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -87.46 -21.65 25.41 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.05 0.386 . . . . 0.0 111.067 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -85.51 -19.5 31.1 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.228 -0.295 . . . . 0.0 110.75 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 84.3 m -76.56 161.29 28.71 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 111.047 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 15.3 t -90.24 -166.02 1.49 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.739 1.216 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 65.06 -154.43 0.28 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.618 1.167 . . . . 0.0 111.509 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.0 133.17 22.89 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 118.51 0.595 . . . . 0.0 112.171 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.58 -19.66 48.09 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.487 2.791 . . . . 0.0 111.586 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.484 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -161.99 170.06 19.98 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.975 0.51 . . . . 0.0 111.052 172.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.2 t -149.29 152.5 35.97 Favored Pre-proline 0 C--O 1.234 0.252 0 C-N-CA 123.639 0.776 . . . . 0.0 109.145 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.72 -8.75 6.15 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.567 2.844 . . . . 0.0 113.998 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -102.98 5.89 38.56 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.18 75.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.581 0.61 . . . . 0.0 113.268 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 51.7 tp -69.64 146.71 51.45 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.382 1.091 . . . . 0.0 110.281 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 m -154.4 105.9 2.7 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.431 1.092 . . . . 0.0 109.121 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -157.27 160.37 38.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.652 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.4 159.28 36.7 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.871 0.869 . . . . 0.0 110.335 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -143.03 153.86 43.39 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-O 120.945 0.403 . . . . 0.0 111.63 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -150.95 -160.3 1.15 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -150.4 156.27 41.16 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 119.55 1.068 . . . . 0.0 109.752 170.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 36.9 tpp -122.62 6.37 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.739 0.416 . . . . 0.0 111.451 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.1 t -143.29 147.39 34.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 81.2 p -152.87 9.1 0.44 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -130.57 6.76 4.81 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -148.06 -37.16 0.19 Allowed 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.428 0.558 . . . . 0.0 112.03 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.5 mtp -142.87 56.01 1.4 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.073 0.549 . . . . 0.0 109.986 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -75.67 44.12 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 0.0 111.035 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 77.9 m -126.5 10.92 7.33 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.197 0.599 . . . . 0.0 110.722 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HE3' ' CZ2' ' A' ' 245' ' ' TRP . 15.6 ttpp -140.57 171.87 13.52 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.091 0.472 . . . . 0.0 111.807 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 42.1 mt-10 -133.38 169.67 16.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.689 1.196 . . . . 0.0 109.46 177.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.2 141.38 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.143 0.977 . . . . 0.0 108.471 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -82.54 139.25 33.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 97.0 t -125.07 128.04 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.0 mt -141.38 127.45 11.23 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -85.75 179.49 3.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.144 3.23 . . . . 0.0 111.406 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -129.89 150.21 51.28 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.901 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.8 m -91.71 171.52 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 C-N-CA 123.377 0.671 . . . . 0.0 111.782 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.11 -37.9 6.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.585 0.754 . . . . 0.0 112.287 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -101.77 13.17 35.66 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.06 17.01 6.17 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.419 0.554 . . . . 0.0 112.197 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.6 m -73.19 -19.84 61.02 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -155.63 145.28 21.19 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.094 0.406 . . . . 0.0 110.251 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -167.79 163.44 14.12 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.719 0.408 . . . . 0.0 110.158 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 379' ' ' TYR . 2.0 t -144.5 146.01 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 171.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -97.17 15.71 21.9 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.1 m -145.35 156.57 53.66 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 124.638 1.175 . . . . 0.0 110.466 -174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.26 158.89 50.92 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.57 2.847 . . . . 0.0 109.863 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.5 t -153.93 155.43 35.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.611 0.364 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -142.98 -24.32 0.62 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.166 0.586 . . . . 0.0 111.056 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -146.68 156.98 43.59 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.718 0.807 . . . . 0.0 110.406 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.7 159.83 40.66 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.485 1.114 . . . . 0.0 108.901 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -140.42 140.69 23.5 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 122.487 0.315 . . . . 0.0 110.871 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.53 -15.66 24.56 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.424 2.75 . . . . 0.0 111.023 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.4 m -92.67 5.95 49.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.343 0.657 . . . . 0.0 111.248 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -134.88 17.69 3.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.609 0.764 . . . . 0.0 110.582 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.9 m -129.54 137.91 51.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 122.961 0.505 . . . . 0.0 109.677 -176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.57 167.47 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.59 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.572 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 21.6 m-85 -89.35 151.84 21.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.89 162.75 4.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.75 0.82 . . . . 0.0 110.16 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 160.72 178.18 34.48 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.15 174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -158.58 142.42 15.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.853 0.861 . . . . 0.0 109.092 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.2 pp 52.22 -22.28 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.76 2.824 . . . . 0.0 116.444 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 356' ' ' ALA . 1.5 t60 -171.7 -35.21 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.556 1.142 . . . . 0.0 109.047 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 73.51 -2.31 39.33 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.622 0.63 . . . . 0.0 112.925 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 48.8 ttp -77.49 93.4 4.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.139 0.969 . . . . 0.0 110.958 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.9 mp -135.25 165.74 24.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.625 0.77 . . . . 0.0 109.418 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.8 151.16 46.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.17 65.2 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -74.52 -31.29 62.1 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.56 0.618 . . . . 0.0 110.094 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.1 -29.4 48.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 99.2 mt -78.64 -32.77 47.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.812 0.278 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.82 66.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 122.163 -0.335 . . . . 0.0 110.937 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -75.23 -37.97 60.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 14.2 pt -80.13 -33.25 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.181 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 -22.1 58.93 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.168 0.895 . . . . 0.0 109.743 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -88.09 -14.79 37.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.008 0.367 . . . . 0.0 111.909 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.7 -16.31 16.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 0.0 112.254 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 3.2 mp -81.66 -22.71 37.35 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.037 -0.414 . . . . 0.0 111.482 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.66 -26.47 0.07 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.956 0.344 . . . . 0.0 111.251 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 80.36 172.73 45.34 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.974 -0.451 . . . . 0.0 111.974 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.55 11.85 61.79 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.965 -0.353 . . . . 0.0 112.498 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.02 146.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.107 0 CA-C-N 117.509 0.655 . . . . 0.0 110.169 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.6 -10.29 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.443 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 339' ' ' VAL . 80.8 t80 -160.74 144.54 13.58 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.147 0.431 . . . . 0.0 111.241 174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.65 159.11 43.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.337 0.655 . . . . 0.0 109.56 172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 168.64 -165.22 38.7 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.83 172.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 123.821 0.848 . . . . 0.0 109.417 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -147.63 172.57 13.82 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.133 0.573 . . . . 0.0 110.921 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 12.6 t -150.09 172.47 15.22 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.237 1.415 . . . . 0.0 108.988 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -82.68 137.03 34.58 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 50.77 14.9 0.2 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.09 1.756 . . . . 0.0 115.61 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -145.19 164.85 30.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.431 1.014 . . . . 0.0 111.21 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -103.35 19.22 20.09 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.469 1.107 . . . . 0.0 111.368 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.82 87.3 55.17 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.37 171.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.374 1 C-N-CA 127.021 5.147 . . . . 0.0 117.102 -170.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.43 HD11 ' H3 ' ' B' ' 3' ' ' ' U' . 5.8 tp -134.29 -13.62 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.071 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 137.97 -2.84 3.03 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.717 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.8 m -71.27 103.53 2.86 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.896 1.348 . . . . 0.0 108.91 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -73.3 154.26 49.02 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 117.999 0.363 . . . . 0.0 112.343 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -145.48 151.49 38.27 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.612 1.165 . . . . 0.0 109.603 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.0 153.3 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 117.755 0.252 . . . . 0.0 111.298 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 25.0 m -136.54 146.91 46.72 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.85 0.86 . . . . 0.0 110.017 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -127.64 168.04 15.58 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.806 0.842 . . . . 0.0 111.14 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.16 0.01 57.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.513 0.725 . . . . 0.0 111.462 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.47 145.53 33.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.59 0.756 . . . . 0.0 108.971 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -80.3 -24.04 40.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.16 0.184 . . . . 0.0 110.838 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -79.89 -37.95 33.64 Favored 'General case' 0 C--O 1.228 -0.077 0 O-C-N 121.863 -0.523 . . . . 0.0 110.471 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 18.2 m -71.85 -26.54 62.41 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -63.83 -62.37 1.69 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.042 0.937 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.676 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.26 -22.8 54.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.242 -173.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.9 -24.61 48.33 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.76 -49.68 15.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.016 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 405' ' ' LEU . 12.1 m -73.05 -19.62 18.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.6 t -130.02 -8.41 4.38 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -120.14 -0.81 10.43 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.926 0.33 . . . . 0.0 110.448 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.97 121.41 25.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -123.0 26.51 8.08 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.849 0.86 . . . . 0.0 110.404 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.75 168.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.987 0.915 . . . . 0.0 112.012 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -123.72 138.25 54.55 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 88.9 mt -135.76 149.3 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.103 0.561 . . . . 0.0 110.001 -172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.19 158.09 43.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.235 0.614 . . . . 0.0 110.358 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 58.3 p -137.57 -151.48 0.4 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.773 1.229 . . . . 0.0 108.093 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 35.4 p -68.92 86.31 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 110.601 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 66.31 43.53 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.452 1.101 . . . . 0.0 111.707 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -154.82 155.74 34.97 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.932 0.893 . . . . 0.0 109.065 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 27.2 m -131.65 150.83 52.02 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 122.913 0.485 . . . . 0.0 110.481 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -145.94 154.11 41.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.62 -173.89 3.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.439 1.896 . . . . 0.0 106.682 170.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.48 138.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 O-C-N 121.034 -1.041 . . . . 0.0 112.233 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -145.42 151.1 37.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.162 0.985 . . . . 0.0 109.48 174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.58 146.43 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.295 0.638 . . . . 0.0 111.13 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.28 110.41 11.63 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.48 141.02 45.2 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.661 2.241 . . . . 0.0 110.718 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -83.63 -10.5 58.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.598 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.076 -178.207 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.405 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.74 0 C5'-C4'-C3' 110.889 -3.074 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.013 0 O4'-C1'-N19 111.775 3.575 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.453 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.097 0 O4'-C1'-N19 112.026 3.826 . 0.174 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.492 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.65 1 O4'-C1'-N19 114.671 6.471 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.572 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.836 0 C3'-C2'-C1' 104.827 3.697 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 66.5 p -70.75 153.08 43.12 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 122.475 0.31 . . . . 0.0 110.233 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -157.24 165.86 34.75 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.007 0.432 . . . . 0.0 111.721 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 36.8 t -152.04 150.94 30.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.748 0.819 . . . . 0.0 109.853 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 70.79 12.97 71.55 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.463 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -91.3 11.52 23.35 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.341 1.07 . . . . 0.0 111.982 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 94.3 mt -110.22 132.69 21.34 Favored Pre-proline 0 CA--C 1.532 0.261 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -79.24 163.65 24.9 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.666 2.911 . . . . 0.0 111.429 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.34 161.8 13.34 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.873 3.048 . . . . 0.0 111.253 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -89.94 126.74 35.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -158.67 150.14 20.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.192 0.197 . . . . 0.0 111.204 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -157.1 157.39 34.44 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -93.27 145.97 24.05 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 122.898 0.479 . . . . 0.0 109.714 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 42.32 47.71 2.84 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.065 0.946 . . . . 0.0 112.976 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.91 156.86 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.501 2.801 . . . . 0.0 111.773 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.9 pt -137.78 149.49 25.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 123.765 0.826 . . . . 0.0 109.096 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.06 155.26 20.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.063 -0.398 . . . . 0.0 110.86 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.4 m -83.06 11.87 5.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.098 0.559 . . . . 0.0 110.915 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.9 m 56.06 30.97 17.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.264 1.026 . . . . 0.0 112.103 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -134.54 151.08 50.86 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.922 0.489 . . . . 0.0 110.182 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.3 154.85 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.896 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.453 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 13.8 t80 -109.01 152.57 24.8 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.551 1.141 . . . . 0.0 110.409 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 13.5 tp -134.31 112.11 10.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -96.6 140.0 14.8 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.578 0.591 . . . . 0.0 114.578 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 324' ' ' LYS . . . 67.53 94.56 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.305 1.431 . . . . 0.0 113.122 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.6 m -141.83 74.51 22.3 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.811 0.844 . . . . 0.0 109.487 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -73.68 0.25 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.63 2.887 . . . . 0.0 111.596 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -77.1 178.96 6.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.494 0.718 . . . . 0.0 111.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.76 44.16 0.36 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.514 1.125 . . . . 0.0 111.989 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.52 144.84 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 124.012 0.925 . . . . 0.0 110.272 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.8 t -142.24 -17.33 0.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -164.19 -25.89 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.69 61.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.644 -0.66 . . . . 0.0 112.01 -174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.17 -38.95 83.39 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 3.3 pp -79.1 -27.05 42.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.414 0.607 . . . . 0.0 111.239 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.82 -9.36 11.81 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 CA-C-N 118.267 0.485 . . . . 0.0 111.222 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -111.88 -23.2 10.7 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.7 t -89.87 -15.99 31.01 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 119.103 0.865 . . . . 0.0 111.835 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -116.89 13.98 15.07 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -69.74 126.71 30.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.39 175.28 9.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 124.087 0.955 . . . . 0.0 108.872 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -68.48 -11.03 59.22 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -88.1 177.8 46.23 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.411 0.529 . . . . 0.0 111.892 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.1 m -85.33 136.89 33.29 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.675 0.79 . . . . 0.0 112.184 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 262' ' ' LEU . 0.6 OUTLIER -147.42 175.59 10.69 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.975 0.91 . . . . 0.0 109.939 171.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.6 t -152.23 163.12 40.05 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.747 0.308 . . . . 0.0 111.035 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -94.7 158.02 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.273 0.629 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.87 137.65 31.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.446 0.641 . . . . 0.0 111.534 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -156.68 137.1 8.95 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 125.293 1.437 . . . . 0.0 108.2 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.34 158.73 44.41 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.632 2.888 . . . . 0.0 111.664 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -73.3 155.8 50.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.88 2.48 30.24 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.354 -0.498 . . . . 0.0 111.852 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.64 -17.37 53.91 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.931 0.332 . . . . 0.0 111.163 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -96.27 1.73 62.75 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.48 179.04 6.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.557 0.743 . . . . 0.0 110.535 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -72.77 148.85 90.08 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.97 -13.48 15.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.753 2.968 . . . . 0.0 113.896 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -133.3 155.59 49.13 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.674 0.79 . . . . 0.0 109.494 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 88.9 m -134.69 155.96 79.05 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 122.708 0.403 . . . . 0.0 111.448 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.37 171.13 14.59 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.342 3.361 . . . . 0.0 110.127 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.79 -8.1 20.34 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.4 2.734 . . . . 0.0 111.715 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -74.37 157.02 36.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -174.45 156.35 23.0 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.914 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.458 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.5 OUTLIER -140.76 143.07 34.72 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.2 158.27 40.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 118.497 0.589 . . . . 0.0 111.138 -170.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.452 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 9.7 m-85 -132.44 164.43 26.57 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -172.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 8.3 tt -149.77 153.47 36.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.55 141.69 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.279 1.032 . . . . 0.0 109.184 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -119.28 159.5 23.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.822 0.849 . . . . 0.0 110.092 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -118.51 25.71 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.0 mt -132.03 113.58 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.626 1.17 . . . . 0.0 111.584 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.24 -23.53 43.63 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.823 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -83.44 -29.63 27.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.826 0.45 . . . . 0.0 112.046 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 28.1 t -85.18 -26.51 26.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.354 0.525 . . . . 0.0 109.864 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.2 t -66.48 -44.19 90.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -75.17 -23.31 57.71 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 121.843 -0.536 . . . . 0.0 110.972 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.6 t -66.34 -41.12 90.05 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 119.636 -0.221 . . . . 0.0 111.237 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.34 -24.7 36.92 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.406 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.5 mp -70.19 -13.69 62.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.583 0.353 . . . . 0.0 110.577 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -116.38 -3.23 11.93 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.3 -18.82 13.66 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 92.7 m -79.08 164.2 24.49 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.528 0.604 . . . . 0.0 110.833 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.3 t -81.29 -173.8 4.55 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.613 0.765 . . . . 0.0 111.489 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.437 ' CG ' ' H ' ' A' ' 302' ' ' ASP . 4.5 t60 63.75 -151.18 0.31 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.129 1.371 . . . . 0.0 112.773 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.437 ' H ' ' CG ' ' A' ' 301' ' ' HIS . 65.8 m-20 -121.27 137.91 27.4 Favored Pre-proline 0 C--N 1.34 0.162 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -167.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.0 -24.5 20.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.494 2.796 . . . . 0.0 111.602 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.7 167.08 25.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 111.965 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 51.2 m -149.5 158.8 37.57 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 125.025 1.33 . . . . 0.0 109.067 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.54 -12.86 18.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.381 2.721 . . . . 0.0 112.502 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -86.79 7.14 28.2 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.985 0.914 . . . . 0.0 111.929 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.68 7.4 85.82 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 61.5 tp -79.48 151.83 30.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 110.859 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 72.1 m -148.43 115.45 6.1 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -156.37 135.52 12.05 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.405 ' HB2' ' CG1' ' A' ' 328' ' ' VAL . 8.0 m-85 -128.08 164.94 21.33 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.3 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -139.79 154.97 47.51 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.338 0.59 . . . . 0.0 111.878 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -160.94 -167.23 1.77 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.729 1.612 . . . . 0.0 107.467 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -145.99 158.7 43.87 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 119.711 1.142 . . . . 0.0 110.545 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 56.9 ttm -129.51 -12.68 4.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.349 0.66 . . . . 0.0 112.06 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.1 t -91.94 154.85 18.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.583 0.706 . . . . 0.0 112.275 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 80.1 p -134.3 7.29 3.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.909 1.284 . . . . 0.0 109.563 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -84.83 174.71 9.64 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.283 1.033 . . . . 0.0 109.341 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -69.49 2.1 3.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.896 0.478 . . . . 0.0 112.263 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 12.0 tpt -110.96 23.94 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.0 110.246 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -70.72 32.47 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.142 1.377 . . . . 0.0 112.634 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.45 25.08 3.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.151 0.58 . . . . 0.0 111.439 -172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.558 ' HD2' ' C6 ' ' B' ' 1' ' ' ' U' . 57.0 tttm -141.64 156.15 45.67 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.151 0.581 . . . . 0.0 111.574 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.49 136.72 53.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.75 138.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 120.954 0.406 . . . . 0.0 110.056 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -83.53 142.72 30.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 312' ' ' TYR . 12.4 p -136.63 134.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 119.019 0.827 . . . . 0.0 109.792 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 13.4 mm -136.89 120.28 11.97 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 123.534 0.734 . . . . 0.0 109.471 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.72 171.91 16.61 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.63 2.887 . . . . 0.0 111.707 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -130.69 148.82 52.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.853 0.359 . . . . 0.0 111.39 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 76.0 t -120.33 147.3 24.15 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.836 0.854 . . . . 0.0 110.342 -173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.12 -38.38 72.3 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.608 0.763 . . . . 0.0 111.633 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -78.06 19.58 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -125.86 2.83 7.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 50.2 m -99.55 -8.59 24.36 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -153.36 113.17 3.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.314 0.506 . . . . 0.0 111.624 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -170.95 163.39 7.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.079 0.552 . . . . 0.0 109.976 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.645 HG13 ' H ' ' A' ' 341' ' ' SER . 1.2 t -155.81 155.33 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.121 0.486 . . . . 0.0 111.334 169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.416 ' H ' ' HB1' ' A' ' 367' ' ' ALA . 74.7 ttt-85 -80.81 -17.59 50.3 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.447 1.099 . . . . 0.0 112.167 -173.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.645 ' H ' HG13 ' A' ' 339' ' ' VAL . 67.0 m -66.42 155.29 88.76 Favored Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 123.505 0.722 . . . . 0.0 110.847 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.83 -4.13 14.51 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.931 3.087 . . . . 0.0 112.167 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 31.7 t -145.46 161.89 38.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.752 0.821 . . . . 0.0 109.293 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.52 131.34 31.64 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.954 0.407 . . . . 0.0 110.449 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -157.91 -175.29 5.28 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.295 1.038 . . . . 0.0 109.055 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 95.7 mt -134.96 172.92 12.32 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 122.809 0.444 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.35 129.14 6.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.529 0.732 . . . . 0.0 109.157 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.46 -0.26 9.9 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.758 2.972 . . . . 0.0 113.163 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 96.3 p -134.23 4.44 3.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 112.283 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -132.33 31.7 4.04 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.283 0.633 . . . . 0.0 111.043 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.6 m -116.16 137.61 51.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.6 164.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.643 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -115.18 152.49 32.53 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.5 m -136.0 148.02 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -113.49 -156.47 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.56 1.076 . . . . 0.0 111.191 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.0 39.72 7.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.477 1.111 . . . . 0.0 113.381 -177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 359' ' ' GLY . 0.9 OUTLIER -141.13 179.75 6.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.379 0.672 . . . . 0.0 110.569 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -66.16 -6.33 13.09 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.604 ' H ' ' HG ' ' A' ' 357' ' ' LEU . . . 80.46 -2.9 75.92 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.278 0.466 . . . . 0.0 112.047 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -146.95 124.65 11.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.385 0.674 . . . . 0.0 109.315 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.6 mt -159.2 172.76 17.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.53 1.132 . . . . 0.0 108.871 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -109.49 160.16 16.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 110.495 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.61 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.81 -33.67 68.72 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.59 0.632 . . . . 0.0 110.85 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -83.87 -35.54 24.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 122.288 -0.257 . . . . 0.0 110.339 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.81 -29.6 65.81 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.234 -0.291 . . . . 0.0 110.337 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 340' ' ' ARG . . . -72.75 -40.67 65.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.737 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.82 65.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 87.2 mt -75.09 -47.18 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 118.033 0.379 . . . . 0.0 110.756 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.58 -16.02 59.7 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.989 -0.444 . . . . 0.0 110.556 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -94.04 -19.02 21.24 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -93.72 -33.08 13.77 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 118.689 0.677 . . . . 0.0 112.535 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.51 -27.72 31.54 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.468 0.576 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -147.32 -18.98 0.39 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.06 -168.12 47.96 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.943 0.792 . . . . 0.0 112.211 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 81.26 4.02 90.54 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 122.438 -0.448 . . . . 0.0 113.206 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.66 147.95 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 117.714 0.757 . . . . 0.0 110.301 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.1 -18.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 122.542 0.337 . . . . 0.0 111.632 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -158.58 148.79 19.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.787 0.267 . . . . 0.0 110.442 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -144.38 153.28 41.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 172.59 -163.2 35.13 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.67 149.82 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.038 0.447 . . . . 0.0 110.057 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -82.57 164.04 21.09 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 43.9 p -139.89 141.51 36.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.33 130.07 34.67 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.394 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm 49.01 19.54 0.29 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.324 1.45 . . . . 0.0 114.511 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -146.88 -162.35 1.52 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.824 0.849 . . . . 0.0 109.539 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -141.72 7.65 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.789 0.836 . . . . 0.0 111.675 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.622 ' H ' ' CD ' ' A' ' 390' ' ' PRO . 63.0 m-85 -134.84 -29.82 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -172.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.622 ' CD ' ' H ' ' A' ' 389' ' ' TYR . 97.5 Cg_endo -76.44 -113.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.842 2.361 . . . . 0.0 112.229 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.4 tp -153.73 162.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 123.449 0.699 . . . . 0.0 110.286 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -174.18 -42.81 0.05 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.7 t -164.61 172.87 12.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.344 0.572 . . . . 0.0 110.67 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.94 21.95 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 118.495 0.589 . . . . 0.0 112.009 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -144.55 153.4 41.78 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.528 0.731 . . . . 0.0 110.785 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 10.7 p -154.46 156.6 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.4 m -137.71 146.36 43.65 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.545 0.738 . . . . 0.0 110.562 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -131.55 175.1 9.45 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.641 1.176 . . . . 0.0 110.917 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.46 3.94 10.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.12 0.568 . . . . 0.0 111.795 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -136.87 136.58 38.84 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -73.92 -24.11 59.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -78.24 -43.39 28.42 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.78 0.264 . . . . 0.0 110.322 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.3 m -73.58 -24.27 60.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -62.41 -64.83 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.416 0.686 . . . . 0.0 110.726 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.67 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.13 -25.64 55.57 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.161 -172.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -75.07 -26.01 59.03 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.411 0.551 . . . . 0.0 110.966 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 411' ' ' ALA . . . -79.2 -41.88 27.31 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.181 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.0 m -80.3 -12.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.4 t -131.85 -2.46 3.69 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -134.84 2.02 3.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 407' ' ' ALA . . . -91.73 31.71 1.18 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.366 0.53 . . . . 0.0 110.661 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -75.71 20.21 0.18 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.587 0.755 . . . . 0.0 111.353 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 411' ' ' ALA . 14.2 m -57.73 162.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.583 1.153 . . . . 0.0 110.214 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.72 127.69 33.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 87.1 mt -128.97 148.56 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.062 0 C-N-CA 122.838 0.455 . . . . 0.0 110.217 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -144.13 147.86 34.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.516 0.727 . . . . 0.0 109.671 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.0 t -127.0 32.16 5.15 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.883 0.873 . . . . 0.0 109.448 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 31.0 p 55.57 22.42 5.2 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.863 1.665 . . . . 0.0 113.499 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -135.8 -30.7 0.97 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.177 0.591 . . . . 0.0 111.291 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -166.81 170.54 12.24 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 110.049 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.9 p -93.02 153.46 18.7 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.811 0.445 . . . . 0.0 110.116 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -145.13 158.72 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.849 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -144.41 -165.93 2.26 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.594 1.958 . . . . 0.0 108.05 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.56 146.53 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 122.078 -0.388 . . . . 0.0 110.839 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -140.1 125.7 19.21 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.218 0.607 . . . . 0.0 109.452 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 6.4 tt -69.05 143.45 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 123.701 0.801 . . . . 0.0 112.254 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -150.58 118.22 3.49 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 171.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.41 143.89 25.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.201 3.267 . . . . 0.0 113.764 -176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -126.47 0.05 6.91 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 111.384 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.981 -179.079 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.558 ' C6 ' ' HD2' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 C5'-C4'-C3' 112.11 -2.26 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.408 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.821 -3.119 . 0.254 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.458 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 O4'-C1'-N19 112.522 4.322 . 0.092 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.452 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.305 1 O4'-C1'-N19 112.953 4.753 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 C5'-C4'-C3' 110.068 -3.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.947 -0.073 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 32.9 m -92.67 140.78 29.18 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.979 0.512 . . . . 0.0 111.654 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -158.6 159.79 35.84 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.833 0.853 . . . . 0.0 110.013 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.9 m -153.6 163.79 39.38 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.192 0.597 . . . . 0.0 110.841 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.82 81.11 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.433 -0.648 . . . . 0.0 113.523 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -122.31 17.07 10.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.299 1.049 . . . . 0.0 111.895 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.2 mm? -70.26 140.17 87.7 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.46 132.12 13.25 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.37 2.713 . . . . 0.0 111.221 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.17 163.83 22.37 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.037 3.158 . . . . 0.0 110.996 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -152.5 149.34 28.43 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.036 0.534 . . . . 0.0 109.585 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.83 165.02 28.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.199 0.6 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -147.41 164.84 32.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.19 0.596 . . . . 0.0 109.558 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -74.44 -12.69 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 49.9 t30 44.36 55.2 12.91 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.895 0.878 . . . . 0.0 112.197 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.03 -29.84 17.28 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.531 2.154 . . . . 0.0 110.892 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.6 pt -150.46 159.16 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.271 1.028 . . . . 0.0 109.788 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -98.39 165.62 11.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.194 0.521 . . . . 0.0 110.909 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.7 t -87.2 172.32 10.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.611 0.764 . . . . 0.0 110.486 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.95 13.27 3.42 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.444 0.698 . . . . 0.0 112.203 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -118.71 137.8 53.08 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.997 0.519 . . . . 0.0 112.182 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.23 145.45 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.107 0.963 . . . . 0.0 109.559 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -101.6 153.73 19.48 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.797 0.839 . . . . 0.0 109.271 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 29.5 tp -138.2 99.75 3.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.454 0.645 . . . . 0.0 109.297 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -82.66 173.85 52.83 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 174.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 79.93 -104.45 2.22 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 326' ' ' VAL . 0.2 OUTLIER 52.22 161.37 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 127.091 2.156 . . . . 0.0 113.653 -171.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.503 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 86.3 Cg_exo -48.86 168.88 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.084 3.19 . . . . 0.0 113.654 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 244' ' ' PRO . 10.3 m-90 -104.82 19.58 20.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.828 -173.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -144.03 15.19 1.71 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 111.085 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.428 HD12 ' C ' ' A' ' 247' ' ' ILE . 2.0 pp -104.28 177.93 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 122.088 0.946 . . . . 0.0 112.147 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 76.7 p -142.45 -162.46 1.42 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.824 1.65 . . . . 0.0 106.766 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -49.11 -23.99 1.46 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.868 0.467 . . . . 0.0 111.828 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.11 -16.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.497 -0.752 . . . . 0.0 111.824 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -65.27 -53.04 35.28 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.545 ' HA ' HG22 ' A' ' 255' ' ' THR . 4.2 pp -81.79 -22.6 37.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.728 0.764 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 250' ' ' ALA . 0.4 OUTLIER -70.24 -21.19 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.729 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -101.6 -19.52 15.42 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 252' ' ' LEU . 1.2 t -80.28 -17.34 52.44 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 119.033 0.833 . . . . 0.0 111.465 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -114.23 -55.83 2.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.4 tpt85 41.3 44.54 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.529 1.132 . . . . 0.0 112.612 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.38 160.8 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.859 -0.526 . . . . 0.0 110.675 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -78.96 -21.63 46.87 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.752 0.421 . . . . 0.0 111.946 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.88 -166.93 40.17 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.5 t -62.13 130.44 45.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.233 0.517 . . . . 0.0 110.022 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.07 128.18 14.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.6 t -141.64 164.09 31.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.105 0.562 . . . . 0.0 110.435 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.35 149.86 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.459 0.704 . . . . 0.0 109.633 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -126.43 146.14 50.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.99 0.424 . . . . 0.0 110.75 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.2 t-105 -152.77 113.29 2.75 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -80.01 2.19 8.63 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 124.355 3.37 . . . . 0.0 111.758 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -77.51 -150.97 4.39 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 123.628 0.632 . . . . 0.0 112.07 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.57 27.48 10.46 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.724 0.81 . . . . 0.0 111.927 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.91 7.94 3.77 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.628 0.771 . . . . 0.0 110.589 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.25 175.24 44.72 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -149.59 169.06 21.83 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.627 0.771 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.528 ' H ' ' CD ' ' A' ' 274' ' ' PRO . 83.8 t60 -115.32 -37.18 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.958 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.528 ' CD ' ' H ' ' A' ' 273' ' ' HIS . 51.8 Cg_exo -59.15 154.75 43.75 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.994 2.462 . . . . 0.0 112.404 176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -84.22 7.8 17.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.359 0.664 . . . . 0.0 111.829 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 69.2 m -68.21 161.56 67.71 Favored Pre-proline 0 N--CA 1.452 -0.361 0 C-N-CA 123.067 0.547 . . . . 0.0 110.519 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.95 160.07 13.26 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.058 3.172 . . . . 0.0 112.327 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.49 -2.14 11.71 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.815 3.01 . . . . 0.0 112.2 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.435 ' HE3' " C5'" ' B' ' 1' ' ' ' U' . 65.7 tttp -69.79 154.91 41.33 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.614 0.366 . . . . 0.0 110.342 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -153.51 -154.56 6.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.402 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -136.68 143.8 43.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.18 165.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 122.988 0.515 . . . . 0.0 111.427 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.469 ' CD2' ' C4 ' ' B' ' 4' ' ' ' U' . 5.7 m-85 -133.97 176.9 8.16 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.2 tt -154.27 139.22 17.26 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.612 -169.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.55 130.35 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.44 153.55 23.52 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.715 0.406 . . . . 0.0 111.771 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -95.05 0.29 54.33 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.61 92.31 4.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.825 0.45 . . . . 0.0 110.745 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.26 -25.92 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -78.21 -26.31 47.42 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.773 0.429 . . . . 0.0 111.62 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 19.6 t -87.63 -25.58 23.48 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.78 -45.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -78.6 -24.07 45.6 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.482 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.9 t -67.32 -36.72 82.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.271 -0.268 . . . . 0.0 111.286 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 pp -91.14 -21.02 21.38 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.43 0.559 . . . . 0.0 111.434 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.3 mp -72.35 -15.75 61.87 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -109.13 -23.64 11.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.283 0.633 . . . . 0.0 111.676 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -88.47 -26.29 22.16 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.562 0.619 . . . . 0.0 111.991 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.3 m -85.42 155.11 21.41 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 53.5 m -73.98 176.42 6.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.29 154.46 36.81 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.34 0.59 . . . . 0.0 112.544 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -139.82 138.47 19.88 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -69.74 -9.05 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 124.053 3.169 . . . . 0.0 112.993 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 5.2 mp -142.67 166.33 24.95 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.741 0.781 . . . . 0.0 110.763 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.4 t -147.1 161.28 37.33 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 125.559 1.544 . . . . 0.0 107.51 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -55.98 -6.75 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.075 2.517 . . . . 0.0 113.635 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -108.54 7.82 26.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.505 0.722 . . . . 0.0 111.971 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.67 37.1 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.914 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.02 167.5 23.19 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.934 1.367 . . . . 0.0 112.342 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.0 m -79.09 144.03 34.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.44 0.296 . . . . 0.0 110.531 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.86 166.93 26.11 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.928 0.491 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -105.68 154.63 20.18 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 123.396 0.678 . . . . 0.0 109.351 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -139.71 150.19 44.55 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -161.92 -173.63 3.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.872 1.269 . . . . 0.0 108.082 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -153.75 160.47 42.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.498 1.044 . . . . 0.0 110.656 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 65.9 mtt -131.3 169.26 16.23 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.323 1.049 . . . . 0.0 109.372 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.3 p -71.05 159.81 34.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.17 0.509 . . . . 0.0 111.993 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 33.1 t -152.34 164.89 36.55 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.461 0.705 . . . . 0.0 110.616 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -136.53 9.93 3.16 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.602 0.761 . . . . 0.0 111.386 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -143.14 4.69 1.44 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.3 mmt -134.06 162.94 30.7 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.311 0.645 . . . . 0.0 109.724 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -81.76 -61.12 2.01 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.098 0.159 . . . . 0.0 111.17 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.2 t -167.12 140.45 3.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 122.289 0.236 . . . . 0.0 111.07 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -158.13 178.18 10.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -131.58 144.13 50.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.26 0.552 . . . . 0.0 110.481 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 243' ' ' VAL . 2.4 m -89.02 161.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.51 149.9 34.51 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.166 -0.333 . . . . 0.0 110.738 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.77 150.42 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.748 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 64.2 mt -136.48 104.99 9.22 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.58 175.12 11.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.108 3.205 . . . . 0.0 110.778 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -134.94 148.57 50.07 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 90.9 t -87.45 154.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.442 0.697 . . . . 0.0 110.064 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.69 108.08 3.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.28 28.95 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.543 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.39 -27.83 52.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.166 0.186 . . . . 0.0 110.722 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.8 m 52.11 20.46 1.3 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -144.17 124.25 13.64 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 119.491 1.041 . . . . 0.0 111.962 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -175.41 -171.06 0.46 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.815 1.246 . . . . 0.0 108.323 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.04 166.61 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.605 -0.684 . . . . 0.0 110.477 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -87.11 -29.75 21.61 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.096 0.559 . . . . 0.0 111.225 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 49.7 m -73.08 164.73 58.75 Favored Pre-proline 0 N--CA 1.452 -0.336 0 C-N-CA 123.446 0.698 . . . . 0.0 111.286 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 157.87 14.8 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.589 2.86 . . . . 0.0 111.976 175.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 81.7 p -143.48 25.2 1.7 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.66 0.384 . . . . 0.0 111.075 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -66.2 -18.35 65.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.353 0.661 . . . . 0.0 111.491 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -147.36 153.59 39.85 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.666 0.386 . . . . 0.0 111.226 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.0 mt -142.99 164.79 29.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.597 1.159 . . . . 0.0 109.091 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 14.4 t70 -146.29 130.93 8.83 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.026 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 32.0 Cg_exo -62.19 -20.9 71.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.226 2.617 . . . . 0.0 114.554 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 50.2 m -94.17 -1.92 53.41 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.298 0.499 . . . . 0.0 111.766 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? -106.25 14.28 27.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.318 0.647 . . . . 0.0 110.671 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.2 m -115.08 136.51 53.04 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.94 0.896 . . . . 0.0 108.847 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.44 165.74 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 119.74 -0.171 . . . . 0.0 110.921 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.561 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 52.6 m-85 -92.46 153.02 19.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 19.9 m -146.38 154.39 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 122.79 0.436 . . . . 0.0 110.042 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 166.49 173.93 35.34 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.116 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -161.96 -36.28 0.04 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.934 1.294 . . . . 0.0 108.177 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 423' ' ' LYS . 1.4 pt? -161.57 140.51 9.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.426 1.49 . . . . 0.0 108.257 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 51.67 -174.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 112.163 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 360' ' ' MET . . . 171.37 3.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.403 ' H ' ' H ' ' A' ' 359' ' ' GLY . 1.8 mpp? -80.19 17.91 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.472 0.709 . . . . 0.0 111.513 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.24 169.28 8.96 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.883 0.873 . . . . 0.0 111.629 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -69.15 145.31 53.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 109.582 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.57 61.3 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 122.054 -0.403 . . . . 0.0 110.62 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.16 -18.9 48.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.2 -33.33 38.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 366' ' ' LEU . 1.8 tm? -72.29 -43.54 64.07 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -52.06 -39.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.981 0.512 . . . . 0.0 111.2 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.43 -38.72 29.57 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 29.3 pt -77.92 -26.42 14.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 C-N-CA 120.224 -0.59 . . . . 0.0 112.34 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.3 mt -98.56 -17.76 18.51 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 119.571 1.078 . . . . 0.0 111.521 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -79.24 -19.61 50.27 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.84 0.745 . . . . 0.0 110.246 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -97.94 -28.23 13.9 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.77 -35.03 30.06 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 407' ' ' ALA . 97.0 m-85 -145.85 -17.46 0.46 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.43 -170.23 45.8 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.598 0.635 . . . . 0.0 111.826 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 76.79 0.16 67.73 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.464 -0.631 . . . . 0.0 113.636 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.94 146.19 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 118.237 1.019 . . . . 0.0 110.054 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.7 -7.98 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -162.89 145.05 10.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.7 0.682 . . . . 0.0 111.618 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -124.19 121.5 35.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.173 0.589 . . . . 0.0 109.857 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -118.23 53.25 0.66 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 394' ' ' GLY . 0.0 OUTLIER -82.49 178.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 30.7 t70 62.64 -71.63 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.539 1.536 . . . . 0.0 113.812 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -103.18 136.9 42.11 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -168.53 -34.6 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.836 0.855 . . . . 0.0 110.678 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -82.09 129.13 34.73 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.201 0.6 . . . . 0.0 110.45 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 47.83 36.31 5.76 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.023 0.529 . . . . 0.0 111.57 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.7 pttp 49.0 27.69 1.76 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.204 1.402 . . . . 0.0 113.767 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -134.74 162.5 57.31 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 123.679 0.792 . . . . 0.0 110.167 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.77 143.74 37.26 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.723 2.949 . . . . 0.0 111.881 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.436 HG12 ' C6 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -147.84 -27.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -177.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 94.78 29.02 9.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 118.239 0.472 . . . . 0.0 112.407 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.8 t -110.18 149.91 29.41 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 117.585 0.692 . . . . 0.0 109.92 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 382' ' ' ILE . . . -104.28 139.99 14.78 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -132.94 149.73 52.22 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.58 152.38 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.546 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 57.0 m -137.03 145.44 44.05 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.775 0.43 . . . . 0.0 110.606 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -128.09 173.61 9.92 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.645 1.178 . . . . 0.0 110.297 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -120.03 12.18 11.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.886 0.474 . . . . 0.0 111.479 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -141.0 137.43 33.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.949 0.9 . . . . 0.0 108.577 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -73.42 -29.31 62.49 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.923 0.329 . . . . 0.0 111.27 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -73.85 -42.55 60.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.6 m -72.88 -24.02 60.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -64.88 -65.39 0.68 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.449 0.699 . . . . 0.0 110.96 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.667 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.31 -23.61 54.31 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 118.693 -1.203 . . . . 0.0 112.283 -173.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 74.0 mmtt -77.62 -25.48 49.8 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.75 0.705 . . . . 0.0 111.239 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 374' ' ' PHE . . . -77.01 -47.59 20.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.514 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 405' ' ' LEU . 15.1 m -71.79 -22.18 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.5 t -125.74 1.16 7.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -131.98 4.34 4.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.055 -0.403 . . . . 0.0 111.427 175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.2 56.44 2.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -68.44 -0.46 4.99 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.255 0.622 . . . . 0.0 111.256 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.09 153.28 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.936 0.894 . . . . 0.0 110.931 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.82 143.26 36.64 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 145.43 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 420' ' ' PHE . 38.7 ttmt -142.72 141.24 31.74 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.48 0.312 . . . . 0.0 110.414 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 71.8 p -103.62 31.9 4.15 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.611 0.764 . . . . 0.0 110.272 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 m 64.86 -2.44 0.69 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.352 1.461 . . . . 0.0 113.436 -175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 9.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 416' ' ' LYS . 0.7 OUTLIER -158.89 150.13 20.41 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 31.9 p -129.66 149.85 51.24 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.099 0.409 . . . . 0.0 112.009 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -154.92 157.22 37.43 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.085 0.554 . . . . 0.0 111.276 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 357' ' ' LEU . 6.7 ptpp? -140.84 174.9 10.07 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.633 1.573 . . . . 0.0 107.969 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.4 p -142.05 146.16 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -142.87 158.01 44.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.935 1.294 . . . . 0.0 109.114 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.9 tt -73.3 146.58 10.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.468 0.651 . . . . 0.0 112.034 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -139.79 100.91 7.27 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.59 147.82 41.17 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.545 2.83 . . . . 0.0 113.419 -169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -132.56 7.6 4.16 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 110.536 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.217 -178.539 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.435 " C5'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 110.941 -3.039 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 1 C5'-C4'-C3' 108.033 -4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.402 " H4'" ' CD2' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 O4'-C1'-N19 114.129 5.929 . 0.036 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.469 ' C4 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.927 0 C3'-C2'-C1' 104.462 3.291 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.561 " H1'" ' CE2' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 112.364 4.164 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.7 p -140.48 156.21 46.42 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.75 0.82 . . . . 0.0 109.858 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 223' ' ' GLN . 6.4 t90 -147.37 131.81 17.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.716 0.406 . . . . 0.0 111.98 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 71.5 p -165.56 137.78 4.14 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.04 -0.413 . . . . 0.0 111.132 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.31 18.3 60.57 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.283 -0.732 . . . . 0.0 114.119 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 220' ' ' TRP . 91.1 mm-40 -87.35 5.1 40.28 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.728 1.264 . . . . 0.0 112.182 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -88.02 155.09 52.6 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 122.92 0.488 . . . . 0.0 110.793 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 150.64 38.53 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.187 2.592 . . . . 0.0 110.555 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.52 126.98 11.34 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.131 2.554 . . . . 0.0 110.721 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.43 152.05 38.42 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.812 0.845 . . . . 0.0 109.808 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -156.46 167.16 31.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.808 0.443 . . . . 0.0 111.051 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.73 158.42 16.27 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.246 0.618 . . . . 0.0 109.974 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -113.7 -20.4 11.19 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.763 0.425 . . . . 0.0 111.677 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -150.72 57.46 2.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 122.876 0.47 . . . . 0.0 110.451 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.16 153.66 62.29 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.354 2.702 . . . . 0.0 111.256 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.55 158.04 16.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.702 0.801 . . . . 0.0 109.649 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -82.19 160.57 23.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.6 t -94.41 -174.7 3.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.851 0.86 . . . . 0.0 110.891 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 31.1 p -79.25 0.33 29.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -126.29 157.93 37.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.13 151.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.802 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CZ ' ' CA ' ' A' ' 241' ' ' GLY . 19.8 t80 -118.93 138.55 52.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.676 0.79 . . . . 0.0 110.1 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.13 106.51 10.83 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' CA ' ' CZ ' ' A' ' 239' ' ' PHE . . . -87.8 138.82 15.43 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 114.308 0.483 . . . . 0.0 114.308 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.92 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.428 1.49 . . . . 0.0 112.975 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.9 90.05 16.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 122.726 0.41 . . . . 0.0 110.077 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -79.84 22.34 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.444 3.429 . . . . 0.0 111.154 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -124.42 176.51 6.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.35 0.66 . . . . 0.0 111.893 -173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -80.46 10.94 4.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.06 0.944 . . . . 0.0 112.188 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 13.4 pt -77.38 5.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.8 t -56.31 133.3 52.62 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.742 0.701 . . . . 0.0 110.226 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 61.4 -35.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.355 1.862 . . . . 0.0 114.614 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -85.02 -28.23 25.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.309 0.959 . . . . 0.0 112.409 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.53 -33.68 63.76 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.456 ' HA ' HG22 ' A' ' 255' ' ' THR . 3.1 pp -87.76 -31.19 19.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.967 0.384 . . . . 0.0 111.286 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 250' ' ' ALA . 2.5 p -73.05 -18.67 18.32 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 118.283 0.492 . . . . 0.0 110.613 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.92 -29.23 12.33 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 252' ' ' LEU . 3.2 t -86.85 -12.57 47.48 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.931 0.787 . . . . 0.0 112.076 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.79 10.62 17.85 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.708 0.403 . . . . 0.0 110.194 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.51 118.88 14.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.51 23.1 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.896 0.878 . . . . 0.0 110.592 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 37.9 t80 59.49 10.25 1.81 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.74 -170.16 27.64 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.413 ' HB3' ' CD1' ' A' ' 286' ' ' PHE . 29.0 m -62.84 136.05 57.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 263' ' ' SER . 2.6 tm? -160.17 130.36 5.4 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -171.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 262' ' ' LEU . 22.8 t -134.62 147.84 50.28 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.017 0.437 . . . . 0.0 110.531 171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.83 151.69 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.337 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -139.02 123.95 18.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.948 0.404 . . . . 0.0 110.599 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 267' ' ' PRO . 20.5 t90 -156.85 127.43 3.48 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 266' ' ' TRP . 54.1 Cg_endo -77.77 -5.22 15.21 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 124.123 3.216 . . . . 0.0 112.136 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.59 13.32 82.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.44 83.56 7.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.44 168.21 17.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.332 0.653 . . . . 0.0 111.195 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.11 27.73 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -130.11 174.8 9.45 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.348 0.659 . . . . 0.0 110.888 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 63.7 t-80 -141.01 142.97 29.62 Favored Pre-proline 0 C--O 1.233 0.19 0 C-N-CA 123.048 0.539 . . . . 0.0 110.149 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 273' ' ' HIS . 52.0 Cg_exo -59.99 -19.93 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.642 2.895 . . . . 0.0 114.768 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.23 6.0 2.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.618 0.644 . . . . 0.0 112.724 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.32 160.86 66.46 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 122.824 0.45 . . . . 0.0 110.48 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.17 170.79 7.22 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.359 2.706 . . . . 0.0 110.334 175.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -49.77 150.1 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.778 2.986 . . . . 0.0 112.526 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -142.43 178.83 7.32 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -170.38 -164.5 26.21 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 146.0 44.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.43 158.05 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.233 0.469 . . . . 0.0 111.77 -169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 15.2 m-85 -140.15 171.02 14.76 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.15 0.58 . . . . 0.0 111.642 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.1 tt -149.34 145.46 27.02 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.534 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.81 122.45 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 261' ' ' SER . 0.2 OUTLIER 168.3 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.938 2.095 . . . . 0.0 110.161 167.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 25.23 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.51 1.524 . . . . 0.0 113.551 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.68 24.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.242 1.017 . . . . 0.0 112.358 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -52.78 -33.75 50.13 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.599 1.09 . . . . 0.0 110.939 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -75.77 -25.43 56.45 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.981 -0.449 . . . . 0.0 111.638 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 31.9 t -94.39 -26.92 16.32 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.681 0.393 . . . . 0.0 110.704 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.12 -36.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -82.46 -31.62 29.32 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.947 0.499 . . . . 0.0 111.463 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.6 t -67.13 -35.76 80.43 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.751 0.25 . . . . 0.0 110.443 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.77 -32.26 40.94 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -17.32 64.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 119.664 -0.208 . . . . 0.0 111.053 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.63 -6.18 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -106.59 -23.97 12.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.655 0.661 . . . . 0.0 112.372 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.55 179.73 5.58 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.432 0.56 . . . . 0.0 111.927 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.2 t -72.8 169.09 17.5 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.555 0.742 . . . . 0.0 111.562 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -150.77 154.43 37.32 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-O 121.347 0.594 . . . . 0.0 112.041 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -140.14 131.45 14.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.97 -13.96 42.27 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 124.244 3.296 . . . . 0.0 114.169 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.74 171.93 18.63 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.423 1.011 . . . . 0.0 112.548 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 t -149.69 157.77 38.14 Favored Pre-proline 0 N--CA 1.452 -0.326 0 C-N-CA 125.003 1.321 . . . . 0.0 107.795 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -11.67 7.63 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.052 2.501 . . . . 0.0 112.805 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.76 6.73 47.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.548 0.739 . . . . 0.0 111.694 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 82.81 21.38 59.66 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.678 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.62 162.02 36.56 Favored 'General case' 0 C--N 1.337 0.064 0 CA-C-N 118.701 1.25 . . . . 0.0 112.79 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 80.9 p -80.31 153.6 28.33 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.842 0.457 . . . . 0.0 109.786 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -144.79 165.95 26.64 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 -175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -121.3 163.31 18.81 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.773 0.829 . . . . 0.0 110.076 -176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -149.63 148.14 28.95 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -154.42 171.69 18.93 Favored 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 123.815 0.846 . . . . 0.0 109.169 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -146.91 159.01 44.06 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.554 1.07 . . . . 0.0 112.247 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -118.65 11.11 12.7 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.293 1.037 . . . . 0.0 110.486 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 73.5 m -134.6 41.17 2.93 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.83 0.852 . . . . 0.0 110.88 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.9 p -65.87 -5.25 8.56 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.218 0.607 . . . . 0.0 112.547 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -131.68 15.63 4.86 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.017 0.927 . . . . 0.0 110.588 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -136.87 -17.8 1.4 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.024 0.529 . . . . 0.0 112.182 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.9 tpt -147.34 151.04 35.89 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.553 0.615 . . . . 0.0 110.187 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -82.23 -19.43 39.71 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 38.2 t -151.16 -118.23 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.604 ' CD ' ' C6 ' ' B' ' 1' ' ' ' U' . 0.1 OUTLIER 56.75 37.79 29.05 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.091 0.956 . . . . 0.0 113.141 174.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.08 137.8 58.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.72 144.76 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.43 ' OE1' " H1'" ' B' ' 2' ' ' ' U' . 55.8 tt0 -80.14 101.37 8.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 122.21 38.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.3 mt -139.78 129.1 13.74 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.73 178.24 5.03 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.895 3.063 . . . . 0.0 110.725 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -124.88 154.31 41.27 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 91.6 t -123.93 149.84 28.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 123.208 0.603 . . . . 0.0 110.475 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 333' ' ' LEU . 3.4 tm? -71.05 121.51 18.36 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.906 0.482 . . . . 0.0 110.3 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 336' ' ' SER . . . -160.89 20.81 0.13 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.352 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.09 1.88 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.491 1.117 . . . . 0.0 112.581 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 334' ' ' ALA . 49.7 m 55.47 -16.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.674 2.39 . . . . 0.0 116.215 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -155.58 129.0 8.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 120.239 1.381 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -171.96 -173.4 1.13 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 125.325 1.45 . . . . 0.0 108.999 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.687 HG13 ' H ' ' A' ' 341' ' ' SER . 0.3 OUTLIER -152.83 178.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 121.533 -0.729 . . . . 0.0 110.612 175.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . 0.408 ' H ' HG22 ' A' ' 339' ' ' VAL . 53.4 ptt85 -65.75 -7.28 14.89 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.042 0.937 . . . . 0.0 112.922 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.687 ' H ' HG13 ' A' ' 339' ' ' VAL . 58.3 m -111.03 144.16 29.82 Favored Pre-proline 0 N--CA 1.453 -0.307 0 C-N-CA 123.805 0.842 . . . . 0.0 110.326 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.95 -26.13 11.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.173 2.582 . . . . 0.0 111.241 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 39.5 t -161.41 141.39 10.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.935 0.494 . . . . 0.0 109.839 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -149.59 164.86 33.95 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.947 0.899 . . . . 0.0 109.711 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -81.33 141.44 34.03 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.17 23.39 9.88 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.385 0.674 . . . . 0.0 111.367 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 22.8 t70 -78.09 -33.3 0.96 Allowed Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.0 Cg_exo -54.64 138.83 76.2 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.696 2.264 . . . . 0.0 112.617 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 34.2 m -81.12 30.93 0.32 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.794 0.837 . . . . 0.0 111.327 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 350' ' ' ARG . 1.1 mmp_? -101.46 15.4 28.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.884 0.874 . . . . 0.0 111.522 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.6 m -71.12 142.03 50.77 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.76 161.51 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 122.878 0.471 . . . . 0.0 111.477 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.463 ' CD1' " H1'" ' B' ' 5' ' ' ' A' . 53.1 m-85 -93.11 148.08 22.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 169.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 29.3 m -149.91 167.46 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.153 0.501 . . . . 0.0 110.738 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.09 -28.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.96 0.38 . . . . 0.0 111.927 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 57.3 mt -145.49 -170.76 3.53 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.112 0.965 . . . . 0.0 108.502 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -5.22 10.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -178.5 -19.0 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 C-N-CA 119.369 -1.396 . . . . 0.0 116.353 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.93 168.28 27.6 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.811 1.805 . . . . 0.0 111.699 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 362' ' ' ASN . 6.0 tp -155.72 165.53 36.24 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.39 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.407 ' H ' ' HG ' ' A' ' 361' ' ' LEU . 57.6 t-20 -82.2 135.5 35.25 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.837 0.455 . . . . 0.0 109.823 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.96 -23.52 58.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.247 -0.283 . . . . 0.0 111.321 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.53 -33.1 70.8 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -69.98 -45.84 66.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.84 -37.52 71.39 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 117.898 0.317 . . . . 0.0 111.487 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.66 -53.01 61.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.014 0.37 . . . . 0.0 111.167 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.8 -39.44 51.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.53 -21.93 11.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.775 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.46 -31.87 32.81 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 119.076 0.853 . . . . 0.0 109.755 175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.38 -8.92 59.62 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.033 -0.508 . . . . 0.0 112.194 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -107.38 -19.97 13.41 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 -65.53 1.0 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.971 0.805 . . . . 0.0 111.249 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -161.98 -4.96 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -84.63 -171.54 48.22 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 121.823 0.68 . . . . 0.0 114.008 -170.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -149.93 44.49 0.71 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.71 140.73 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.473 0.709 . . . . 0.0 111.356 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.29 -3.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 C-N-CA 123.527 0.731 . . . . 0.0 110.975 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -158.7 138.16 11.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.764 0.316 . . . . 0.0 111.343 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 152.69 -169.44 31.77 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 121.607 0.559 . . . . 0.0 112.301 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 10.8 mm -119.74 125.24 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.61 148.85 36.81 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 11.9 p -127.59 162.81 25.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.04 16.72 0.21 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 55.81 24.26 7.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.524 ' H ' ' HG3' ' A' ' 390' ' ' PRO . 28.5 t-80 -100.78 -147.24 0.35 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.517 ' H ' ' CG ' ' A' ' 387' ' ' HIS . 99.0 mttt -75.13 73.17 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.521 0.729 . . . . 0.0 111.017 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.422 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 21.2 m-85 58.41 45.27 1.33 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.524 ' HG3' ' H ' ' A' ' 387' ' ' HIS . 97.5 Cg_endo -73.21 -163.21 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.401 3.401 . . . . 0.0 110.664 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.7 tt -165.17 154.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.115 0.966 . . . . 0.0 109.386 -172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -159.45 -32.23 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.413 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 30.8 t -165.15 152.32 10.79 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.942 1.371 . . . . 0.0 111.896 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.63 149.54 46.81 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.741 -0.599 . . . . 0.0 112.201 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -154.1 142.19 20.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 122.648 -0.325 . . . . 0.0 110.343 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 11.1 p -155.55 159.15 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 122.116 -0.365 . . . . 0.0 111.369 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 37.3 m -136.89 143.47 43.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.697 0.799 . . . . 0.0 110.432 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.97 172.98 7.81 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.612 1.165 . . . . 0.0 110.284 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.78 7.46 6.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.869 0.468 . . . . 0.0 111.564 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -122.63 174.47 7.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.249 1.019 . . . . 0.0 109.276 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -110.14 -51.86 2.83 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 122.302 0.241 . . . . 0.0 111.207 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -75.55 -37.23 60.13 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 118.005 0.366 . . . . 0.0 110.761 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 11.0 m -70.95 -23.25 62.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -69.23 -61.61 1.72 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.357 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.468 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.74 -23.61 45.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 119.006 -1.078 . . . . 0.0 112.394 -173.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.5 -28.35 37.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.734 0.697 . . . . 0.0 111.778 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -83.03 -43.78 15.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.396 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.3 p -78.53 -18.09 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.8 t -123.29 -10.01 8.06 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -130.96 5.89 4.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -81.13 46.09 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.294 0.497 . . . . 0.0 110.838 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -70.14 5.95 1.47 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.096 0.558 . . . . 0.0 111.073 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.43 149.62 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.172 0.989 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.72 136.44 48.95 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 64.2 mt -130.76 134.65 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -148.11 162.99 38.28 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.767 0.794 . . . . 0.0 112.261 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -130.47 29.09 4.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.79 1.236 . . . . 0.0 109.394 172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 m 61.69 3.66 0.91 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.295 1.438 . . . . 0.0 113.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -142.47 -0.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.503 0.721 . . . . 0.0 111.719 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -163.17 155.12 17.88 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 30.2 m -132.52 147.32 52.36 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 122.338 0.255 . . . . 0.0 110.414 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -140.02 151.61 45.59 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -139.52 174.08 10.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.81 2.044 . . . . 0.0 107.483 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.5 152.16 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 119.293 0.952 . . . . 0.0 112.073 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -150.28 156.37 41.43 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.369 1.068 . . . . 0.0 109.703 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 12.2 tt -93.17 149.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 123.171 0.589 . . . . 0.0 112.352 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -131.99 91.44 32.6 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.76 27.52 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 1 C-N-CA 125.345 4.03 . . . . 0.0 113.286 -170.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -76.8 4.83 8.84 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 430' ' ' LEU . 3.1 tm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.604 ' C6 ' ' CD ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.674 1 O4'-C1'-N19 112.367 4.167 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.43 " H1'" ' OE1' ' A' ' 327' ' ' GLN . . . . . . . . 0 O4'--C4' 1.418 -2.915 0 C5'-C4'-C3' 109.606 -3.93 . 0.182 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.417 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.624 1 O4'-C1'-N19 114.146 5.946 . 0.231 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.484 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.716 0 O4'-C1'-N19 111.448 3.248 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.463 " H1'" ' CD1' ' A' ' 353' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.801 0 C5'-C4'-C3' 110.098 -3.601 . 0.161 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 38.8 p -62.77 145.47 54.79 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 122.67 0.388 . . . . 0.0 110.653 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -156.29 167.73 29.53 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.389 0.276 . . . . 0.0 110.944 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.0 t -141.72 140.24 33.09 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.088 0.555 . . . . 0.0 110.527 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 72.4 20.45 79.35 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.099 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -94.87 18.64 11.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.376 1.088 . . . . 0.0 112.724 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.4 mm? -73.09 151.37 90.37 Favored Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 122.005 -0.434 . . . . 0.0 110.397 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.51 164.81 34.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.701 2.934 . . . . 0.0 110.884 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.44 166.66 5.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.03 3.153 . . . . 0.0 112.515 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -83.71 144.52 29.31 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -139.15 16.73 2.61 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -142.48 153.11 43.36 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.26 0.482 . . . . 0.0 110.944 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -127.14 140.56 52.17 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.993 0.917 . . . . 0.0 109.084 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -84.86 117.34 68.57 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 122.752 0.421 . . . . 0.0 111.06 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.18 -41.4 7.21 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.061 2.508 . . . . 0.0 113.077 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 22.1 pt -154.45 161.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 118.029 0.377 . . . . 0.0 110.453 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 -177.08 3.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.683 1.193 . . . . 0.0 108.892 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.436 ' HB3' ' HB ' ' A' ' 292' ' ' VAL . 21.6 m 63.9 21.22 12.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 78.4 m -82.15 -11.57 58.66 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.644 0.656 . . . . 0.0 111.456 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -156.46 152.71 27.76 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.743 0.817 . . . . 0.0 108.831 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.65 151.25 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.944 0.402 . . . . 0.0 111.53 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.599 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.6 t80 -130.08 150.1 51.49 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.085 0.954 . . . . 0.0 109.221 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.72 116.53 15.0 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -100.86 176.04 26.86 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 64.15 11.51 45.96 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 118.688 1.244 . . . . 0.0 112.004 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 244' ' ' PRO . 14.0 m -62.76 169.69 3.11 Favored Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.336 1.054 . . . . 0.0 110.857 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 243' ' ' VAL . 82.4 Cg_exo -48.17 160.97 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.323 3.349 . . . . 0.0 114.943 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.409 ' HE3' ' H ' ' A' ' 245' ' ' TRP . 3.8 m-90 -76.96 -0.51 24.64 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.155 1.382 . . . . 0.0 111.988 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -153.08 85.45 1.22 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.28 151.0 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.108 0.48 . . . . 0.0 112.032 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 14.9 t -148.77 -13.46 0.32 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.873 0.869 . . . . 0.0 110.114 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -168.95 -25.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.48 0.712 . . . . 0.0 112.867 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -67.32 -34.68 77.86 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -169.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -71.44 -35.1 63.3 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.4 pp -88.13 -20.39 25.72 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.173 0.487 . . . . 0.0 111.904 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.9 p -82.39 -17.47 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.053 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.22 -33.04 13.43 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.455 HG23 ' CD1' ' A' ' 256' ' ' PHE . 3.0 t -92.75 -8.65 43.17 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.338 0.517 . . . . 0.0 111.831 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.455 ' CD1' HG23 ' A' ' 255' ' ' THR . 94.9 m-85 -121.98 33.16 5.57 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -75.63 115.87 15.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.1 p -152.49 160.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.604 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -84.51 -10.99 56.95 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.51 -169.21 43.53 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 4.3 m -68.88 134.94 50.31 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.489 HD13 ' C ' ' A' ' 262' ' ' LEU . 1.4 tm? -158.37 132.04 7.69 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 63.1 m -144.83 150.98 38.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.501 0.667 . . . . 0.0 111.987 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.63 153.49 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.671 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -140.81 141.95 34.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.439 0.638 . . . . 0.0 110.751 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -136.86 158.59 72.67 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.684 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -59.41 141.38 97.46 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.345 2.696 . . . . 0.0 111.472 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.12 -16.55 1.58 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.971 0.796 . . . . 0.0 112.435 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 50.3 tttm 47.57 31.32 1.98 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 112.131 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.24 146.39 39.06 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.833 0.453 . . . . 0.0 110.903 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.93 -171.74 55.15 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.25 11.72 10.86 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.264 0.626 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -139.85 156.11 70.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 123.948 0.899 . . . . 0.0 109.465 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.56 156.86 44.69 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.887 2.392 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -115.7 -176.26 2.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.239 0.616 . . . . 0.0 110.804 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.8 p -60.39 159.84 21.21 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 122.485 0.314 . . . . 0.0 110.597 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.03 123.05 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.416 2.744 . . . . 0.0 112.52 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.84 51.46 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.872 1 C-N-CA 125.301 4.001 . . . . 0.0 110.861 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.613 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 5.9 tmtm? 61.4 -67.58 0.06 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.782 1.633 . . . . 0.0 113.204 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -171.2 21.5 0.08 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.64 -174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.01 130.78 24.24 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.973 0.886 . . . . 0.0 109.697 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.45 156.26 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.681 0.792 . . . . 0.0 110.367 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.464 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 37.3 m-85 -125.98 162.76 24.51 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.2 tt -152.62 145.53 24.45 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.669 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 286' ' ' PHE . 13.1 p -143.6 175.85 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.587 0.755 . . . . 0.0 110.534 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.585 ' H ' HG22 ' A' ' 285' ' ' VAL 0.292 81.0 m-85 87.93 179.56 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 128.716 2.806 . . . . 0.0 114.305 -173.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 289' ' ' GLU . 22.2 pt-20 -65.97 33.63 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.524 2.73 . . . . 0.0 115.849 -168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.61 25.71 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.814 0.846 . . . . 0.0 110.586 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 287' ' ' GLU . 31.5 tt0 -51.06 -43.93 61.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.53 0.732 . . . . 0.0 111.61 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -79.09 -22.32 45.42 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 29.6 t -85.67 -32.24 22.08 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 235' ' ' SER . 38.8 t -63.47 -50.43 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -72.32 -27.77 62.64 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.559 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 46.8 t -68.09 -36.73 80.27 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.03 0.377 . . . . 0.0 110.366 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.7 -20.98 22.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.839 -0.6 . . . . 0.0 111.067 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.66 -19.75 63.59 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.833 0.742 . . . . 0.0 109.733 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -104.7 -16.09 15.06 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.99 -15.43 22.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.429 0.558 . . . . 0.0 112.21 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 19.5 p -83.6 -178.27 6.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.818 0.447 . . . . 0.0 111.404 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.7 m -83.45 166.86 17.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.289 0.636 . . . . 0.0 110.277 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -138.48 156.35 47.62 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.69 0.396 . . . . 0.0 111.786 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.22 128.32 7.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.79 -6.63 14.51 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.453 2.769 . . . . 0.0 113.512 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -153.87 177.6 10.84 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.937 0.875 . . . . 0.0 112.114 173.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.3 t -149.74 158.45 37.4 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 124.998 1.319 . . . . 0.0 107.721 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.19 -9.09 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.841 2.361 . . . . 0.0 112.567 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.22 0.24 50.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.359 0.664 . . . . 0.0 112.009 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.54 18.38 45.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.121 -0.821 . . . . 0.0 115.143 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.62 162.35 39.3 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.876 1.338 . . . . 0.0 112.722 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.9 p -72.14 145.25 48.24 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.265 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -143.22 170.69 15.26 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.279 0.632 . . . . 0.0 111.066 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -113.82 152.1 31.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.863 0.865 . . . . 0.0 109.376 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -146.37 148.39 32.29 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -152.0 175.99 11.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.393 1.077 . . . . 0.0 109.088 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -148.63 157.11 43.23 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.995 0.816 . . . . 0.0 109.784 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 63.1 mtt -127.29 -160.78 1.03 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 63.3 p -55.83 141.98 36.72 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 m -136.99 163.88 29.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -80.94 170.31 16.42 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.525 0.73 . . . . 0.0 110.308 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.59 7.75 16.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -1.72 11.39 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.949 0.795 . . . . 0.0 113.123 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -152.51 168.22 26.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.43 0.559 . . . . 0.0 111.321 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.1 p -135.59 38.45 2.87 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.041 1.336 . . . . 0.0 108.953 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -57.59 155.98 8.95 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.684 1.193 . . . . 0.0 111.617 -173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.53 138.15 54.36 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 243' ' ' VAL . 1.4 m -70.38 141.98 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -94.33 107.48 19.43 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 49.5 t -95.0 132.91 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.23 126.99 4.95 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -87.54 177.81 3.58 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.545 3.497 . . . . 0.0 112.698 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -132.02 157.63 43.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.026 171.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.04 149.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 122.311 0.244 . . . . 0.0 111.054 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.17 112.46 9.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -159.0 6.16 0.1 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 54.8 t0 56.29 106.54 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 111.682 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.8 m -74.16 4.17 6.02 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -136.49 127.99 28.61 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.921 0.782 . . . . 0.0 111.934 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 363' ' ' ALA . 74.6 t80 -175.16 174.84 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.993 1.317 . . . . 0.0 108.519 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.486 ' CG1' ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -149.45 151.86 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 O-C-N 121.585 -0.697 . . . . 0.0 111.112 171.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -84.93 -3.54 58.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.46 1.104 . . . . 0.0 113.275 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.486 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 47.7 t -71.27 147.64 93.25 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.06 -15.28 17.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.73 2.953 . . . . 0.0 112.898 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.3 m -139.72 158.36 44.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.767 0.827 . . . . 0.0 109.615 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -134.92 152.23 51.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -153.4 156.41 38.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 347' ' ' ASP . 0.3 OUTLIER -142.72 133.2 24.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.457 ' N ' HD13 ' A' ' 346' ' ' LEU . 25.1 t70 -149.98 135.01 9.65 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.89 -7.12 19.61 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.451 2.767 . . . . 0.0 112.82 -175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.6 m -108.52 7.23 26.71 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.11 0.414 . . . . 0.0 110.96 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -132.66 5.82 4.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.155 0.582 . . . . 0.0 111.408 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.8 t -97.17 160.09 14.54 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 39.6 t -143.02 148.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 395' ' ' ARG . 21.4 m-85 -97.54 139.38 33.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.77 139.36 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.813 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -76.75 141.35 26.31 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -155.4 173.29 16.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.342 0.657 . . . . 0.0 109.852 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 357' ' ' LEU . 2.1 pt? -78.54 22.52 0.34 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 112.323 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 30.9 p80 47.36 33.56 2.77 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.806 1.242 . . . . 0.0 112.469 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -61.83 164.23 22.49 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.1 OUTLIER -97.85 24.04 7.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 -175.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.05 153.22 26.01 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.078 0.951 . . . . 0.0 111.32 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -80.11 156.94 26.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.291 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 338' ' ' PHE . . . -66.71 -21.62 66.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.335 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.12 -24.78 60.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.52 -34.32 35.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.72 -36.66 62.69 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.16 -29.61 69.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 122.155 -0.341 . . . . 0.0 111.153 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -80.94 -35.88 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.5 -32.63 37.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 118.433 0.56 . . . . 0.0 110.751 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.28 -32.33 64.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -73.05 -21.08 60.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 119.565 -0.255 . . . . 0.0 111.449 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.96 -24.23 17.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.299 0.5 . . . . 0.0 111.739 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 89.4 mt -101.36 -27.15 13.33 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -149.05 -35.1 0.19 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.731 1.15 . . . . 0.0 114.083 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 70.93 -167.97 50.62 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 79.07 0.24 81.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.269 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.01 149.7 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 117.861 0.83 . . . . 0.0 111.047 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.88 -15.11 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.54 0.736 . . . . 0.0 111.36 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -158.56 143.56 16.24 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.33 19.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.964 0.412 . . . . 0.0 110.756 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 142.43 176.07 16.25 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-O 121.616 0.565 . . . . 0.0 112.218 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.42 130.71 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -73.45 165.27 25.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.441 ' CB ' ' HA ' ' A' ' 389' ' ' TYR . 31.7 p -138.31 168.54 19.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -169.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -65.3 -1.18 2.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.543 1.137 . . . . 0.0 112.886 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 54.76 20.58 3.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.59 1.156 . . . . 0.0 113.774 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.08 -27.97 3.8 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.15 0.58 . . . . 0.0 111.332 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -136.07 0.04 2.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.229 0.612 . . . . 0.0 110.506 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 390' ' ' PRO . 59.6 m-85 51.0 41.19 0.94 Allowed Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 389' ' ' TYR . 35.9 Cg_endo -100.08 -54.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.209 1.939 . . . . 0.0 114.244 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 392' ' ' GLY . 3.5 tp -162.63 155.37 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.603 0.761 . . . . 0.0 110.211 -173.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.446 ' H ' HD12 ' A' ' 391' ' ' ILE . . . 178.48 -38.84 0.08 OUTLIER Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.747 -0.474 . . . . 0.0 112.437 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.1 t -168.53 -150.39 0.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -128.93 152.33 19.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.664 0.665 . . . . 0.0 111.538 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.476 ' HD2' ' CE2' ' A' ' 353' ' ' PHE . 59.0 mtp180 -148.31 154.92 40.64 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.005 0.922 . . . . 0.0 110.506 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.01 153.7 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.022 0.929 . . . . 0.0 109.2 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.9 m -137.99 144.18 40.99 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.582 0.753 . . . . 0.0 109.627 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -126.18 178.18 5.95 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.578 0.751 . . . . 0.0 112.0 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -120.42 3.84 10.75 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.885 0.874 . . . . 0.0 112.071 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -143.98 138.15 28.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -70.88 -24.6 62.52 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -74.59 -44.04 52.68 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 33.9 m -75.99 -19.57 58.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -63.45 -69.43 0.27 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.688 0.795 . . . . 0.0 110.277 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.78 -24.88 48.76 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 118.884 -1.126 . . . . 0.0 112.2 -173.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -71.24 -38.61 71.92 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.57 0.623 . . . . 0.0 110.179 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.54 52.09 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.947 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.26 -20.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.965 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.8 t -115.26 2.34 14.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -129.79 1.55 4.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.04 -0.413 . . . . 0.0 111.175 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -80.53 14.14 2.19 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -71.54 2.63 4.81 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.066 -0.396 . . . . 0.0 111.358 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.89 154.84 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.707 0.803 . . . . 0.0 110.11 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.24 136.4 53.48 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.208 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 81.4 mt -135.06 136.11 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -144.01 149.34 36.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.803 0.441 . . . . 0.0 112.083 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -169.33 147.5 3.7 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.917 0.887 . . . . 0.0 108.912 171.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.1 m 48.9 31.92 3.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.804 0.442 . . . . 0.0 111.693 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 63.07 26.9 15.61 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 112.326 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -115.37 150.81 35.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.5 m -125.84 149.0 48.99 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.558 0.163 . . . . 0.0 111.174 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -141.62 147.53 37.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.798 0.439 . . . . 0.0 111.99 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -144.44 162.89 35.36 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 126.224 1.809 . . . . 0.0 107.58 171.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.15 151.53 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 111.293 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -149.12 154.44 39.21 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.711 0.404 . . . . 0.0 111.42 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.8 tt -66.71 148.33 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.078 0.951 . . . . 0.0 112.922 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -145.95 127.51 7.58 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.887 1.275 . . . . 0.0 108.888 172.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.04 162.46 36.99 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.752 2.968 . . . . 0.0 111.63 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -146.48 154.46 41.59 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.28 0.632 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.257 -1.354 . . . . 0.0 110.152 -178.264 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.613 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.425 -2.304 1 O4'-C1'-N19 113.163 4.963 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.963 1 O4'-C1'-N19 112.3 4.1 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.599 ' C6 ' ' CE2' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 113.357 5.157 . 0.066 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.464 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.794 0 O4'-C1'-N19 111.904 3.704 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 109.789 -3.808 . 0.019 2o . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -85.14 142.07 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 122.719 0.408 . . . . 0.0 110.725 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.437 ' CZ2' HG22 ' A' ' 369' ' ' ILE . 56.1 p-90 -155.26 163.88 39.55 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.978 0.911 . . . . 0.0 109.31 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 416' ' ' LYS . 76.0 p -154.22 160.26 41.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.75 72.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.392 -0.671 . . . . 0.0 114.231 171.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -104.21 2.88 32.23 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.381 1.091 . . . . 0.0 112.635 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -94.85 144.64 28.19 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 118.193 0.452 . . . . 0.0 109.988 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.36 134.02 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.311 2.674 . . . . 0.0 110.865 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.63 -11.82 14.0 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.604 2.869 . . . . 0.0 112.426 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -115.02 128.89 56.54 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.403 ' ND2' HD21 ' A' ' 362' ' ' ASN . 36.9 m-80 -143.64 6.2 1.42 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.916 0.486 . . . . 0.0 111.387 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -142.08 163.74 32.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.629 0.772 . . . . 0.0 109.94 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -134.77 -20.13 1.78 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 122.742 0.417 . . . . 0.0 111.389 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -150.79 58.34 2.89 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 109.982 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.04 160.87 44.82 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.359 2.706 . . . . 0.0 111.56 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 21.4 pt -144.94 157.67 14.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.275 1.03 . . . . 0.0 108.758 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -79.91 147.88 31.48 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.449 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -92.24 177.47 6.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 25.6 p -74.47 8.95 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.067 0.947 . . . . 0.0 112.28 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -126.31 139.84 52.99 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.692 0.678 . . . . 0.0 111.367 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.0 m -145.0 171.83 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.569 0.747 . . . . 0.0 110.948 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -129.26 149.61 50.98 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.837 1.255 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 48.1 tp -134.06 86.18 2.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.649 0.78 . . . . 0.0 109.526 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.05 -175.81 43.82 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 76.48 25.28 65.91 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.006 -0.886 . . . . 0.0 112.595 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 m -112.86 70.78 1.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 118.317 1.059 . . . . 0.0 111.989 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.7 -6.34 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.399 2.733 . . . . 0.0 111.232 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -84.92 3.17 39.41 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.551 0.74 . . . . 0.0 111.67 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.44 47.66 22.19 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.809 1.244 . . . . 0.0 113.417 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.9 23.81 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.8 t -49.21 146.66 3.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.814 1.246 . . . . 0.0 113.01 -170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 60.45 -34.79 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.198 2.199 . . . . 0.0 114.442 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -83.95 -36.38 23.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.459 1.027 . . . . 0.0 111.639 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.22 87.52 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.4 -28.1 56.56 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 1.9 p -78.97 -14.51 13.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 CA-C-N 118.694 0.679 . . . . 0.0 111.025 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.31 -16.8 15.05 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -109.11 -3.46 17.34 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.236 0.925 . . . . 0.0 112.644 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -128.24 6.97 5.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -106.19 58.85 0.65 Allowed 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 121.28 0.562 . . . . 0.0 109.925 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.93 -22.96 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -158.64 -26.95 0.08 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.19 0.45 . . . . 0.0 111.946 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.73 -158.44 29.35 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.3 p 52.59 1.27 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 126.66 1.984 . . . . 0.0 115.48 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 262' ' ' LEU . 3.4 tm? -75.85 125.03 28.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.549 0.613 . . . . 0.0 109.923 -176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.8 t -121.23 143.44 49.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 m -87.66 146.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -128.29 122.12 30.88 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.158 0.504 . . . . 0.0 110.293 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -158.69 129.03 3.48 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.793 1.637 . . . . 0.0 107.194 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.71 -2.42 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.43 2.753 . . . . 0.0 112.006 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 86.07 122.92 1.38 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -141.23 30.78 1.76 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.483 0.713 . . . . 0.0 110.53 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.05 153.61 17.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.71 0.404 . . . . 0.0 111.184 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -146.05 32.22 1.55 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 54.81 39.85 31.64 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.522 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 63.6 t-80 -135.08 145.33 53.87 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 108.494 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 57.2 Cg_endo -64.5 -4.23 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.617 2.878 . . . . 0.0 113.061 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -142.57 156.36 45.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.386 0.539 . . . . 0.0 110.366 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.56 156.63 90.27 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.307 0.643 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.32 159.27 53.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.618 2.879 . . . . 0.0 111.477 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.79 173.76 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.344 3.363 . . . . 0.0 111.532 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.425 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 72.5 tttt 51.51 38.39 22.06 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.156 0.983 . . . . 0.0 112.251 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.8 172.7 55.18 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.29 144.17 30.6 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.33 158.98 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 118.255 0.479 . . . . 0.0 111.517 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CG ' ' C4 ' ' B' ' 4' ' ' ' U' . 0.0 OUTLIER -143.68 173.81 11.34 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.813 -175.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.454 HD22 ' C ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -166.93 171.64 11.02 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.9 140.08 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.808 0.843 . . . . 0.0 109.255 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.45 141.69 16.24 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.957 0.903 . . . . 0.0 110.47 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.4 -3.53 21.35 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -168.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.93 86.97 5.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.217 0.462 . . . . 0.0 111.351 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.23 -26.62 68.48 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -76.86 -20.39 56.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.088 -0.383 . . . . 0.0 111.612 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.2 t -97.18 -26.29 15.0 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.471 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.94 -34.13 68.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -83.52 -28.51 28.6 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 122.365 -0.21 . . . . 0.0 110.659 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.8 t -69.51 -27.69 65.4 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -51.05 63.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.877 0.871 . . . . 0.0 109.949 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.9 mp -76.05 -15.69 60.07 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.343 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -99.81 -12.74 19.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.75 0.705 . . . . 0.0 111.731 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.42 -13.17 24.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.909 0.322 . . . . 0.0 111.064 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.3 m -96.36 162.76 13.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.052 0.541 . . . . 0.0 110.913 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 71.0 m -80.92 173.43 12.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -151.15 153.36 34.84 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.774 0.321 . . . . 0.0 111.339 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -147.25 114.21 4.18 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -91.76 26.77 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 125.982 4.455 . . . . 0.0 113.558 -171.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mp -68.22 -41.17 81.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -167.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 46.8 t -159.26 139.87 9.07 Favored Pre-proline 0 N--CA 1.461 0.1 0 CA-C-N 120.586 1.539 . . . . 0.0 112.855 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.36 1.22 3.19 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.6 2.867 . . . . 0.0 112.063 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.84 18.67 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.552 0.741 . . . . 0.0 111.193 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.41 25.22 9.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 31.5 tp -134.19 9.64 3.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.581 0.752 . . . . 0.0 110.975 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 89.8 p -115.76 39.03 3.12 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.166 0.986 . . . . 0.0 110.348 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.78 -177.39 4.09 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -90.47 159.54 16.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.995 0.918 . . . . 0.0 110.92 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -147.32 149.5 32.94 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -149.53 -163.56 1.81 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.961 1.304 . . . . 0.0 108.162 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.13 155.23 43.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 120.642 -1.286 . . . . 0.0 110.502 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.17 1.09 4.69 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 56.9 m -134.76 142.39 46.72 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.482 0.583 . . . . 0.0 110.909 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.0 p 46.13 -166.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.994 1.718 . . . . 0.0 113.216 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -80.94 -33.36 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -161.96 145.97 12.4 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 123.821 0.848 . . . . 0.0 109.543 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.44 112.5 11.61 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 43.29 -118.13 0.51 Allowed 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.78 19.84 9.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.896 0.878 . . . . 0.0 110.203 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -81.39 153.19 27.08 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 121.892 0.853 . . . . 0.0 112.975 -173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.28 147.51 29.41 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.068 1.747 . . . . 0.0 107.808 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 24.4 m -76.47 148.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.49 136.38 38.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 84.9 t -118.18 126.62 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.46 127.13 15.36 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -85.88 -179.57 3.35 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.972 3.115 . . . . 0.0 111.609 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -123.15 151.51 42.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.41 161.01 25.99 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 117.798 0.272 . . . . 0.0 110.915 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 47.4 tp -44.56 113.42 0.54 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 124.065 0.946 . . . . 0.0 111.07 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -167.62 177.43 5.88 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 123.63 0.581 . . . . 0.0 110.234 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -106.68 -1.84 22.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.227 0.611 . . . . 0.0 110.363 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 16.4 m 57.53 0.17 0.09 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 114.402 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -160.03 143.31 13.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.656 0.782 . . . . 0.0 109.684 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -168.4 164.49 12.81 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.117 0.567 . . . . 0.0 109.61 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.2 t -164.74 162.91 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.2 0.6 . . . . 0.0 109.566 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -102.02 19.77 17.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.123 0.969 . . . . 0.0 112.484 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.563 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 42.4 m -134.17 56.58 19.48 Favored Pre-proline 0 CA--C 1.531 0.222 0 C-N-CA 123.752 0.821 . . . . 0.0 111.149 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -70.4 174.42 10.09 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.79 2.993 . . . . 0.0 111.241 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.4 p 53.6 20.82 2.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.813 1.645 . . . . 0.0 114.292 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -103.13 17.15 24.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.91 0.484 . . . . 0.0 110.895 174.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 59.7 163.0 0.05 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.643 1.577 . . . . 0.0 114.002 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.9 mt -130.58 15.89 5.41 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.364 1.066 . . . . 0.0 109.759 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 348' ' ' PRO . 36.7 m-20 -70.92 -30.7 1.78 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 347' ' ' ASP . 75.3 Cg_exo -54.39 145.94 54.12 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.965 1.777 . . . . 0.0 112.522 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 79.6 p -75.37 9.82 1.94 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.407 0.683 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -83.41 53.59 2.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.206 1.002 . . . . 0.0 110.45 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.6 m -122.56 135.47 54.64 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.796 0.838 . . . . 0.0 108.846 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.64 167.48 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.04 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -112.12 161.16 16.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 160.91 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.017 0.437 . . . . 0.0 110.521 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.06 -134.89 1.75 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.651 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 64.33 -1.18 0.77 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.761 1.625 . . . . 0.0 112.707 -171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 423' ' ' LYS . 53.6 tp -160.6 147.17 15.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -139.49 151.3 46.06 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.513 0.325 . . . . 0.0 110.154 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.3 -155.84 26.44 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -135.88 122.77 21.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -149.54 166.38 29.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.116 0.966 . . . . 0.0 109.093 173.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.403 HD21 ' ND2' ' A' ' 228' ' ' ASN . 64.8 m-20 -73.33 141.93 47.1 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.959 0.409 . . . . 0.0 111.908 -172.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -79.03 -20.86 47.88 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.153 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.86 -29.83 63.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.44 -34.75 61.0 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 366' ' ' LEU . 2.3 tm? -64.23 -45.51 87.86 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 339' ' ' VAL . . . -58.61 -34.98 71.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.962 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -81.42 -39.82 24.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.437 HG22 ' CZ2' ' A' ' 220' ' ' TRP . 33.9 pt -69.89 -26.75 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.62 0.646 . . . . 0.0 110.576 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.4 mt -88.97 -20.37 24.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.543 0.61 . . . . 0.0 111.055 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -75.44 -16.12 60.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -107.97 -27.72 10.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 37.6 tp -74.17 -61.27 1.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.774 0.716 . . . . 0.0 111.413 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -161.84 133.05 5.24 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 64.16 -140.07 43.05 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.51 149.22 14.76 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -104.04 157.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.542 0.737 . . . . 0.0 110.597 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.73 -6.51 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -160.1 133.9 7.16 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -121.94 147.81 45.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.0 0.428 . . . . 0.0 111.233 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -156.5 47.4 0.48 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 382' ' ' ILE . 0.7 OUTLIER -60.01 115.19 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.538 0.735 . . . . 0.0 111.433 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 62.06 -3.49 0.25 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.253 1.021 . . . . 0.0 112.87 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 391' ' ' ILE . 70.2 p -123.3 144.49 49.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.623 0.769 . . . . 0.0 110.984 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -136.91 -178.49 5.21 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.621 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -51.7 154.86 1.83 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.28 1.032 . . . . 0.0 111.243 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -58.81 -11.14 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.476 1.11 . . . . 0.0 113.489 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -73.42 -29.73 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.02 0.827 . . . . 0.0 110.944 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -154.74 58.16 1.94 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.057 0.943 . . . . 0.0 109.819 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.28 168.22 22.85 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.8 2.333 . . . . 0.0 111.217 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 6.2 tp 41.12 78.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.681 1.192 . . . . 0.0 112.198 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.11 -1.26 0.04 OUTLIER Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.69 -1.061 . . . . 0.0 115.212 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 78.9 p -165.26 159.52 17.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.577 1.689 . . . . 0.0 112.536 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -100.02 140.02 14.73 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 57.3 ttp85 -151.49 145.32 25.1 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 117.541 0.671 . . . . 0.0 109.756 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.29 156.4 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.5 m -138.28 142.51 39.83 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.771 0.828 . . . . 0.0 109.88 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.28 179.7 5.15 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.997 0.919 . . . . 0.0 111.476 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -120.08 2.93 10.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.059 0.944 . . . . 0.0 112.148 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -144.33 145.86 32.23 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -73.58 -33.4 64.63 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.547 0.158 . . . . 0.0 111.346 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -76.2 -37.68 57.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.927 -0.483 . . . . 0.0 110.681 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.3 m -74.43 -24.76 59.13 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.59 -66.01 0.6 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.314 0.646 . . . . 0.0 110.782 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.667 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -76.38 -24.67 54.14 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.988 -173.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 64.9 tttp -75.19 -31.1 60.86 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.551 0.614 . . . . 0.0 110.694 -176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -76.17 -44.34 38.55 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.827 -0.546 . . . . 0.0 109.912 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 405' ' ' LEU . 18.2 m -73.67 -17.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 7.7 t -128.9 8.52 5.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -141.21 3.69 1.78 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 41.29 0.46 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.001 0.364 . . . . 0.0 111.323 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.19 14.58 0.88 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.41 0.684 . . . . 0.0 111.303 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 33.9 m -58.95 161.16 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 123.42 0.688 . . . . 0.0 110.73 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.51 84.36 6.38 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.96 -0.463 . . . . 0.0 110.007 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.7 mt -76.61 141.31 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 221' ' ' SER . 36.1 ttmt -151.6 140.71 21.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 45.6 p -89.79 -63.81 1.23 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.4 p -151.84 -36.21 0.13 Allowed 'General case' 0 C--O 1.23 0.053 0 C-N-CA 124.036 0.934 . . . . 0.0 110.548 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -145.55 17.53 1.49 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.707 1.203 . . . . 0.0 111.033 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -144.34 141.73 29.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 44.9 p -119.94 154.17 34.84 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.428 0.291 . . . . 0.0 111.559 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -138.63 149.39 45.16 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.186 0.517 . . . . 0.0 111.279 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.526 ' H ' HD23 ' A' ' 357' ' ' LEU . 68.0 mttm -147.48 166.7 26.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.049 2.14 . . . . 0.0 107.282 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.83 148.99 15.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.949 0.34 . . . . 0.0 111.197 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -137.34 143.85 42.25 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.24 0.616 . . . . 0.0 110.073 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.1 tt -70.4 145.53 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.781 0.832 . . . . 0.0 113.171 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -135.66 98.58 12.07 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.6 154.2 37.95 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.744 3.629 . . . . 0.0 113.786 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.7 148.57 50.79 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.371 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.592 -179.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.425 " H3'" ' HE3' ' A' ' 279' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 O4'-C1'-N19 111.506 3.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 0 C3'-C2'-C1' 104.673 3.526 . 0.309 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 O4'-C1'-N19 113.259 5.059 . 0.169 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.453 ' C4 ' ' CG ' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 O4'-C1'-N19 111.648 3.448 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 1 C5'-C4'-C3' 107.71 -5.194 . 0.579 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 92.4 mtp . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 22.6 p -148.9 126.36 11.6 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.779 0.431 . . . . 0.0 110.428 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -164.81 158.8 17.83 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.582 0.753 . . . . 0.0 110.736 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.6 m -150.62 159.12 44.72 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.417 0.687 . . . . 0.0 110.955 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.24 16.4 79.77 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.521 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -122.09 29.79 6.89 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.171 0.986 . . . . 0.0 111.453 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 224' ' ' LEU . 1.3 pt? -134.21 44.52 1.24 Allowed Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 62.8 Cg_endo -66.15 153.51 77.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.307 2.005 . . . . 0.0 110.242 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 32.1 Cg_exo -61.71 157.64 41.41 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.665 2.91 . . . . 0.0 113.331 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.2 mmt85 -142.63 179.16 7.14 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.115 1.366 . . . . 0.0 108.607 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.36 7.32 0.33 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.743 1.617 . . . . 0.0 115.197 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.85 151.5 52.01 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.205 0.602 . . . . 0.0 110.823 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -151.49 -26.89 0.19 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.353 0.661 . . . . 0.0 110.409 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.15 64.65 7.56 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.739 0.815 . . . . 0.0 109.284 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -70.5 166.22 29.22 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 124.013 3.142 . . . . 0.0 112.078 -176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.84 157.39 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.33 1.052 . . . . 0.0 108.195 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -115.36 155.63 27.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.3 m -86.67 175.15 8.42 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.689 1.196 . . . . 0.0 109.978 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 61.7 m -84.61 28.8 0.64 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.112 0.565 . . . . 0.0 111.836 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -118.01 132.73 56.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.384 0.674 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.2 160.28 4.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 CA-C-O 121.183 0.515 . . . . 0.0 111.064 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -120.4 156.89 30.47 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.624 1.169 . . . . 0.0 110.412 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 28.4 tp -142.35 125.94 16.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 109.529 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -133.19 173.86 20.87 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 91.28 18.6 45.35 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.69 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.98 44.31 0.8 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.321 1.061 . . . . 0.0 113.568 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.36 7.82 3.92 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.285 2.657 . . . . 0.0 112.546 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -80.29 51.98 1.51 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.062 0.945 . . . . 0.0 112.613 -171.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 54.65 28.99 10.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.346 0.658 . . . . 0.0 111.722 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.18 141.55 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.545 0.738 . . . . 0.0 109.958 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 12.6 t -155.62 157.63 37.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 61.09 -35.44 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.021 1.728 . . . . 0.0 114.687 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -72.69 -31.8 65.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.287 0.948 . . . . 0.0 111.403 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.39 -41.05 91.45 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 252' ' ' LEU . 4.2 pp -82.37 -21.74 35.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 117.058 0.429 . . . . 0.0 112.118 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.3 p -84.75 -7.81 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 CA-C-N 118.603 0.638 . . . . 0.0 110.77 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -108.62 -18.89 13.61 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.414 HG23 ' CD2' ' A' ' 256' ' ' PHE . 2.6 t -108.59 -0.48 20.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.403 1.001 . . . . 0.0 112.873 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 255' ' ' THR . 99.0 m-85 -132.57 26.82 4.4 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -84.56 124.25 31.2 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.75 168.1 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.07 -170.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.96 48.71 0.86 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.116 0.967 . . . . 0.0 112.231 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.35 -159.32 10.49 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -67.01 152.36 45.93 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.247 0.524 . . . . 0.0 111.156 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.26 121.64 5.26 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.8 m -136.86 148.14 46.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.846 0.831 . . . . 0.0 111.889 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 17.5 t -87.72 152.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.081 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -139.82 138.82 36.1 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.61 0.719 . . . . 0.0 111.335 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.44 ' CD2' ' HD2' ' A' ' 267' ' ' PRO . 76.8 t-105 -151.17 141.55 14.64 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.768 1.627 . . . . 0.0 107.39 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 42.5 Cg_endo -83.27 -10.5 10.03 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.852 2.368 . . . . 0.0 112.802 -170.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.4 13.63 77.23 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.91 -0.383 . . . . 0.0 112.574 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -83.95 15.15 3.53 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.771 0.829 . . . . 0.0 111.859 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -74.55 165.69 24.78 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.211 0.604 . . . . 0.0 110.754 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.39 1.48 87.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.252 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -146.38 163.88 34.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.439 0.696 . . . . 0.0 110.458 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 23.5 t60 47.35 54.14 15.0 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.703 0.801 . . . . 0.0 112.187 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.32 169.71 20.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.883 3.055 . . . . 0.0 111.21 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.21 157.41 45.47 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.612 0.765 . . . . 0.0 109.833 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -78.51 -52.02 1.43 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.457 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.29 150.55 25.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.157 1.904 . . . . 0.0 110.07 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.8 122.95 7.63 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.283 2.655 . . . . 0.0 109.917 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -156.37 153.18 28.54 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -177.93 169.5 41.42 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.441 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -146.36 156.64 43.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -177.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.22 147.67 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 118.999 0.818 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.471 ' CD2' ' C2 ' ' B' ' 4' ' ' ' U' . 4.2 m-30 -115.06 158.76 21.69 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.837 -0.539 . . . . 0.0 111.452 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.2 tt -146.85 144.99 29.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.474 0.654 . . . . 0.0 112.492 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.6 142.81 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.356 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -163.18 0.95 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.571 0.748 . . . . 0.0 109.774 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.1 9.14 15.85 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -105.18 114.27 28.36 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.81 -32.99 46.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -71.41 -24.11 61.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 111.264 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 24.3 t -78.42 -45.63 21.82 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.48 -43.18 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -67.16 -24.09 65.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.054 -0.404 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 23.7 t -64.35 -53.15 53.16 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.239 0.472 . . . . 0.0 110.47 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -80.9 -10.48 59.71 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.787 0.721 . . . . 0.0 112.656 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.88 -11.94 60.01 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -125.67 6.7 7.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -125.79 -33.91 2.67 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.606 0.639 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 67.5 m -71.04 162.19 29.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.205 0.912 . . . . 0.0 110.726 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 34.8 m -81.39 -164.67 0.8 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.11 0.964 . . . . 0.0 112.105 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 67.1 -149.16 0.17 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.841 1.256 . . . . 0.0 112.087 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.09 125.0 27.15 Favored Pre-proline 0 N--CA 1.461 0.121 0 CA-C-N 118.937 0.789 . . . . 0.0 112.554 -168.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.92 -35.23 12.54 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.907 2.405 . . . . 0.0 112.137 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.447 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -162.62 159.06 24.1 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.39 0.276 . . . . 0.0 111.576 176.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 m -150.9 156.96 35.86 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 123.921 0.888 . . . . 0.0 109.314 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.1 -13.64 20.12 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.5 2.8 . . . . 0.0 112.394 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -88.75 5.8 41.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.71 0.804 . . . . 0.0 111.939 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.32 82.71 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.839 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.41 144.68 54.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.871 0.835 . . . . 0.0 110.519 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.6 m -162.42 80.48 0.52 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.305 1.042 . . . . 0.0 108.587 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -140.94 145.04 35.53 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -129.38 148.5 51.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.14 0.576 . . . . 0.0 110.358 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -135.17 156.04 49.67 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 111.784 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 12.7 t80 -160.82 -163.15 1.01 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 21.7 pttp -145.01 153.88 41.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 119.754 1.161 . . . . 0.0 110.577 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 40.4 tpp -117.8 -3.76 11.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.143 0.577 . . . . 0.0 111.565 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.9 t -149.99 155.54 40.12 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.679 0.392 . . . . 0.0 110.263 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 79.1 p -148.95 5.15 0.66 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.347 0.659 . . . . 0.0 111.115 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -113.52 -15.58 12.54 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.353 0.661 . . . . 0.0 111.435 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -120.64 -7.88 9.57 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.864 0.466 . . . . 0.0 111.16 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 mmt -145.62 149.34 34.33 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.402 1.081 . . . . 0.0 108.981 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -134.7 6.73 3.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.505 0.722 . . . . 0.0 110.878 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 28.3 p -143.9 23.91 1.7 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 111.649 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.582 ' HE3' " C1'" ' B' ' 1' ' ' ' U' . 27.7 mmtm -125.0 156.47 38.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.415 0.686 . . . . 0.0 111.868 -177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -145.95 151.85 38.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.377 1.471 . . . . 0.0 108.835 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.78 162.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -134.81 142.83 46.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.96 144.0 37.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.388 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.36 125.9 10.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -87.37 -176.49 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 125.072 3.848 . . . . 0.0 111.367 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.492 ' CD2' HG23 ' A' ' 384' ' ' THR . 3.1 t-105 -127.13 148.47 50.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.386 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.93 145.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.073 0.949 . . . . 0.0 110.21 -175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 333' ' ' LEU . 1.7 pp -87.72 170.81 10.92 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 111.636 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . 54.59 20.02 2.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.466 0.706 . . . . 0.0 112.726 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -107.59 -152.97 0.49 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.7 0.8 . . . . 0.0 108.957 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 24.5 m 60.49 7.94 1.51 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.354 1.061 . . . . 0.0 112.937 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -159.35 95.55 1.24 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.692 0.797 . . . . 0.0 109.224 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -163.45 152.49 14.4 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.416 0.151 . . . . 0.0 110.695 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 341' ' ' SER . 1.1 t -160.67 158.94 2.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.88 0.371 . . . . 0.0 110.461 169.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -86.91 16.41 4.93 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.947 0.899 . . . . 0.0 111.972 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.491 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 59.0 m -129.03 151.07 77.01 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 123.444 0.698 . . . . 0.0 110.328 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.78 131.74 43.82 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.172 2.582 . . . . 0.0 111.547 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.5 t -162.13 149.61 14.17 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 122.988 0.515 . . . . 0.0 110.167 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -142.24 -21.76 0.69 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.993 0.517 . . . . 0.0 110.793 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -158.6 150.93 21.68 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.815 0.846 . . . . 0.0 108.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 87.3 mt -93.38 140.33 29.68 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 348' ' ' PRO . 20.4 t70 -157.73 -46.48 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-O 118.633 -0.699 . . . . 0.0 112.515 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' A' ' 347' ' ' ASP . 87.4 Cg_endo -75.5 152.64 38.73 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.464 1.443 . . . . 0.0 110.708 -176.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 39.5 m 48.93 -143.8 0.47 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 111.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -141.1 176.61 8.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.972 0.909 . . . . 0.0 109.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.2 t -120.83 156.21 32.42 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 9.7 p -153.2 157.74 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.579 -172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -100.85 151.02 22.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.705 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.58 151.29 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.045 0.45 . . . . 0.0 111.357 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -93.24 154.55 21.89 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' HIS . . . -143.23 31.44 1.37 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.948 0.499 . . . . 0.0 110.326 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 357' ' ' LEU 0.28 2.0 pp 51.99 6.46 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.469 1.907 . . . . 0.0 113.723 -173.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 356' ' ' ALA . 23.4 m-70 -147.26 147.55 30.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.654 1.582 . . . . 0.0 108.108 173.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -87.94 2.93 85.95 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.206 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' A' ' 360' ' ' MET . 0.0 OUTLIER -145.9 134.57 22.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 117.713 0.757 . . . . 0.0 109.411 -174.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.9 mt -166.56 -175.13 3.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.615 1.566 . . . . 0.0 107.437 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -118.65 146.38 44.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.532 0.605 . . . . 0.0 112.051 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.54 61.53 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.09 -36.32 79.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -77.22 -28.94 53.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.523 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.82 -40.96 79.2 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.85 74.22 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.849 0.46 . . . . 0.0 111.058 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -74.12 -46.42 42.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.618 0.19 . . . . 0.0 111.482 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 20.4 pt -68.53 -34.1 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.718 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.68 -25.16 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.26 0.482 . . . . 0.0 110.836 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -70.66 -28.22 64.62 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.134 0.424 . . . . 0.0 110.547 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.77 -24.54 15.41 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.67 -38.76 62.33 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.868 0.467 . . . . 0.0 112.166 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -160.6 -24.37 0.06 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.879 0.309 . . . . 0.0 111.698 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 74.96 -170.29 54.3 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.65 89.25 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.849 -0.417 . . . . 0.0 113.297 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.5 147.12 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 117.843 0.821 . . . . 0.0 110.656 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.96 -11.82 4.14 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 123.092 0.557 . . . . 0.0 111.042 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -158.01 144.7 17.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.483 0.313 . . . . 0.0 110.415 174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 339' ' ' VAL . . . -144.91 165.35 28.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -179.04 152.6 11.34 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.0 mm -120.7 147.61 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.48 118.36 30.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 331' ' ' TRP . 6.5 t -155.32 38.9 0.4 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.855 0.862 . . . . 0.0 110.236 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.14 -178.98 3.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.241 1.417 . . . . 0.0 110.766 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -151.76 17.93 0.69 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -129.85 -30.21 2.05 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.704 -0.622 . . . . 0.0 112.452 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -135.79 -13.95 1.9 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.731 0.812 . . . . 0.0 110.908 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.402 ' HB3' ' HD2' ' A' ' 390' ' ' PRO . 78.4 m-85 -142.38 166.38 21.46 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.102 0.961 . . . . 0.0 109.087 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 389' ' ' TYR . 40.2 Cg_endo -92.35 -169.94 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.961 3.774 . . . . 0.0 110.43 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.431 ' CG1' ' HA ' ' A' ' 384' ' ' THR . 10.9 tt -137.32 157.22 34.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 CA-C-O 120.942 0.401 . . . . 0.0 112.018 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 89.66 15.91 57.51 Favored Glycine 0 C--N 1.339 0.734 0 CA-C-O 119.017 -0.879 . . . . 0.0 112.15 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.1 t -145.2 164.93 29.83 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 118.295 1.048 . . . . 0.0 113.512 -171.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.05 149.66 21.37 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 168.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.21 151.73 48.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 117.731 0.765 . . . . 0.0 110.563 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.0 153.38 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 122.405 0.282 . . . . 0.0 110.957 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 40.3 m -141.88 144.85 34.03 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.813 0.845 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -122.74 170.96 9.54 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.132 0.973 . . . . 0.0 110.926 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -100.03 -5.81 27.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.23 157.32 44.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -80.2 -30.11 38.66 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 122.234 -0.291 . . . . 0.0 110.74 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 -67.21 -41.15 86.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.833 0.288 . . . . 0.0 110.425 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 68.1 p -78.27 -20.31 51.87 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 122.459 -0.151 . . . . 0.0 110.678 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.413 ' O ' HG12 ' A' ' 408' ' ' VAL . 53.6 t80 -64.17 -57.09 10.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -86.37 -21.09 27.39 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.298 0.954 . . . . 0.0 113.202 -174.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -70.27 -40.13 74.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 119.262 0.937 . . . . 0.0 110.022 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.92 -49.94 10.38 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.984 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 404' ' ' TYR . 1.4 p -87.12 -11.66 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.965 0.348 . . . . 0.0 111.633 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -127.97 -5.76 5.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -131.5 -0.83 3.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.732 0.697 . . . . 0.0 112.035 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -74.56 126.44 30.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.638 172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -107.69 17.51 22.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.899 0.88 . . . . 0.0 110.854 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.89 148.72 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.278 0.631 . . . . 0.0 112.207 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -121.81 138.27 54.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 86.3 mt -132.14 149.89 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.543 0.337 . . . . 0.0 110.63 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.65 153.08 49.9 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.538 0.735 . . . . 0.0 110.382 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 24.6 p -125.46 -69.51 0.78 Allowed 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.38 0.672 . . . . 0.0 112.052 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.5 t -143.19 63.58 1.37 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.617 1.167 . . . . 0.0 108.57 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 65.23 38.29 6.03 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.091 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -138.0 154.72 49.31 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.139 1.776 . . . . 0.0 106.72 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 8.3 p -123.13 154.95 37.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.018 0.437 . . . . 0.0 111.844 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -143.2 148.89 37.21 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.072 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -141.19 -175.65 4.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.679 1.591 . . . . 0.0 107.809 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.05 142.43 22.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 118.298 0.499 . . . . 0.0 111.033 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -150.75 142.26 23.49 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.961 0.505 . . . . 0.0 109.945 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.3 tt -84.26 144.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -145.51 136.86 12.7 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.042 0.937 . . . . 0.0 108.891 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.58 124.88 11.6 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.543 2.829 . . . . 0.0 111.577 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -86.99 172.36 10.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.093 0.557 . . . . 0.0 111.063 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.124 -178.077 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.582 " C1'" ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.979 1 C5'-C4'-C3' 109.309 -4.127 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.881 2 C3'-C2'-C1' 105.6 4.555 OUTLIER-DELTA 0.055 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.441 " H4'" ' CD1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.179 0 O4'-C1'-N19 112.069 3.869 . 0.292 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.471 ' C2 ' ' CD2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.605 0 O4'-C1'-N19 112.091 3.891 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.511 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.773 1 C5'-C4'-C3' 108.426 -4.716 . 0.31 2u . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 37.7 p -146.82 144.51 29.39 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.442 0.697 . . . . 0.0 111.064 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -164.53 164.84 21.66 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.424 0.69 . . . . 0.0 109.719 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 56.0 p -155.09 158.24 38.74 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.933 0.493 . . . . 0.0 111.618 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.92 10.2 83.75 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.964 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -103.66 19.33 20.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.501 1.151 . . . . 0.0 112.456 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.16 152.8 95.64 Favored Pre-proline 0 C--O 1.232 0.16 0 O-C-N 121.97 -0.456 . . . . 0.0 110.302 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.96 142.16 97.94 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.267 2.645 . . . . 0.0 112.257 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.74 1.2 9.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.216 3.277 . . . . 0.0 111.964 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -64.68 153.88 38.27 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.792 0.329 . . . . 0.0 111.074 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -151.72 160.94 43.41 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.307 0.643 . . . . 0.0 109.809 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -73.26 149.73 42.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.304 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -108.94 147.03 32.85 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.046 0.539 . . . . 0.0 110.322 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 46.52 58.33 16.6 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.373 0.669 . . . . 0.0 110.906 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.59 152.01 74.87 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.705 2.936 . . . . 0.0 112.383 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 63.5 mt -141.86 139.47 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -99.21 148.57 23.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.9 0.318 . . . . 0.0 111.113 -174.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 33.1 t -97.93 172.76 7.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.877 0.871 . . . . 0.0 110.508 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 28.2 p -68.01 -10.13 51.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.442 0.697 . . . . 0.0 111.95 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -89.63 134.5 34.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.312 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.38 153.49 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.678 0.791 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.6 t80 -125.9 143.23 51.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.932 0.893 . . . . 0.0 110.631 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 5.5 mp -138.42 131.13 29.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -140.23 141.03 11.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.47 ' HA2' H5'' ' B' ' 1' ' ' ' U' . . . 143.17 15.09 0.29 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.476 -0.625 . . . . 0.0 112.765 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.8 m -123.5 65.97 33.84 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 117.921 0.86 . . . . 0.0 112.376 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.17 0.49 9.68 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.798 2.998 . . . . 0.0 110.398 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -72.22 -177.86 2.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 111.874 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -67.58 -4.97 13.29 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.953 0.901 . . . . 0.0 112.279 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.98 149.45 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 O-C-N 121.928 -0.483 . . . . 0.0 110.038 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 250' ' ' ALA . 13.6 t -154.62 135.84 14.0 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 56.63 -14.28 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.378 1.471 . . . . 0.0 113.947 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -81.44 -24.59 36.75 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.513 -0.742 . . . . 0.0 110.948 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.33 64.6 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.64 -29.48 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.765 -0.256 . . . . 0.0 111.226 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 250' ' ' ALA . 1.6 p -78.83 -17.39 13.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.041 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -93.8 -23.99 17.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.071 -0.393 . . . . 0.0 111.977 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.411 HG23 ' CD2' ' A' ' 256' ' ' PHE . 5.9 t -96.12 -4.19 43.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.552 0.615 . . . . 0.0 111.347 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.491 ' CD2' HD13 ' A' ' 284' ' ' LEU . 94.5 m-85 -132.85 35.64 3.55 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.099 0.959 . . . . 0.0 109.662 174.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -65.92 -12.76 57.08 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.67 147.62 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.624 0.37 . . . . 0.0 111.291 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 59.5 -28.44 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.797 2.039 . . . . 0.0 116.036 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.26 14.79 60.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.229 0.922 . . . . 0.0 113.267 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.0 m -95.52 21.8 7.8 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.213 1.006 . . . . 0.0 111.946 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 262' ' ' LEU . 3.2 pp -86.52 169.61 12.65 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.9 m -141.3 147.23 37.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.632 169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.83 148.44 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.327 0.651 . . . . 0.0 109.314 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.55 147.21 34.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.57 0.7 . . . . 0.0 111.87 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -152.42 157.49 33.71 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 125.319 1.448 . . . . 0.0 107.592 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.18 -174.02 2.07 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.077 2.518 . . . . 0.0 111.537 -173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -66.39 16.21 0.26 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.482 1.039 . . . . 0.0 113.921 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -86.2 16.81 4.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.169 0.985 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -62.31 157.56 19.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.696 0.799 . . . . 0.0 111.333 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.7 -172.29 42.88 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.28 -6.59 59.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.542 0.737 . . . . 0.0 111.302 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 63.4 t60 -64.82 145.08 98.97 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 273' ' ' HIS . 75.8 Cg_exo -53.64 158.88 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.729 2.953 . . . . 0.0 113.489 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -85.43 11.84 9.59 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.642 0.777 . . . . 0.0 111.848 -177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 84.4 m -127.03 58.44 29.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.613 0.765 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.35 160.27 50.47 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.252 2.635 . . . . 0.0 110.813 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.61 -14.17 34.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.017 3.145 . . . . 0.0 113.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.518 ' HE3' " H3'" ' B' ' 1' ' ' ' U' . 22.6 tptm -151.88 143.62 23.65 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.289 0.636 . . . . 0.0 109.673 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 175.58 170.35 38.35 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.645 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.468 ' CD1' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -147.51 160.81 42.19 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.067 1.747 . . . . 0.0 106.306 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.7 154.14 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.773 1.169 . . . . 0.0 113.164 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' CE2' ' C2 ' ' B' ' 4' ' ' ' U' . 24.4 m-85 -121.92 166.12 14.91 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.24 0.616 . . . . 0.0 111.465 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.491 HD13 ' CD2' ' A' ' 256' ' ' PHE . 8.9 tt -156.84 146.65 20.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.038 -176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 286' ' ' PHE . 13.6 t -145.05 -178.05 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.635 0.774 . . . . 0.0 109.722 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.703 ' H ' HG12 ' A' ' 285' ' ' VAL 0.3 88.3 m-85 84.12 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.337 2.255 . . . . 0.0 115.299 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -56.36 -0.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.782 2.033 . . . . 0.0 116.162 -166.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.03 11.06 2.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.523 -0.736 . . . . 0.0 111.575 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -52.68 -35.99 56.31 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.42 0.555 . . . . 0.0 111.061 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -78.38 -20.65 50.77 Favored 'General case' 0 C--O 1.231 0.081 0 O-C-N 122.209 -0.307 . . . . 0.0 111.418 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.5 t -87.26 -25.72 23.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 65.0 t -63.69 -43.52 98.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -68.7 -36.07 78.01 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 t -67.33 -38.23 84.55 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 119.751 -0.166 . . . . 0.0 111.076 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 2.9 pp -84.86 -23.56 28.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.98 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 330' ' ' PRO . 1.8 mp -68.39 -17.12 64.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.9 0.773 . . . . 0.0 109.435 172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -94.64 -20.9 19.18 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.039 0.536 . . . . 0.0 110.969 173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -95.96 -14.32 23.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 9.7 p -133.62 162.18 32.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.626 0.648 . . . . 0.0 109.883 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 82.7 p -170.1 170.13 7.6 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -160.16 -44.91 0.05 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.247 0.619 . . . . 0.0 111.135 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -156.37 104.89 2.03 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.44 -16.06 34.64 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.293 2.662 . . . . 0.0 113.976 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.49 165.79 34.69 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 118.919 0.781 . . . . 0.0 112.472 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.5 t -144.41 154.33 56.69 Favored Pre-proline 0 N--CA 1.454 -0.255 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.351 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.16 -11.51 8.03 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.351 2.701 . . . . 0.0 113.485 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -99.66 10.42 41.38 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.236 0.614 . . . . 0.0 111.381 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.75 89.69 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.24 -0.755 . . . . 0.0 114.789 172.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 309' ' ' LEU . 1.6 pt? -94.52 177.2 6.01 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.652 1.226 . . . . 0.0 111.658 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 67.5 p -134.1 160.32 38.15 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.358 1.463 . . . . 0.0 109.15 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -147.68 145.84 29.06 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.084 -0.385 . . . . 0.0 111.339 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -142.3 154.48 44.74 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -141.22 151.99 44.22 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.652 0.381 . . . . 0.0 111.289 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -151.43 -175.7 5.29 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.783 1.633 . . . . 0.0 107.697 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -141.7 163.64 32.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 119.507 1.049 . . . . 0.0 111.809 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 64.3 mtt -133.71 171.27 14.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.342 1.057 . . . . 0.0 109.599 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.5 m -65.9 146.13 55.1 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-O 120.777 0.322 . . . . 0.0 111.238 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 91.9 p -156.14 170.78 21.42 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 123.067 0.547 . . . . 0.0 110.187 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -130.89 18.57 5.07 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.831 0.452 . . . . 0.0 111.272 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 -135.55 -15.89 1.84 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.2 mmm -134.96 162.41 32.5 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.182 0.446 . . . . 0.0 111.225 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -140.32 8.73 2.24 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.411 0.685 . . . . 0.0 111.522 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 27.0 p -146.6 7.99 0.99 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.941 0.337 . . . . 0.0 111.559 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.67 ' HE3' ' C6 ' ' B' ' 1' ' ' ' U' . 15.7 tppt? -85.31 149.45 25.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.793 0.33 . . . . 0.0 110.352 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -140.17 146.59 38.96 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.178 0.991 . . . . 0.0 108.763 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 29.2 m -85.25 141.78 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -82.4 131.59 35.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 56.6 t -119.86 124.67 73.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.4 mt -142.54 125.24 9.13 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.448 ' HG3' HD21 ' A' ' 296' ' ' LEU . 3.5 Cg_endo -89.58 -167.11 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 124.661 3.574 . . . . 0.0 110.172 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -126.63 143.95 51.06 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 333' ' ' LEU . 2.4 p -135.81 -178.37 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 123.219 0.607 . . . . 0.0 109.877 -170.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.541 ' H ' HG22 ' A' ' 332' ' ' VAL 0.255 2.8 pp 54.73 -175.09 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.167 1.787 . . . . 0.0 112.757 177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -125.49 7.48 7.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -169.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.501 ' H ' HD13 ' A' ' 333' ' ' LEU . 58.1 t0 -149.68 115.36 5.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 48.3 m -82.58 7.06 15.63 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.18 148.72 46.76 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.274 0.488 . . . . 0.0 111.214 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -168.96 165.2 11.51 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.076 0.55 . . . . 0.0 110.052 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 341' ' ' SER . 0.9 OUTLIER -156.31 156.36 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.169 0.588 . . . . 0.0 109.7 172.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -100.73 2.52 41.44 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.105 0.962 . . . . 0.0 112.894 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.562 ' H ' HG13 ' A' ' 339' ' ' VAL . 40.2 t -76.22 150.69 83.14 Favored Pre-proline 0 CA--C 1.529 0.154 0 C-N-CA 122.686 0.394 . . . . 0.0 110.666 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.47 -8.49 7.07 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.948 3.099 . . . . 0.0 112.92 174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 40.1 t -121.19 151.41 39.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.11 0.564 . . . . 0.0 110.318 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -135.9 16.63 3.29 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.086 0.954 . . . . 0.0 110.479 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -68.84 159.54 32.28 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.064 0.545 . . . . 0.0 111.305 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 96.8 mt -141.31 159.11 42.91 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.682 0.793 . . . . 0.0 110.825 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -142.75 146.83 39.62 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.542 0.737 . . . . 0.0 109.252 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.52 0.88 8.08 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.312 3.341 . . . . 0.0 112.849 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 80.7 p -129.47 7.96 5.39 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -120.57 14.12 11.81 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.084 0.554 . . . . 0.0 112.293 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 5.4 t -106.85 155.11 20.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.171 0.441 . . . . 0.0 110.924 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.92 155.63 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 C-N-CA 123.685 0.794 . . . . 0.0 108.967 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.425 ' CE2' " H1'" ' B' ' 5' ' ' ' A' . 57.0 m-85 -94.25 140.79 29.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.0 143.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 121.865 -0.522 . . . . 0.0 109.817 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -98.09 134.96 11.92 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -147.2 133.11 19.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.628 0.714 . . . . 0.0 109.763 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 51.0 tp 57.47 -71.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.545 1.538 . . . . 0.0 111.462 -172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -151.22 -0.42 0.37 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.344 1.058 . . . . 0.0 111.141 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 126.67 3.32 6.54 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 123.574 0.607 . . . . 0.0 112.306 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 ttp -151.62 147.34 26.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 118.24 1.02 . . . . 0.0 110.691 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.495 HD22 ' HE3' ' A' ' 422' ' ' LYS . 1.9 tp -158.91 -171.33 3.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 108.42 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -82.73 134.38 35.14 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -73.59 -31.99 63.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -82.47 -11.6 58.39 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 118.433 0.56 . . . . 0.0 110.566 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.0 -34.26 33.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 366' ' ' LEU . 4.6 tt -69.82 -39.53 76.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.94 75.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 122.146 -0.346 . . . . 0.0 111.368 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.04 -39.4 34.06 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 31.0 pt -68.14 -35.03 69.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.894 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.17 -16.32 50.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.036 0.834 . . . . 0.0 110.9 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -72.36 -23.87 61.2 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -107.0 -23.42 12.34 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 11.1 tp -89.54 -14.88 34.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.407 0.549 . . . . 0.0 112.308 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -145.66 -42.74 0.22 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.581 0.352 . . . . 0.0 111.162 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 145.61 -13.93 1.79 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.402 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 151.06 162.21 10.53 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.667 1.233 . . . . 0.0 112.696 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.34 150.24 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 125.186 1.394 . . . . 0.0 108.454 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 21.3 m -95.45 -15.96 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 118.793 0.724 . . . . 0.0 112.948 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -156.47 140.24 16.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.498 0.59 . . . . 0.0 111.546 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.26 160.6 40.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.064 0.545 . . . . 0.0 110.461 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 179.83 145.03 6.2 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 382' ' ' ILE . 0.0 OUTLIER -153.92 100.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.278 0.631 . . . . 0.0 109.959 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -172.21 168.83 5.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.35 1.46 . . . . 0.0 107.266 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 8.9 t -86.24 158.73 19.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.193 0.597 . . . . 0.0 112.512 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.449 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 13.1 t70 -90.19 128.97 36.5 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.829 0.851 . . . . 0.0 110.798 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.417 ' HE2' HG21 ' A' ' 285' ' ' VAL . 49.2 tptt -160.88 148.5 15.67 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.614 0.365 . . . . 0.0 110.547 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 48.3 -80.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.495 1.918 . . . . 0.0 113.639 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.59 3.93 23.34 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 122.815 0.446 . . . . 0.0 111.487 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 41.6 p90 44.19 51.53 8.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.342 1.057 . . . . 0.0 112.519 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.56 -21.34 25.88 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.473 2.115 . . . . 0.0 113.852 -170.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.6 HG23 ' H ' ' A' ' 392' ' ' GLY . 7.7 tt -157.69 -71.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.202 1.364 . . . . 0.0 114.121 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 391' ' ' ILE . . . 81.57 105.2 0.36 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.636 0.636 . . . . 0.0 111.662 -171.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.8 t 53.73 -163.21 0.11 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 124.528 1.131 . . . . 0.0 111.793 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -79.83 141.35 23.4 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -142.8 140.38 31.33 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.52 146.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 35.3 m -141.96 146.18 35.34 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.815 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.13 177.72 7.24 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.998 1.319 . . . . 0.0 110.658 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -106.97 -1.75 21.91 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -148.27 163.55 36.69 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.936 0.494 . . . . 0.0 109.708 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -79.47 -17.34 54.39 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -78.22 -46.46 20.32 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.657 0.662 . . . . 0.0 110.609 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 85.1 p -75.03 -18.89 60.26 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -63.54 -69.03 0.3 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.122 0.969 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.68 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.41 -24.42 50.45 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 118.673 -1.211 . . . . 0.0 111.884 -173.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 410' ' ' ALA . 57.6 tptt -73.41 -31.45 63.87 Favored 'General case' 0 C--O 1.225 -0.212 0 O-C-N 122.193 -0.317 . . . . 0.0 110.583 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.54 -45.39 25.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.658 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.4 m -68.43 -18.46 23.34 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.7 t -129.56 11.34 5.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 406' ' ' LYS . . . -136.05 2.27 2.81 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.369 0.267 . . . . 0.0 110.643 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -83.71 27.83 0.61 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.327 -0.233 . . . . 0.0 111.51 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -72.98 10.25 0.96 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.682 0.793 . . . . 0.0 112.406 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 12.1 p -62.26 151.02 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.539 0.735 . . . . 0.0 110.754 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.18 135.52 35.26 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.6 mt -138.17 147.46 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.485 0.714 . . . . 0.0 109.279 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -138.22 156.25 47.87 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.061 0.457 . . . . 0.0 111.23 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 76.0 p -128.12 21.03 6.3 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.429 1.092 . . . . 0.0 109.952 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 23.6 p 59.42 13.39 3.18 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.532 1.533 . . . . 0.0 112.974 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -134.04 -19.59 1.99 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.518 0.727 . . . . 0.0 111.495 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.4 173.99 14.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 10.6 m -124.85 133.22 53.17 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.495 ' HE3' HD22 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -135.51 160.73 37.56 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -173.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.29 -176.63 5.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.265 2.226 . . . . 0.0 107.395 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.26 153.07 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 CA-C-N 118.309 0.504 . . . . 0.0 110.531 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -138.29 137.33 37.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.698 0.799 . . . . 0.0 110.607 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 426' ' ' ILE . 5.7 tt -66.08 142.52 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 123.723 0.809 . . . . 0.0 111.305 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -152.15 113.36 2.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 123.101 0.561 . . . . 0.0 109.547 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.06 160.67 42.44 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.019 2.479 . . . . 0.0 112.394 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -73.3 171.41 13.09 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.471 0.708 . . . . 0.0 110.463 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 116.997 -1.478 . . . . 0.0 110.72 -179.477 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.67 ' C6 ' ' HE3' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.914 1 C5'-C4'-C3' 108.78 -4.48 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 1 C5'-C4'-C3' 108.745 -4.503 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.468 " H4'" ' CD1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.846 1 O4'-C1'-N19 112.667 4.467 . 0.22 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.456 ' C2 ' ' CE2' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 C5'-C4'-C3' 110.888 -3.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.475 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.418 2 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 119.798 -0.144 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.2 t -83.66 152.85 24.55 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.302 0.241 . . . . 0.0 111.22 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -154.49 170.12 22.17 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.08 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.9 p -152.44 164.63 37.15 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.71 20.89 73.1 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.229 -0.762 . . . . 0.0 114.279 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -128.86 26.7 5.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.464 1.132 . . . . 0.0 112.218 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 224' ' ' LEU . 73.1 mt -110.29 147.88 37.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 122.71 0.404 . . . . 0.0 111.645 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.37 160.33 22.81 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.378 3.385 . . . . 0.0 111.885 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.74 -169.4 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.976 3.784 . . . . 0.0 110.634 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -130.09 114.51 15.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.658 0.783 . . . . 0.0 109.93 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -151.79 156.53 40.41 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.144 0.978 . . . . 0.0 109.581 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 15.4 p90 -154.37 163.19 40.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.746 0.418 . . . . 0.0 110.298 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -77.78 151.36 34.07 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.185 0.594 . . . . 0.0 111.639 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 46.5 55.96 16.26 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.272 1.029 . . . . 0.0 111.778 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.459 ' HA ' ' CE2' ' A' ' 229' ' ' TYR . 92.8 Cg_endo -73.2 156.69 51.07 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.585 2.857 . . . . 0.0 113.192 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 67.2 mt -135.88 138.09 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.48 150.02 47.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 50.9 m 55.78 19.35 3.4 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.433 1.493 . . . . 0.0 114.138 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 24.0 t -61.76 -18.25 59.12 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.395 -0.815 . . . . 0.0 110.989 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.38 154.84 36.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.694 0.798 . . . . 0.0 109.19 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.3 m -145.29 160.88 13.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.43 ' CZ ' " O4'" ' B' ' 3' ' ' ' U' . 9.3 t80 -105.93 145.84 30.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.442 1.097 . . . . 0.0 108.745 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.7 111.87 10.32 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.74 -177.32 48.08 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 75.2 -131.13 11.93 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.4 m 43.71 49.2 4.91 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.978 1.311 . . . . 0.0 113.619 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.84 -8.39 20.19 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.123 2.549 . . . . 0.0 111.828 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -70.01 165.68 21.3 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.894 0.478 . . . . 0.0 110.411 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -67.2 118.98 11.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.314 -0.241 . . . . 0.0 110.542 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 33.2 pt -149.0 170.96 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 110.715 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 9.5 t -143.89 43.34 1.46 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.913 0.885 . . . . 0.0 109.359 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 59.48 11.25 2.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.582 1.153 . . . . 0.0 112.542 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.481 ' HA ' HG12 ' A' ' 253' ' ' VAL . . . -75.43 -21.32 58.27 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.89 -0.506 . . . . 0.0 110.509 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.31 -45.08 62.43 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.99 -30.61 50.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.535 0.667 . . . . 0.0 111.878 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 250' ' ' ALA . 3.4 p -74.51 -19.81 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 118.534 0.606 . . . . 0.0 111.108 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.22 -19.36 14.53 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -102.31 -8.16 21.46 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.979 0.809 . . . . 0.0 112.547 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -123.93 1.97 8.69 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 117.787 0.267 . . . . 0.0 111.12 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -92.56 136.3 33.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.06 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 124.783 1.233 . . . . 0.0 109.033 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.2 p90 53.59 7.55 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.132 1.773 . . . . 0.0 113.899 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -93.46 -159.74 34.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.5 t -68.91 153.82 43.13 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.862 0.363 . . . . 0.0 110.76 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 263' ' ' SER . 0.2 OUTLIER -157.95 128.33 6.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.458 ' N ' HD13 ' A' ' 262' ' ' LEU . 63.8 m -127.12 121.61 31.91 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.37 152.61 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -136.87 137.64 39.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.832 0.825 . . . . 0.0 111.245 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.596 ' CG ' ' HD2' ' A' ' 267' ' ' PRO . 38.5 t-105 -150.73 155.82 35.89 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 106.608 -174.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 266' ' ' TRP . 61.2 Cg_endo -76.71 -161.97 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.489 2.126 . . . . 0.0 110.954 -175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -60.34 -3.42 2.89 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.967 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -78.83 -4.83 51.48 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.88 0.84 . . . . 0.0 110.495 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -65.34 163.45 15.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.669 0.787 . . . . 0.0 111.066 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.71 90.26 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.23 165.41 27.47 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.281 1.032 . . . . 0.0 109.328 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' A' ' 274' ' ' PRO . 57.4 t-80 -68.91 140.11 91.17 Favored Pre-proline 0 CA--C 1.531 0.231 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 273' ' ' HIS . 73.3 Cg_endo -69.18 -9.94 27.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.364 2.71 . . . . 0.0 112.334 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 52.91 30.46 9.26 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.439 1.096 . . . . 0.0 112.885 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 36.1 t 49.57 81.14 0.27 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.134 0.973 . . . . 0.0 111.533 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.97 153.61 72.2 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.318 2.678 . . . . 0.0 110.994 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.11 -13.92 21.06 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.87 3.047 . . . . 0.0 112.04 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -134.05 160.04 38.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.367 0.667 . . . . 0.0 110.207 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -95.71 -126.0 4.86 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.371 0.51 . . . . 0.0 113.083 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 0.0 OUTLIER 63.59 121.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.588 1.955 . . . . 0.0 111.319 -171.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.92 161.14 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.914 0.886 . . . . 0.0 109.874 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.51 ' CD1' ' C4 ' ' B' ' 4' ' ' ' U' . 7.1 m-85 -126.97 160.59 30.61 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 9.7 tt -150.16 143.28 24.94 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 65.7 t -142.52 135.52 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 124.519 1.127 . . . . 0.0 109.091 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -178.76 6.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.319 0.647 . . . . 0.0 111.294 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.45 16.32 18.88 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.077 0.551 . . . . 0.0 112.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.71 72.17 2.63 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.818 0.447 . . . . 0.0 110.103 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -64.25 -18.82 64.92 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.245 -0.285 . . . . 0.0 111.118 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -80.06 -33.54 38.92 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.68 0.673 . . . . 0.0 110.833 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 47.1 t -76.84 -42.98 38.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.2 p -64.25 -37.66 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.83 -20.53 59.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 20.8 t -63.17 -44.45 95.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.211 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.777 ' H ' HD13 ' A' ' 295' ' ' LEU . 0.0 OUTLIER -94.48 -10.54 32.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.46 -11.36 59.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -112.31 -17.15 12.8 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.255 0.622 . . . . 0.0 112.405 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -108.54 -34.31 6.78 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.25 0.477 . . . . 0.0 112.118 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.9 m -85.93 145.14 27.28 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 88.1 p -165.93 162.42 18.18 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -159.93 -54.81 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.212 172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.22 85.46 2.84 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.03 2.14 3.96 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.03 3.153 . . . . 0.0 114.325 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -153.08 168.77 24.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 119.184 0.902 . . . . 0.0 112.873 176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 68.3 m -145.71 175.77 2.57 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.776 1.23 . . . . 0.0 108.881 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.67 -11.6 14.99 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.121 2.547 . . . . 0.0 111.777 170.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -115.64 173.92 6.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.56 1.544 . . . . 0.0 109.171 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -66.12 10.98 0.53 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.001 0.81 . . . . 0.0 113.29 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 42.5 tp -73.26 150.31 42.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.962 0.905 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 59.2 m -139.17 144.15 38.45 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.362 1.065 . . . . 0.0 108.412 172.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -144.15 147.17 33.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.282 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -144.34 154.85 43.45 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -126.38 148.15 49.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.569 0.7 . . . . 0.0 111.882 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -148.26 -165.95 2.41 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.407 1.883 . . . . 0.0 107.222 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -152.92 164.85 37.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.97 1.259 . . . . 0.0 111.73 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 96.3 mmm -125.84 -179.66 4.78 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 0.0 109.922 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 79.7 p -140.97 139.88 34.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.209 0.528 . . . . 0.0 111.593 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -164.76 -165.91 0.99 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.295 1.438 . . . . 0.0 107.592 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -57.44 137.88 55.68 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -91.54 146.11 24.06 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -152.15 -30.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.499 1.119 . . . . 0.0 108.948 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -150.04 178.39 8.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 126.073 1.749 . . . . 0.0 107.948 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 75.4 m -135.07 133.92 39.8 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 325' ' ' GLU . 24.0 tttm -159.24 173.71 15.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 112.517 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' A' ' 324' ' ' LYS . 41.5 mt-10 -117.58 142.23 47.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 168.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 16.4 m -85.34 146.58 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 122.879 0.471 . . . . 0.0 110.293 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -80.83 147.68 30.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 38.3 t -140.54 128.55 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.6 mt -140.96 124.88 10.3 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.18 166.68 10.93 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 124.132 3.221 . . . . 0.0 111.979 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -152.72 165.83 34.07 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.954 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 15.4 m -82.77 169.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 121.765 0.793 . . . . 0.0 111.676 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -32.72 65.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.675 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -69.74 158.82 34.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.95 159.58 34.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.457 1.103 . . . . 0.0 110.388 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 41.0 m -124.88 3.28 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -113.22 138.19 50.35 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 118.464 0.574 . . . . 0.0 109.973 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 339' ' ' VAL . 50.4 t80 -170.22 165.43 9.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.696 0.398 . . . . 0.0 110.382 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 341' ' ' SER . 1.7 t -158.94 153.41 5.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 125.982 1.713 . . . . 0.0 107.539 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -98.56 -15.36 19.54 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 339' ' ' VAL . 42.6 m -77.97 166.48 43.15 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.037 0.935 . . . . 0.0 110.378 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.21 158.49 14.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.505 2.803 . . . . 0.0 111.824 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 86.4 p -128.39 13.34 6.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.161 0.584 . . . . 0.0 111.988 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -87.93 11.43 15.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.199 0.599 . . . . 0.0 111.901 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -123.99 14.38 9.18 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.23 0.612 . . . . 0.0 112.091 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.55 145.57 53.88 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 18.5 t70 -156.56 141.78 12.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.181 -0.438 . . . . 0.0 109.872 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 47.5 Cg_exo -59.49 -21.59 62.44 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.973 2.448 . . . . 0.0 114.17 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.5 m -91.59 9.59 31.56 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.993 0.36 . . . . 0.0 111.362 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -126.41 19.09 7.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.578 0.751 . . . . 0.0 110.462 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 99.6 m -117.4 143.7 45.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.6 p -158.51 160.09 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 395' ' ' ARG . 9.9 p90 -112.18 155.19 24.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.008 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.36 165.8 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.292 0.567 . . . . 0.0 111.602 -172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -156.17 -145.15 4.11 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 67.95 15.55 9.53 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.939 1.296 . . . . 0.0 113.546 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.462 HD22 ' C ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.24 160.63 43.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.893 0.477 . . . . 0.0 110.972 171.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -148.5 141.28 24.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 149.64 3.03 0.28 Allowed Glycine 0 CA--C 1.527 0.781 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.943 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 37.18 47.3 0.64 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.118 1.367 . . . . 0.0 113.834 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -72.49 172.62 10.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.586 0.354 . . . . 0.0 111.497 -178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.5 136.74 55.06 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.54 64.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.886 -0.509 . . . . 0.0 110.787 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.57 -24.63 62.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.81 -26.63 44.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.528 HD13 ' HB1' ' A' ' 380' ' ' ALA . 0.1 OUTLIER -71.06 -44.82 64.98 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -56.7 -31.5 64.55 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.186 0.194 . . . . 0.0 111.089 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.79 -42.59 40.1 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.92 -22.48 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.607 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -19.87 29.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.841 0.292 . . . . 0.0 110.514 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -93.13 -12.22 30.95 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.349 -0.219 . . . . 0.0 111.121 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -111.11 -24.77 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.82 -60.62 2.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.715 0.689 . . . . 0.0 111.066 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -160.21 135.17 7.83 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.044 0.538 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 65.6 -141.35 42.19 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.58 160.18 33.72 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 161.65 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.52 0.728 . . . . 0.0 111.039 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.33 -12.26 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -157.3 134.88 10.63 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 366' ' ' LEU . . . -133.29 153.46 51.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 122.062 0.934 . . . . 0.0 113.401 -175.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -165.83 141.23 6.85 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -148.11 108.62 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -176.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.8 t0 62.78 2.26 0.94 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.063 0.545 . . . . 0.0 109.85 -173.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 391' ' ' ILE . 40.8 p -115.02 149.25 37.73 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.833 1.653 . . . . 0.0 110.871 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.2 166.18 24.83 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.719 0.408 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -81.04 -37.29 29.33 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.756 . . . . 0.0 113.003 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -155.41 -10.03 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -80.26 53.71 1.83 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 44.0 t80 65.29 140.95 0.06 OUTLIER Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 125.975 1.71 . . . . 0.0 108.921 -166.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 389' ' ' TYR . 66.2 Cg_exo -56.89 -13.08 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.015 2.477 . . . . 0.0 114.672 -173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 384' ' ' THR . 32.6 pt -143.19 170.83 9.99 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.848 0.749 . . . . 0.0 112.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 126.98 -4.4 7.38 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.48 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.0 t -171.0 160.6 6.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.783 1.292 . . . . 0.0 112.795 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -110.42 147.39 17.46 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.457 -0.777 . . . . 0.0 111.588 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 353' ' ' PHE . 38.7 ttp-105 -154.22 143.41 21.27 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.027 0.531 . . . . 0.0 109.685 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.22 153.08 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 122.11 0.164 . . . . 0.0 110.669 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 91.8 m -135.86 143.47 45.09 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 110.512 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -124.32 177.49 5.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.264 1.026 . . . . 0.0 111.67 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -119.67 -0.44 10.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.767 0.827 . . . . 0.0 111.295 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -144.92 138.0 26.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 108.724 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.27 -26.2 62.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.323 0.249 . . . . 0.0 111.329 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -72.06 -46.49 56.71 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 117.914 0.325 . . . . 0.0 110.443 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.8 m -72.76 -24.58 60.97 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -60.76 -71.59 0.13 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.177 0.991 . . . . 0.0 110.613 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.668 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.49 -25.01 50.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.391 -172.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -76.37 -24.34 54.15 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.773 -0.58 . . . . 0.0 111.109 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.34 -46.58 14.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.529 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 405' ' ' LEU . 19.3 m -73.42 -15.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.337 0.046 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 8.4 t -128.47 -13.33 4.88 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -123.01 5.4 9.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.29 72.56 4.82 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -77.51 23.96 0.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.604 0.762 . . . . 0.0 111.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 27.5 m -69.17 166.34 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 123.765 0.826 . . . . 0.0 111.889 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -128.1 65.96 1.37 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.458 1.103 . . . . 0.0 108.341 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 73.9 mt -69.02 151.89 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.198 0.999 . . . . 0.0 110.324 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -141.61 136.66 31.23 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.118 0.485 . . . . 0.0 110.745 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 224' ' ' LEU . 4.3 t -149.27 141.06 23.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.9 m 47.67 27.0 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.128 0.489 . . . . 0.0 111.096 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 55.15 34.13 21.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.594 1.158 . . . . 0.0 113.45 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 422' ' ' LYS . 0.1 OUTLIER -99.95 -16.8 17.84 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 3.7 m 59.41 140.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.97 1.708 . . . . 0.0 113.323 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 420' ' ' PHE . 61.9 tttm -138.22 142.75 39.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.135 0.574 . . . . 0.0 112.434 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -142.51 173.41 11.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.039 1.736 . . . . 0.0 107.147 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.7 p -146.59 146.77 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 118.466 0.575 . . . . 0.0 111.247 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.78 136.78 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.839 0.456 . . . . 0.0 110.048 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.31 147.49 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.846 0.858 . . . . 0.0 112.946 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -139.18 105.24 7.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.5 148.19 27.55 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.708 3.606 . . . . 0.0 114.425 -172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -75.64 147.68 39.33 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.565 0.746 . . . . 0.0 110.545 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 430' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.777 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.457 " O4'" ' CE ' ' A' ' 324' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.481 0 O4'-C1'-N19 109.706 1.506 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.485 " H4'" ' CE1' ' A' ' 281' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 109.82 -3.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.43 " O4'" ' CZ ' ' A' ' 239' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.08 2 O4'-C1'-N19 114.153 5.953 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.51 ' C4 ' ' CD1' ' A' ' 283' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.461 0 C5'-C4'-C3' 110.102 -3.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.421 " H5'" ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 O4'-C1'-N19 112.021 3.821 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 stop_ save_